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A highly regio- and chemoselective methodology for the ligand-directed 
palladium-catalyzed C-H activation/acetoxylation of sp3 C-H bonds was developed. The 
reaction was found to be general with a variety of directing groups such as oxime ethers, 
isoxazolines and pyridines. In addition, the reaction exhibited high selectivity for the 
acetoxylation of 1° sp3 C-H bonds.  
The ligand directed palladium-catalyzed C-H activation/acetoxylation of sp2 and 
sp3 C-H bonds was shown to be effective with alternative oxidants such as Oxone and 
K2S2O8 in place of PhI(OAc)2. The use of these peroxide based oxidants over PhI(OAc)2 
is advantageous because they are cheaper and do not release toxic byproducts such as 
iodobenzene. 
A comprehensive investigation to elucidate the factors affecting the C-H 
activation/acetoxylation by one ligand over another was conducted.  It was determined 
that in the presence of multiple chelating functionalities in a reaction, the substrate 
bearing the most basic ligand would lead to the predominant product under our reaction 
conditions. These transformations are believed to proceed via a PdII/IV catalytic cycle. 
Mechanistic studies implicate that ligand directed palladium mediated C-H activation is 
the rate-limiting step in these reactions.  
Finally, Pd-alkyl intermediates generated via aminopalladation were intercepted 
using strong oxidants such as PhI(OAc)2 to afford 1,2-difunctionalized products.  Under 
our optimal conditions, the use of alkenes bearing tethered alcohols, acids, or amines led 












The direct catalytic functionalization of C–H bonds is an important challenge in 
organic chemistry.1-7 Traditionally, the introduction of a functional group in a molecule 
requires a pre-functionalized starting material (Scheme 1.1, pathway a), which might be 
challenging to access in the context of complex molecule synthesis. In contrast, C–H 
bonds are ubiquitous in nature; hence their direct transformation to diverse functional 
groups would be highly desirable (Scheme 1.1, pathway b).  
 
Scheme 1.1: Routes for Introducing Functional Groups (FG) into Organic Molecules 
R FGA R FGB R H




The direct functionalization of C–H bonds is challenging because C–H bonds are 
unreactive and robust. Their low reactivity can be attributed to the fact that they are 
strong, localized, and unpolarized bonds.2, 8 Transition metal catalysis can be used to 
assist in converting C–H bonds to more reactive carbon-metal bonds that can 
subsequently be functionalized to afford the desired product (Scheme 1.2).  
 
Scheme 1.2: Transition Metal-Catalyzed Activation/Functionalization of C–H Bonds 
R H
C–H Activation






There were a number of examples of transition metal-catalyzed C–H 
activation/C–C bond formation prior to our work.9 In contrast, C–H activation/carbon–
heteroatom bond forming reactions were very limited.10 Our initial goal was to develop a 
transition metal-catalyzed mild, regio-, and chemoselective method to convert C–H bonds 
to C–O bonds. This transformation would be very useful because C–O bonds are widely 
prevalent in biologically active molecules. Additionally, the petroleum and chemical 
industries have interest in finding efficient ways to convert inert alkanes into oxygenated 
hydrocarbons.  
Crabtree and coworkers demonstrated the direct transformation of an arene C–H 
bond to a C–OAc bond.11 In particular, they showed that substrates such as 
chlorobenzene can be acetoxylated in the presence of catalytic Pd(OAc)2 and 
stoichiometric PhI(OAc)2. As depicted in Scheme 1.3, a mixture of ortho, meta and para 
regioisomers of the acetoxylated product were obtained. The authors proposed that 
PhI(OAc)2 served as the source of the acetate in the final product, and as an oxidant that 
effects the oxidative functionalization of the carbon-palladium bond resulting from C–H 
activation. While this report was an important demonstration that C–H bonds can be 
oxygenated with readily available catalysts under mild conditions, this reaction was 
limited by its very low yield, the need for large excess of substrate, and the lack of 
regioselectivity.  
 
Scheme 1.3: Palladium-Catalyzed Acetoxylation of Chlorobenzene with PhI(OAc)2 














Our group sought to address the challenge of regioselectivity by employing a 
ligand directed approach for the palladium-catalyzed oxidative functionalization of C–H 
bonds. This strategy involves the use of substrates bearing coordinating functional 
groups, such as L in Scheme 1.4, that can chelate to the metal and direct the activation of 
a proximal C–H bond. We reasoned that the cyclopalladated complex formed upon C–H 
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activation could then be functionalized using electrophilic reagents such as PhI(OAc)2 to 
afford the desired ortho-oxygenated product.  
 


















AcOstep (i) step (ii)  
 
The first step for the proposed reaction, namely ligand-directed C–H activation at 
PdII (cyclopalladation), is well documented in literature.12 One of the earliest reports 
appeared in 1965 with stoichiometric cyclopalladation of azobenzene (Scheme 1.6).13 
Since this report, there have been examples illustrating cyclopalladation with a variety of 
directing groups such as pyridines, amines, amides, and oximes. Additionally, Miura,14 
Sames,15 Fujiwara16 and others have effectively employed the ligand-directed approach 
for palladium metal catalyzed C-H activation/C–C bond forming reactions. The 
feasibility for the oxygenation step is supported by the palladium-catalyzed arene 
acetoxylation reaction discussed above (Scheme 1.3). 
 










In 2004, our group reported that the approach shown in Scheme 5 provides an 
efficient route to the ligand-directed acetoxylation of arene C–H bonds.17 This 
methodology was shown to be general with respect to a wide variety of directing groups 
such as pyridines, pyrazoles, and azo-linkages to afford the acetoxylated products in good 
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yields (Scheme 1.7).18 Importantly, these reactions were highly selective for 
functionalization of the C–H bond adjacent to the chelating group. 
 



























This reaction was proposed to proceed through a PdII/IV catalytic cycle.17, 19 As 
shown in Scheme 1.8, the key steps of the catalytic cycle are proposed to involve: (i) 
ligand directed C–H activation to afford the cyclopalladated complex A, (ii) oxidation of 
A by PhI(OAc)2 to generate the PdIV intermediate B, and (iii) C–O bond-forming 
reductive elimination from B to release the desired acetoxylated product and regenerate 
the PdII catalyst. 
 
















A B  
 
All of our group’s initial work in this area involved functionalization of arene C–
H bonds using PhI(OAc)2 as the terminal oxidant.  As such, the goals of my research (as 
outlined in this thesis) were as follows: 
  
Chapter 2: To extend this methodology to the oxidation of sp3 C–H bonds (Scheme 1.9). 
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Chapter 3: To explore the use of alternative oxidants (particularly peroxides) in place of 
PhI(OAc)2 for Pd-catalyzed directed C–H activation/oxidation reactions (Scheme 1.10). 
 
















Chapter 4: To determine the factors that control which ligand will direct C–H 
activation/functionalization when multiple potential chelating functionalities are present 
in solution (Scheme 11). 
 











Chapter 5: To oxidatively intercept Pd-alkyl intermediates, generated via 
aminopalladation of alkenes, to form 1,2-difunctionalized products (Scheme 1.12).  
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Palladium-Catalyzed Acetoxylation of sp3 C-H Bonds 
 
 
2.1 Background and Significance 
 
 
Alkane carbon-hydrogen (C–H) bond activation and functionalization has been a 
formidable challenge in synthetic organic chemistry. In general, sp3 C–H bonds are much 
more difficult to activate than sp2 C–H bonds. The unreactive nature of alkanes is 
attributed to (i) the lack of available lone pairs, empty orbitals of low energy, or filled 
orbitals of high energy, (ii) the low polarity of these substrates, and (iii) the high 
homolytic and heterolytic strength of C–H bonds (typical bond dissociation energies 
range from 90-110 kcal mol-1 and pKa values are greater than 40).1, 2  In addition, the 
metal-alkyl intermediates that are generated upon C–H activation (for example, A in 
Scheme 2.1) are typically susceptible to β-hydride elimination. Alkanes are ubiquitous in 
nature, and are found in diverse organic compounds, including petroleum, natural gas, 
organic polymers, natural products, pharmaceuticals, and agrochemicals. Hence, 
developing a methodology for the direct functionalization C–H bonds in alkanes could 
have a great practical impact on a variety of different fields.  
 















Many research groups have attempted to address the challenge of alkane 
oxidation.3 One of the most promising approaches to alkane C–H 
activation/functionalization involves the use of group 10 metal (Pt and Pd) catalysts. 
Although several promising systems have been developed, most are not suitable for 
practical use. The most prominent early example comes from the 1970’s by Shilov and 
co-workers.4 They demonstrated that sp3 C–H bonds of simple alkanes such as methane 
could be functionalized to C–O bonds using catalytic PtII salts in conjunction with 
stoichiometric PtIV-based oxidants (Scheme 2.2).  
 



























(1) (2) (3)  
 
While the mild conditions and simplicity of the catalysts in these reactions are 
remarkable, the utility of this transformation is limited by (i) the requirement of 
stoichiometric amounts of PtIV and (ii) low selectivity. For instance, pentane is converted 
to pentyl chloride with only 56% terminal selectivity (Scheme 2.3).5 Chlorination at other 
positions on the alkyl chain was also observed. Despite its limitations, this platinum 
system shows potentially useful features and would be rendered more practical if the PtIV 
could be replaced with another strong oxidant. 
 








56% selectivity  
 
An important recent advancement in Pt-catalyzed alkane oxidation was reported 
by Periana in 1998.6 This report demonstrated the oxidation of methane to 
methylbisulfate using a PtII catalyst (bpym)Pt(Cl)2 (bpym = bipyrimidine) in fuming 
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sulfuric acid with SO3 as the terminal oxidant (Scheme 2.4). The mechanism of this 
reaction is proposed to involve: (i) electrophilic C–H activation to afford a platinum alkyl 
complex, (ii) oxidation by SO3 to afford a PtIV species, and finally (iii) reductive 
elimination from this PtIV intermediate to provide methyl bisulfate. This reaction is 
attractive due to its high yield (90%) and selectivity (81%). Installation of an electron 
withdrawing sulfonic acid group protects the product from further oxidation. However, 
the utility of this reaction is limited by the requirement of fuming sulfuric acid and high 
temperatures (200 ºC). Other hydrocarbon substrates, under these harsh conditions, result 
in low turnover numbers and low levels of regio- and chemoselectivity.  
 















Sames has reported some of the earliest examples of group 10 metal catalyzed 
alkane C–H functionalization, addressing regioselectivity by using a directing functional 
group.7, 8 As shown in Scheme 2.5, directed arylation of ortho-tert-butylaniline with 
phenylvinylsilanol was achieved in the presence of catalytic Pd(OAc)2 using Cu(OAc)2 
as a terminal oxidant. A mechanism involving dual coordination of the imine and the 
thioether to Pd was proposed to lead to the high selectivity for the 1º C–H bond. Though 
catalytic, the reaction is limited by its modest substrate scope. For example, replacing the 
tert-butyl in 6 with an iso-propyl moiety resulted in only trace amounts of the desired 
product 9 (Scheme 2.5).  
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4 mol % Pd(OAc)2










4 mol % Pd(OAc)2






(8) (9)  
 
Sames has also reported one of the first examples of heteroatom-directed 
oxygenation of sp3 C–H bonds involving the PtII-catalyzed selective functionalization of 
α-amino acids in water.9 As shown in Scheme 2.6, this report demonstrated that 
subjection of valine to 5 mol % K2PtCl4 and 7 equiv CuCl2 in water at 160 ºC resulted in 
56% NMR yield of lactone 11. The reaction was proposed to proceed via chelate-directed 
electrophilic C–H activation by PtII followed by oxidative functionalization to form the 
C–O bond. Although this reaction is an important advancement in directed 
functionalization of alkyl groups in complex substrates, its utility is limited by the 
moderate yields and the harsh reaction conditions (particularly the high temperatures and 
the requirement for large excesses of oxidant). Importantly, there were no examples of 
palladium-catalyzed directed sp3 C–H activation/C–O bond formation when we started 
this project. 
 




5 mol % K2PtCl4
7 equiv CuCl2





(10) (11)  
 
We aimed to address the challenge of C-H activation/functionalization of sp3 C-H 
bonds by employing the PdII/IV catalyzed methodology developed for functionalization of 
sp2 C–H bonds (Chapter 1, Scheme 1.7). The key step in the sp2 C–H bond 
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functionalization reaction is the oxidative interception of a palladium-aryl intermediate, 
generated upon C–H activation, with PhI(OAc)2 (Scheme 1.8, Chapter 1).10 Our goal was 
to generate an analogous palladium-alkyl intermediate 13 via ligand-directed sp3 C–H 
bond activation (Scheme 2.7). Oxidative cleavage of the Pd–C bond in 13 with 
PhI(OAc)2, would then allow us to install an OAc group at the sp3 carbon center via the 
PdIV intermediate 14.  
 


























(12) (13) (14) (15)  
 
While Pd-catalyzed directed sp3 C–H activation/oxygenation reactions were 
unprecedented prior to our work, several previous reports had described stoichiometric 
versions of this transformation.11-13 For example, Baldwin and co-workers illustrated that 
the reaction of pinacolone oxime 16 with stoichiometric K2PdCl4 leads to the formation 
of palladacycle 17 via ligand directed activation of a terminal C–H bond of the tert-butyl 
group. Subsequent oxidation of 17 with Pb(OAc)4 was then shown to form the 
acetoxylated product 18 (Scheme 2.8).11 
 
















(17) (18)(16)  
 
Although this reaction demonstrates the viability of directed sp3 C–H bond 
activation, it is impractical for several reasons. First of all, it is stoichiometric in both an 
expensive PdII salt and a highly toxic PbIV salt. Second, it has a very limited substrate 
scope. As shown in Table 2.1, methylated cyclohexanone oximes 19 and 21 and the 
steroid derivative 23 were the only substrates that were successfully acetoxylated by 
 12 
Baldwin using this method. In contrast, isolable palladacycles could not be obtained for 
substrates that lacked α-branching (for example, 25 in Figure 2.1), for substrates in which 
the C–H bond and the directing group were not coplanar (for example, 27 and 28 in 
Figure 2.1), and for substrates that were susceptible to β-hydride elimination upon C–H 
activation (for example, 25 and 26 in Figure 2.1). 
 































Conditions: (i) Na2PdCl4, (ii) pyridine (iii) Pb(OAc)4 and (iv) NaBH4  
 











(27) (28)  
 
Based on this early report, we aimed to develop an efficient palladium-catalyzed 
method to acetoxylate sp3 C-H bonds that was directed by ketone or aldehyde-derived 
directing groups. We wanted to use a terminal oxidant that was less toxic and more 
practical than Pb(OAc)4. Additionally, in order to make this reaction general for a wide 
variety of substrates, we hoped to develop reaction conditions under which the relative 
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rate of oxidative cleavage of the Pd–C bond in 13 was faster than the undesired β-hydride 
elimination reaction (Scheme 2.9). 
 



















Importantly, the proposed methodology could potentially allow access to β-amino 
alcohols, β-hydroxy ketones, and functionalized β-amino acids (Scheme 2.10). It could 
also provide a tool for the synthesis and functionalization of alkaloids and polyketides as 
well as other classes of natural products. The ability to selectively functionalize a variety 
of C–H bonds to C–O bonds could also allow for the efficient synthesis of drug 
molecules to be tested in structure-activity relationship (SAR) studies. Finally, the 
insights gained from this palladium-catalyzed ligand–directed oxygenation of sp3 C–H 
bonds could then potentially be applied towards functionalization of alkane C–H bonds 
without the use of directing groups. This would then allow us to address an important 
challenge of methane oxidation to methanol. 
 



























2.2  Initial Results 
 
Our studies began with using pinacolone oxime 16 as the substrate. This choice 
was based on Baldwin’s results, which demonstrated the successful oxygenation of the β-
C–H bond of 16 using stoichiometric K2PdCl4 and Pb(OAc)4 (Scheme 2.8).12 We first 
subjected 16 to the reaction conditions developed in our lab for sp2 C–H acetoxylation (5 
mol % Pd(OAc)2, 1.5 equiv PhI(OAc)2 in AcOH at 100 ºC). However, under these 
conditions we obtained none of the desired oxygenated product 18 and instead recovered 
the deprotected ketone 29 (Scheme 2.11). This indicates that the relative rate of 
deprotection of the oxime was faster than the rate of oxime-directed C–H activation at 
PdII. The ketone product of this deprotection is then expected to be a poor ligand for 
palladium, and hence unable to direct the functionalization. 
 















This result suggested that in order to achieve the desired catalytic oxygenation 
reaction, we would need to prevent deprotection of the oxime. As depicted in Scheme 
2.12, a key step in the proposed mechanism for this deprotection involves nucleophilic 
attack of the oxime hydroxyl group on the iodine.14 Based on this mechanism we 
hypothesized that replacing the hydroxyl group with an alkyl ether might attenuate the 























Based on this analysis, the oxime ether substrate 30 was synthesized and 
subjected to the catalytic reaction conditions (5 mol % Pd(OAc)2, 1.5 equiv PhI(OAc)2 in 
AcOH at 100 ºC). Gratifyingly, the desired monooxygenated product 31 was obtained in 
14% isolated yield along with the corresponding di- (34%) and tri-acetoxylated 
compounds (15%) (Scheme 2.13). Notably, the use of an excess of PhI(OAc)2 (4.5 equiv) 
increased the yield of the tri-oxygenated product 33 to 59%. 
 






















2.3  Substrate Scope of Pd-Catalyzed Acetoxylation of 1º sp3 C-H 
Bonds  
 
Highly Branched Substrates. We were pleased to find that ligand-directed Pd-
catalyzed C–H bond activation/acetoxylation was general with respect to a variety of 
directing groups (Table 2.2).15 My colleague Kami Hull demonstrated the use of pyridine 
directing groups in these reactions, while my work showed that oxime ethers (34-38) and 
isoxazolines (42-48) are also effective in mediating the desired acetoxylation reaction. 
Furthermore, acetoxylation was achieved in systems that proceeded via either a five-
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membered (entries 1-6) or a six-membered palladacyclic intermediate (entry 8). Unlike 
substrate 48, the six-membered cyclopalladation is not facile with unactivated C-H bonds 
such as in substrate 46. Selectivity between mono-, di- or tri-acetoxylated products could 
be tuned by changing the stoichiometry of the oxidant. For example, the di- and tri-
acetoxylated products 43 and 45 were formed in 45% and 55% isolated yields using 
either two or three equivalents of PhI(OAc)2, respectively. Importantly, control reactions 
(in the absence of Pd catalyst) were run for each substrate, and generally showed no 
reaction under our standard conditions. 
Interestingly, the C–H bond in camphor methyl oxime ether 34 was successfully 
acetoxylated (entry 1). This is particularly notable because Baldwin was unable to obtain 
an isolable palladacycle with this substrate. We believe that 34 affords the product under 
our reaction conditions because, unlike in stoichiometric experiments, a catalytic reaction 
does not require that the palladacycle have an appreciable lifetime. Instead, it just needs 
to be generated transiently and then can be intercepted by the oxidant to afford the 
desired product.  
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Table 2.2: Scope of Pd-Catalyzed Directed sp3 C–H Activation/Acetoxylation with 










































a Conditions: 5 mol % Pd(OAc)2, 1.5 equiv PhI(OAc)2, AcOH, 100 °C; 
b 2.0 equiv PhI(OAc)2 were used






















Substrates Containing β-Hydrogens. The substrates presented in Table 2.2 do not 
bear hydrogens α to the carbon being functionalized. Hence, β-hydride elimination from 
the palladacyclic intermediate is not a potential competing reaction in these systems. As 
such, we next turned our attention towards substrates that could undergo β-hydride 
elimination following C–H activation. We wanted to explore whether the relative rate of 
oxidative cleavage of intermediate 13 would be faster than the undesired β-hydride 
elimination under our reaction conditions (Scheme 2.9).  
 We first synthesized the oxime ether of methyl cyclohexanone. We were pleased 
to find that subjection of this substrate to our reaction conditions did not afford any of the 
β-hydride elimination product 53. Furthermore, the desired acetoxylated product 51 was 
obtained from this reaction, albeit in a modest yield of 4% (Scheme 2.14). This low yield 
was due to competitive formation of the corresponding ketone 52. 
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Scheme 2.14: Pd-Catalyzed Reaction of Cyclohexanone Methyl Oxime Ether with 




















The ketone 52 was not formed via oxidative deprotection of the directing group, 
since substrate 50 also reacted to generate 52 in AcOH in the absence of PhI(OAc)2. 
Instead, we theorized that since 50 is less sterically hindered than the previously studied 
substrates, it was simply undergoing hydrolysis in the reaction medium. This result 
suggested that the addition of acetic anhydride (Ac2O) might be used to sequester the 
water in the reaction mixture and hence prevent this competing hydrolysis. In order to 
probe this hypothesis, we subjected substrate 50 to the catalytic reaction conditions using 
50% AcOH/50% Ac2O as the solvent in place of pure AcOH. We were delighted to find 
that these conditions afforded the acetoxylated product 51 in 81% yield. 
 
Scheme 2.15: Pd-Catalyzed Reaction of Cyclohexanone Methyl Oxime Ether with 











(50) (51)  
 
These optimal reaction conditions were general for a variety of other substrates 
containing β-hydrogens (Table 2.3).15 Importantly, products resulting from β-hydride 
elimination were not observed for any of these substrates, indicating that the oxidative 
cleavage of the palladacyclic intermediate out-competes β-hydride elimination in these 
systems. Interestingly, substrates that did not afford isolable palladacycles in the Baldwin 
system were successfully functionalized under our catalytic conditions (entries 1 and 3).11 
Additionally, substrates lacking branching at the α-position (54) were also acetoxylated. 
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Such systems were challenging to functionalize under the reaction conditions developed 
by both Baldwin and Sames.  
 
Table 2.3: Scope of Pd-Catalyzed Directed sp3 C–H Activation/Acetoxylation with 
PhI(OAc)2: Substrates with β-Hydrogens 
(54) (55)












































































In the isoxazoline substrates containing a stereocenter, the functionalization of 
diastereotopic methyl groups proceeded with no selectivity. However, after our initial 
findings, Yu reported 82% de in the Pd-catalyzed acetoxylation of prochiral methyl 
groups in oxazoline substrate 70.16 Notably, substrates in which the tert-butyl group on 
the tertiary carbon was replaced with other alkyl groups or ethers exhibited lower dr 
values ranging between 18% and 60%. Based on these results, it appears that both the 
location of the stereocenter within the substrate as well as the steric nature of the 




Scheme 2.16: Palladium-Catalyzed Acetoxylation of Prochiral Methyl Groups with 
Lauroyl Peroxide  
 5 mol % Pd(OAc)2
2 equiv Lauroyl peroxide
 Ac2O













Conformational Effects on Reactivity. While conducting these studies we made an 
interesting observation regarding the reactivity differences between substrates 50 and 60. 
Both these substrates lead to similar yields of the corresponding products 51 and 61. 
However, while reaction of substrate 50 took 3 h to reach completion, reaction of 60 was 
finished in only 5 min. This dramatic difference can be rationalized based on the relative 
amounts of the reactive conformers of 50-eq and 50-ax in solution (Scheme 2.17). 
Methyl cyclohexanone 50 exists in two conformers of similar energy that are at rapid 
equilibrium – one in which the methyl group is in the equatorial position (50-eq) and one 
in which the methyl group is in the axial position (50-ax). However, only conformer 50-
eq has the C–H bond of the methyl group co-planar with the oxime, the geometry 
required for cyclopalladation. In contrast, substrate 60, possessing a tert-butyl group on 
the cyclohexane ring, essentially exists only as the more reactive conformer 60-eq with 
the β-C–H bond coplanar with the oxime ether.  
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Regioselectivity. We were next interested in exploring the relative preference for 
functionalization of 1º relative to 2º sp3 C–H bonds under our reaction conditions. In 
addition, we wanted to compare the selectivity for the functionalization of sp3 C–H bonds 
that are four versus five bonds away from the chelating group. Substrate 72 was 
synthesized in order to investigate both issues. This substrate possesses three potential 
sites for C–H activation: (i) a 2º β-C-H bond (Ha), whose activation would lead to the 
formation of a five-membered palladacycle intermediate 73, (ii) a primary β-C-H bond 
(Hb), whose activation would also afford a five-membered palladacycle 74, and (iii) a 1º γ 
C–H bond (Hc), whose activation would afford the six-membered palladacycle 75 
(Scheme 2.18). When 72 was subjected to our reaction conditions, we were pleased to see 
that C–H activation/acetoxylation proceeded with very high selectivity. This reaction 
afforded 78% isolated yield of a single product (77), in which a 1º β-C–H bond was 
acetoxylated. This result indicates that directed C–H activation at Pd(OAc)2 shows a high 
preference for 1º over 2º C–H bonds. Notably, the observed selectivity is much higher 
than that in the Pt-catalyzed Shilov system.4 This selectivity is complementary to that 
obtained using other C–H functionalization methods that proceed by radical or cationic 
mechanisms.1, 17, 18 In addition, the results in Scheme 2.18 show that there is a preference 
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for the formation of five-membered palladacycles over six-membered palladacycles. This 
preference is further exemplified by the lack of reactivity of substrates such as 64 (Table 
2.3) and 46 (Table 2.2). Notably, although formation of both 5- and 6-membered 
palladacycles is reported in literature,19 generally a preference for 5-membered 
metallacycles has been noted. It has been reasoned that this could be due to the 
requirement of a square-planar coordination environment at the metal. Six membered 
palladacycles have been achieved when (i) C-H bonds that can form five-membered 
metallacycle are absent and (ii) steric features of the substrate influence metallacycle 
formation.19 
 









































Cyclopropane Substrates. During efforts aimed at expanding the scope of this 
methodology, an interesting reaction was observed with the cyclopropyl methyl oxime 
ether substrate 79. Subjection of 79 to the standard reaction conditions (5 mol % 
Pd(OAc)2, 1.2 equiv PhI(OAc)2 in a 1:1 mixture of AcOH/Ac2O at 100 °C) resulted in 
the formation of a ring opened product 81, rather than the expected acetoxylated product 
80 (Scheme 2.19). Importantly, control experiments in the absence of Pd(OAc)2 showed 
none of product 81, indicating that this reaction is palladium-catalyzed. Interestingly, 
product 81 was also obtained when the reaction was carried out in the presence of 
benzoquinone, a weaker oxidant than PhI(OAc)2 that is traditionally used in Pd0/II 
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catalyzed reactions. This result indicates that the acetate in the product is derived from 
the solvent and further that the reaction does not involve PdIV intermediates.  
 

























(80, 0%) (81, 10%)
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Substrate 82 also yielded the ring-opened product in 83% yield when subjected to 
catalytic conditions (5 mol % Pd(OAc)2, 1.5 equiv benzoquinone, 100 °C in 
AcOH/Ac2O) (Scheme 2.19). However, interestingly, the analogous reaction with 
ketones 84 and 86 did not afford ring opened products (Scheme 2.19). Instead, unreacted 
starting material was recovered. This indicates that the oxime ether directs ring opening 
in the reaction.  
Notably, Yu and co-workers observe C_H activation/iodination of the 
cyclopropane C-H bond, resulting in products similar to 80, instead of ring-opened 
products such as 81, using oxazoline directing groups.20 These transformations occur in 
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CH2Cl2 at room temperature with 10 mol% Pd(OAc)2, I2 in conjunction with PhI(OAc)2. 
These results are in sharp contrast to the cyclopropane ring-opening observed in our 
reactions. 
A proposed mechanism for this reaction involves the Pd0/II pathway shown in 
Scheme 2.20. Simultaneous coordination of the palladium to the oxime ether and 
cyclopropane could facilitate either intramolecular (path a) or intermolecular (path b) 
acetate attack on the 3-membered ring to afford intermediate 82a (Scheme 2.20). 
Subsequent β-hydride elimination from intermediate 82a would then afford product 83. 
 
























Even though we have not conducted detailed mechanistic studies, the above 
mechanism can be surmised based on preliminary data and on literature precedence. First, 
the lack of reactivity with ketones 84 and 86, implicates the necessity of a directing group 
and its possible role in assisting the metal to activate the cyclopropane ring. Second, 
control reactions of substrates 79 and 82, in the absence of palladium, did not afford even 
traces of 81 and 83. This result and the fact that benzoquinone is necessary for turnover, 
together indicate the possibility of a PdII/0 catalytic cycle. 
There are a few literature reports of nucleophilic directed ring opening of 
cyclopropanes at PdII. For example, Backvall has shown the nucleophilic ring opening of 
the cyclopropane in substrates such as 2-carene using stoichiometric Pd(Cl)2(MeCN)2 
(Scheme 2.21).21 He speculates that the palladium binds to the olefin, which assists the 
metal in activating the cyclopropane for nucleophilic attack by the solvent, acetic acid. 




















2.4  Competition Studies: sp2 versus sp3 C–H bonds 
 
We next desired to investigate the relative rates of functionalization of sp2 and sp3 
C–H bonds. It has been widely reported that cyclometallation of sp3 C–H bonds is much 
more difficult at transition metal centers than their sp2 counterparts.22, 23 Several reports 
have studied the competition between sp2 and sp3 C–H bonds in stoichiometric 
cyclopalladation reactions.24-27 However, the effects of directing group and of chelate 
ring size on the relative rate of sp2 versus sp3 C–H bond functionalization has not been 
systematically investigated in Pd-catalyzed reactions. 
We began our investigations by carrying out a competition experiment between 
oxime ether substrates 91 and 58, bearing sp2 and sp3 C-H bonds, respectively. When 91 
and 58 were subjected to the catalytic reaction conditions in the same reaction vessel, a 
4.7 : 1 ratio of products 92 : 59 was obtained. After statistical correction for the number 
of C–H bonds available in each case, we obtain a relative reactivity of 15.6 : 1 for the sp2 
and sp3 C–H bond, respectively. However, this is not a completely fair comparison, as 
oxime ether coordination is likely to be favored for the less-sterically hindered substrate 
91, thereby further favoring formation of product 92.  
 















(92, 70%) (59, 15%)(91) (58)  
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In order to exclude the possibility of varying coordinating abilities of the oxime 
ether in two different substrates, we designed substrates 93 and 96, which contain both 
sp3 and sp2 C–H bonds to be functionalized in the same molecule. The Pd-catalyzed 
acetoxylation of these molecules resulted in preferential functionalization of the sp2 C-H 
bond (Scheme 2.23). With substrate 96, product 97 was formed exclusively and none of 
the corresponding sp3 C–H acetoxylation product was observed.  
 

































The formation of 94 as the major product might be due to the greater propensity 
of arene C–H bonds to undergo C–H activation. Alternatively, this preference of sp2 C–H 
bond acetoxylation could result from the biases in the oxime isomer conformers. As 
illustrated in Scheme 2.24, substrate 93 can exist in two different oxime isomer 
conformations that equilibrate under our reaction conditions. Oxime isomer conformation 
93’ favors cyclopalladation of the sp2 C-H bond while 93 would lead to C–H activation at 
an sp3 site.  
 









We next carried out a systematic study of the effects of different directing groups 
on the relative rates of acetoxylation of sp2 and sp3 C–H bonds. We began with studying 
the competition between sp2 C-H bonds and benzylic C–H bonds. Substrates bearing four 
different directing groups were synthesized – oxime ether (102), isoxazoline (99), 
pyridine (105) and pyrazole (108). In these systems, functionalization of the benzylic 
position would require formation of a six membered palladacyclic intermediate while 
activation of the arene site would proceed via a 5-membered palladacycle (Table 2.4). As 
shown in Table 2.4, the pyridine and pyrazole directing groups led to products 106 and 
109, resulting from exclusive functionalization of an arene C–H bond (entries 3 and 4). 
Substrate 102 bearing the oxime ether directing group exhibited somewhat decreased 
selectivity for acetoxylation of the sp2 C-H bond and produced 103 and 104 in a 12 : 1 
ratio (entry 2). Interestingly, the isoxazoline substrate 99 presented only modest 
preference for sp2 over sp3 C–H bonds, affording a mixture of products 100 and 101 in a 
0.8 : 1 ratio. Notably, after correcting for statistics (the number of C–H bonds available), 
the ratio of sp2 to sp3 for substrate 99 becomes 2 : 1. Hence, the sp2 center is still slightly 
favored, even here. 
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Table 2.4: Competition Between Benzylic sp3 C–H Bonds and sp2 C–H Bonds as a 
Function of Directing Group 

























(100, 27%) (101, 34%)
(103, 58%) (104, 5%)
(106, 65%) (107, 0%)






























As mentioned above, the ring sizes of the palladacyclic intermediates formed with 
sp2 and sp3 C–H bonds in substrates 99-108 were different. Therefore, we wondered if the 
selectivity would be reversed if the two ring sizes were switched. However, before 
answering this question, we sought to determine the largest size palladacycle that could 
be formed and functionalized under our reaction conditions. Three different directing 
groups – isoxazoline, pyridine and methyl oxime ether – were selected for this study, and 
the chain length between the directing group and an appended phenyl ring was 
systematically varied. As shown in Table 2.5, isoxazoline substrates 113 and 114, which 
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react via 6- and 7-membered palladacycles, respectively, afforded the acetoxylated 
products in high yields (entries 2 and 3). However, substrates 117-121, which require 
formation of 8-, 10-, and 12-membered palladacyclic intermediates, did not form 
appreciable amounts of the desired acetoxylated products (entries 4, 5, and 6, 
respectively).  
 
Table 2.5: Effect of Palladacycle Ring Size on Yields of Pd-Catalyzed C–H 






































































Unlike the isoxazolines, the oxime ether and pyridine directing groups only 
afforded C–H activation/acetoxylation products via the formation of 5- or 6-membered 
palladacycles (Table 2.6). The oxime ether substrate 127 provided low (17%) yield of the 
acetoxylated product 128 generated via a seven-membered palladacycle (entry 3), while 
the corresponding pyridine substrate 133 showed essentially no reaction (entry 6). 
  
Table 2.6: Effect of Palladacycle Ring Size on Yields in Pd-Catalyzed C–H 


































































With this data in hand, we predicted that an sp3 C–H bond that was five bonds 
away from the chelating group might be functionalized selectively over an sp2 C–H bond 
that was further removed. To test this hypothesis, we synthesized isoxazoline substrates 
135-141, which all contain an sp3 C–H bond 5 bonds from the directing group and an sp2 
C–H bond 5, 6, or 7 bonds away from the chelating nitrogen atom (Table 2.7). However, 
surprisingly, reaction of substrates 135 and 138 afforded predominantly sp2 C–H 
functionalization products 136 and 139, along with only traces of 137 and 140. Even 
when the sp2 C–H bond was too far to undergo efficient functionalization, such as in 
substrate 141, the sp3 C–H bond did not react.  
 
Table 2.7: Effect of Palladacycle Ring Size on Yields in Pd-Catalyzed C–H 
Activation/Acetoxylation with Isoxazoline Directing Groups II 


















































 We thought that this lack of reactivity might be due to a steric or conformational 
effect of the alkyl chain in these systems. In order to test this proposal, we replaced the 
phenyl group with a propyl chain (substrate 62). As shown in Scheme 2.25, even this 
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substrate afforded only modest 30% yield of the acetoxylated product (compared to 47% 
for the corresponding i-Pr substituted derivative 66), confirming that this class of 
substrates exhibits inherently low reactivity.  
 
Scheme 2.25: Effect of Sterics on Acetoxylation of 62 









(62) (63)  
 
We wondered if the effect discussed above was specific to isoxazoline directing 
groups. Consequently, we repeated the above experiment with oxime ether substrate 144, 
which could undergo sp2 C–H activation to form a 6-membered palladacycle or sp3 C–H 
activation to generate a 5-membered palladacycle (Scheme 2.26). Subjection of 144 to 
the catalytic reaction conditions afforded similar results as the isoxazoline, and only 
products 145 and 146, resulting from mono- and di-functionalization of the arene, were 
observed.  
 











(145, 43%) (146, 22%)










In all, these results indicate that in general, regardless of the nature of the 
directing group or the size of the palladacyclic intermediates, the relative rate of 
functionalization of an arene C–H bond appears to be faster than that of an sp3 C-H bond. 
However, these studies also emphasize how difficult it is to design systems that really 
give a fair comparison. 
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2.5  Functionalization of Secondary sp3 C-H bonds 
 
As discussed above, the activation of 2º sp3 C–H bonds is even more challenging 
than that of the corresponding 1º substrates. For example, substrate 99, which bears a 1º 
C–H bond and a sp2 C–H bond proximal to the directing group, reacted to form a 2 : 1 
(after statistical correction) mixture of the two possible mono-acetoxylation products 
(Scheme 2.27). However the analogous substrate 148, where the methyl group is replaced 
by an ethyl group, afforded only 8% of the 2° sp3 C-H bond functionalized product 150 
(Scheme 2.27). Furthermore, this functionalization took place after the sp2 C-H bond was 
already acetoxyated (ie, when no other sites were available for directed C–H activation). 
In addition, substrate 148 contains an “activated” benzylic 2° sp3 C–H bond. These 
results emphasize that unactivated 2º C–H bonds are expected to be even more 
unreactive. 
 



























Several different features were explored in an attempt to promote Pd-catalyzed C–
H activation/acetoxylation of unactivated 2º sp3 C–H bonds. These include: (i) increasing 
branching α to the directing group (substrates 152 and 155 in Figure 2.2), (ii) the use of 
substrates that would form 5- or 6-membered palladacycles (151, 153-155 and 152, 
respectively), and (iii) the use of different directing groups. However, none of these 
substrates afford any of the desired acetoxylated products under our standard conditions 
(5 mol % Pd(OAc)2, 1.5 equiv PhI(OAc)2 in AcOH or AcOH/Ac2O at 100 °C). 
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(152) (153) (154) (155)  
 
We believe that the functionalization of 2º sp3 C-H bonds is challenging for two 
reasons. First, literature studies show that activation of 2º sp3 C–H bond at transition 
metal centers is less thermodynamically favourable. Bergman illustrated this concept 
through studies of the reaction of Ir complexes with cyclohexane and n-pentane.28 As 
shown in Scheme 2.28, a Keq of 10.8 was obtained, indicating that the 1º Ir alkyl complex 
157 was more stable than the 2º alkyl species 156.  
 











Another reason 2° sp3 C-H bonds are hard to functionalize is due to 
conformational restriction. It can be challenging to achieve co-planarity between the 
directing group and the C–H bond, which is known to facilitate C–H activation. As such, 
we thought we could promote activation of 2º sp3 C-H bonds, by taking advantage of the 
double chelation effect and the conformational effects observed earlier (Scheme 2.17).  
Double Chelation Effect. The strategy behind ‘double chelation’ is to employ 
substrates consisting of two different potential directing groups rather than just one. In 
these systems, the simultaneous coordination of both the ligands to the metal center is 
expected to lock the Pd proximal to the desired C–H bond (for example, intermediate 159 
in Scheme 2.29 where L1 and L2 are two different chelating ligands for palladium), hence 
leading to more facile activation of the 2º C–H bond. This concept has been demonstrated 
in the cyclometalation literature. For example, Canty has shown that the cyclopalladation 
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of substrate 161 proceeds in 12% yield (Scheme 2.30). In contrast, 2-butylpyridine is 
unreactive under identical conditions.29 
 













 PhI(OAc)2 cat. Pd(OAc)2
(158) (159) (160)  
 







12 h, 12 %
 
 
After the introduction of our chemistry in 2004, several other groups described 
related Pd-catalyzed reactions involving directed functionalization of sp3 C–H bonds. 
Several of these reports, including work by Daugulis and by Corey, described the use of 
the double chelation strategy for the functionalization of 2º sp3 C–H bonds. In one 
example, Daugulis demonstrated the arylation of a 2º sp3 C–H bond in substrate 163, and 
proposed a mechanism involving simultaneous coordination of the quinoline and amide 
directing groups to the PdII center (Scheme 2.31).30 Similarly, Corey successfully 
transformed a 2º sp3 C–H bond in 8-aminoquinoline derivative 166 into a C–OAc bond.31 
Again, dual chelation of the amide and quinoline functionalities was proposed to be 
critical for the success of this reaction (Scheme 2.32). 
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Scheme 2.31: Application of Dual Chelation Strategy: Pd-Catalyzed Arylation of a 2º sp3 









5 mol % Pd(OAc)2
AgOAc







(163) (164) (165)  
 
Scheme 2.32: Application of Dual Chelation Strategy: Pd-Catalyzed Acetoxylation of a 
























(166) (167) (168)  
 
We had similarly reasoned that a dual chelation strategy might be applied in our 
C–H activation/acetoxylation reactions. In order to investigate this possibility, we 
synthesized a number of different substrates containing multiple functionalities with the 
ability to coordinate to the palladium. Substrate 169, containing an oxime ether and an 
ester functionality, displayed no reactivity under the reaction conditions (5 mol % 
Pd(OAc)2, 1.5 equiv PhI(OAc)2 at 100 ºC in AcOH/Ac2O) (Scheme 2.33). Reaction of 
substrate 171, containing pyridine and oxime ether directing groups, under our standard 
conditions afforded only product 172, where pyridine-directed functionalization occurred 
at the 1° sp3 C-H bond α to the oxime (Scheme 2.34). Oxime ether derived substrates 
174-177 (Figure 2.3), which contain amide and pyridine functionalities as the two 
directing groups, did not afford an appreciable amount of acetoxylated products under the 
standard reaction conditions. Optimization studies involving different solvents, 
temperatures, and catalysts with substrates 174-177, either led to decomposition 
(substrates 174 and 177) or recovered starting material (substrates 175 and 176). The 
application of Corey’s conditions with these substrates also produced similar results.31 
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(174) (175) (176) (177)  
  
Since substrates 169-177 did not afford any acetoxylation at the 2° positions, we 
next examined substrates more similar to Corey’s compound 166 under our reaction 
conditions.31 Hence, substrate 178, containing an amide and a quinoline as potential 
directing groups, was synthesized and subjected to 10 mol % Pd(OAc)2, 2 equiv 
PhI(OAc)2 in AcOH at 100 °C (Scheme 2.35). Gratifyingly, product 180, in which a 2º 
C–H bond was acetoxylated, was obtained, albeit in low (15%) yield. This low yield 
appears to be due to competitive N-acetoxylation to form product 179. To address this 
side reaction, we next examined the analogous N-methylated substrate 181. However, as 
shown in Scheme 2.35, 181 displayed no reactivity, implicating that the free amide is 
involved in binding to the palladium and directing C–H activation in substrate 178. 
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Conformational Lock Effect. We next sought to explore the application of 
conformational effects to facilitate 2º sp3 C–H bond functionalization. We reasoned that 
C–H activation would be facilitated in substrates with the 2º sp3 C–H bond locked in the 
same plane as the directing group. To test this hypothesis, we synthesized the methyl 
oxime ether of trans-decalone (182.) In this substrate there are two β 2º C–H bonds, one 
in the axial position and the other in the equatorial position. As shown in Scheme 2.36, 
the C–H bond in the equatorial position is locked in the same plane as the directing 
group.  
 










(182) (183)  
 
We were pleased to find that the trans-decalone oxime ether underwent clean C–
H bond acetoxylation under our standard conditions (5 mol % Pd(OAc)2, 1.1 equiv 
PhI(OAc)2 in AcOH/Ac2O at 100 °C) to provide 184 in 81% yield as a single 
diastereomer (Scheme 2.37). Importantly, both NMR coupling constant analysis and x-
ray crystallography revealed that this diastereomer contained the acetate in the equatorial 
position, cis to the proton at the junction of the fused rings. The coupling constant 
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between Ha and Hb was 10.9 Hz, indicating a trans relationship. Since oxime ether 182 
was an oil, the crystal structure of the deprotected ketone product 185 was obtained 
(Figure 2.4), and, again, this confirmed the proposed stereochemistry.  
 
Scheme 2.37: Conformational Lock Strategy: Pd-Catalyzed Acetoxylation of  trans-
Decalone Oxime Ether 
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2.6  Stereochemical Nature of Reductive Elimination 
 
The high diastereoselectivity of the reaction in Scheme 2.37 indicates that C–H 
activation and functionalization occur with high stereochemical fidelity in this system. 
This substrate also serves as a probe for the stereochemical nature of the reductive 
elimination step. As shown in Scheme 2.38, after oxidation of the cyclopalladated 
complex 186 to PdIV, there are two potential pathways through which reductive 
elimination can take place. These are: (i) external acetate attack via an SN2-type 
mechanism leading to inversion of stereochemistry at carbon or (ii) direct reductive 
elimination of coordinated acetate leading to retention of stereochemistry at carbon. 
There is precedent for the oxidative functionalization of Pd-alkyl intermediates with both 
inversion (Scheme 2.39) 32 and retention (Scheme 2.40)33 in the literature. 
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5 mol % PdCl2(PhCN)2
(55%)  
 
In order to confirm which mechanism is operating in this system, we studied the 
stoichiometric conversion of a cyclopalladated trans-decalone oxime complex to the 
mono-acetoxylated organic product 184. Initial attempts to synthesize a palladacycle of 
the oxime ether 182 yielded complex mixtures of products that could not be separated. 
However, literature precedent suggested that palladacycle formation is much more facile 
for oximes.11 Hence, we synthesized the chloride-bridged palladacycle dimer of trans-
decalone oxime (189), by stirring 188 in MeOH with stoichiometric Na2PdCl4 and 
NaOAc at room temperature for 3 days (Scheme 2.41). Reaction of the dimer with 
pyridine in THF, then afforded the desired chloride-monomer along with Pd(py)2(Cl)2 (py 
= pyridine) as an impurity (Scheme 2.41). The reaction time was critical in dictating the 
amount of impurity formed, and 10 min was found to be optimal, leading to a 
Pd(py)2(Cl)2 : 190 ratio of 1.5 : 1. Multiple purifications by column chromatography and 
crystallization afforded the desired complex in 93% purity. The chloride monomer was 
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also transformed to the acetate monomer 191 by reaction with AgOAc in AcOH (Scheme 
2.41). 
 







































The structures of the chloride and acetate monomers 190 and 191 were confirmed 
by X-ray crystallography. The crystal structures of these complexes are shown in Figures 
2.5 and 2.6. As predicted in Scheme 2.41 above, the palladacycles formed via activation 
of the equatorial β C–H bond. 
 


























We next studied the oxidation of 190 and 191 with PhI(OAc)2. Reaction of the 
acetate monomer 191 with PhI(OAc)2 at 100 ºC in AcOH, provided the acetoxylated 
ketone product 185 as a single diastereomer. As shown in Scheme 2.12 above, the ketone 
was presumably formed via deprotection of the oxime in the presence of the hypervalent 
iodine oxidant. The crystal structure of product 185 is shown in Figure 2.4 and clearly 
confirms that the OAc group is in the equatorial position. This data definitively 
demonstrates that the C–O bond-forming reaction proceeds with retention of 
stereochemistry at the carbon center, which implicates pathway ii in Scheme 2.38. 
 















(191) (185)  
 
Interestingly, the reaction of the chloride monomer with PhI(OAc)2 yielded two 
organic products – the expected acetate compound 185 and the chloride-containing 
product 192. Importantly, both had the new functional group in the equatorial position, 
again demonstrating retention of stereochemistry at carbon in this reaction. The 
stereochemistry of the chloride product 192 was determined via coupling constant 
analysis (the coupling constant was 10.8 Hz, indicating a trans relationship between the 
ring junction hydrogen and the hydrogen on the carbon bearing the acetate). The 
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formation of 185 and 192 in an approximately 1 : 1 ratio implies that C–O and C–Cl 
bond-forming reductive elimination from PdIV are  competitive under these conditions.  
 












100 oC, 12 h





The next question we hoped to address was the relative rates of reductive 
elimination of different functional groups from Pd. In order to probe this, we carried out 
the reactions of chloro and acetate complexes 190 and 191 with two additional oxidants –
PhICl2 and MeI. Interestingly, the reaction of acetate monomer 191 with PhICl2 afforded 
the chloride product 192 exclusively (Scheme 2.44), suggesting that despite the acetate 
ligand initially on the metal, only C–Cl bond-forming reductive elimination took place. 
Similarly, when MeI was used as the oxidant in the reaction of 191, methylated 
compound 193 was the sole organic product obtained (Scheme 2.44).  Again, the Me 
group was in the equatorial position (verified by x-ray crystal structure), indicating that 
reductive elimination occurred with retention. 
 































As shown in Scheme 2.45, reaction of the chloride monomer 190 with MeI 
formed solely the methylated product 193, indicating preferential C–Me bond forming 
reductive elimination. As expected subjection of the chloride monomer 190 to PhICl2 
afforded the chloride product 192 (Scheme 2.45).  
 





























The data discussed above suggests that the order of preference for reductive 
elimination from PdIV is Me > Cl > OAc. Notably, we do realize that the cis versus trans 
geometry of the ligands in the transient PdIV intermediate can also influence the reductive 
elimination product distribution, since the X ligand must be cis to the carbon center for 
bond formation to take place. Nonetheless, the results thus far suggest a higher preference 
for reductive elimination of the most nucleophilic ligand. Importantly, the trend observed 
in the stoichiometric oxidation studies above is consistent with what has been observed in 
the benzoate PdIV complexes studied previously in our lab. Reductive elimination 
reactions from complexes such as 194 proceeded fastest with more electron donating 
substituents X on the benzoate ligand (Scheme 2.46).34 
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Notably, we have not yet been able to observe any appreciable amount of 
chlorinated or methylated products in catalytic reactions where PhI(OAc)2 was 
substituted with PhICl2 and MeI. With PhICl2 we observed substrate decomposition 
and/or unselective chlorination. Reactions with MeI were hampered by the lack of 
catalytic turnover, and we typically recovered unreacted starting material.  
 
2.7  Deprotection of Directing Groups 
 
 As mentioned in the introduction, the advantage of employing oxime ethers and 
isoxazolines as directing groups for C–H bond acetoxylation is that the products are 
useful synthons. Through functional group manipulations, we can access β-amino acids, 
β-hydroxy ketones, β-amino alcohols, and 1,3-diols. Several groups have studied the 
synthetic applications of isoxazolines. For example, Mapp and co-workers have 
developed an attractive method to transform isoxazolines into β-amino acids (Scheme 
2.47).35  
 












(195) (196) (197)  
 
 Methyl oxime ethers are robust protecting groups, and hence there are relatively 
limited literature examples of their deprotection.36 In some cases, we have found that 
 46 
oxime ethers can be deprotected under acidic conditions. However, under those 
conditions, we also observe competitive elimination and/or hydrolysis of the acetate 
group. For example, subjection of substrate 198 to 0.5 M HCl in CH2Cl2 afforded the 
hydrolyzed product 200 along with alkene 199 (Scheme 2.48). A similar distribution of 
undesired products was obtained when the reaction of substrate 198 was conducted in 
refluxing 1 M AcOH. 36 
 

















39% by GC  
 
 These side reactions could be avoided using a procedure developed by Corey in 
the synthesis of prostaglandins.37 Subjection of substrate 184 to Corey’s conditions (2 
equiv TiCl3 and 2 equiv of NH4OAc, in a refluxing mixture of 1:10 H2O : dioxane) 
afforded deprotected β-keto-acetate product like 185 (Scheme 2.49) in 56% yield. This 
product could then be readily converted to the corresponding β-hydroxy ketone in 75% 
yield by reaction with 0.1 equiv K2CO3 in MeOH (Scheme 2.49).  
 


















(185) (201)  
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2.8  Conclusion 
 
In summary, Pd-catalyzed selective oxidation of 1º sp3 C–H bonds was achieved 
using directing groups such as oxime ethers and isoxazolines. Importantly, this reaction 
was applied to diverse substrates, and competitive β-hydride elimination was not 
observed. Competition studies between sp2 and sp3 C–H bonds indicated a high 
preference for sp2 C–H activation/functionalization. The functionalization of an 
unactivated 2° sp3 C–H bond was achieved by taking advantage of conformational effects 
in trans-decalone. This reaction proceeded with high diastereoselectivity, and allowed 
determination that C–O, C–Cl, and C–Me bond-forming reductive elimination from PdIV 
all proceed with retention of stereochemistry in this system. These studies also revealed a 
high preference for the reductive elimination of more nucleophilic ligands, with Me > Cl 
> OAc. Finally, products from these C–H activation/acetoxylation reactions have been 
converted to useful synthons via functional group interconversion reactions. 
 
 
2.9  Experimental Procedure 
 
General Procedures:  NMR spectra were obtained on a Varian Inova 500 
(499.90 MHz for 1H; 125.70 MHz for 13C) or a Varian Inova 400 (399.96 MHz for 1H; 
100.57 MHz for 13C) spectrometer. 1H NMR chemical shifts are reported in parts per 
million (ppm) relative to TMS, with the residual solvent peak used as an internal 
reference.  Multiplicities are reported as follows: singlet (s), doublet (d), doublet of 
doublets (dd), doublet of triplets (dt), triplet (t), quartet (q), multiplet (m), and broad 
resonance (br). 
 
Materials and Methods:  Oxime ether substrates were prepared by reaction of 
the analogous ketones with MeONH2•HCl/pyridine.38 Oximes were obtained as mixtures 
of E/Z isomers when the α-position was mono or disubstituted. The parent ketones of 
substrates 8 and 15 were prepared by alkylation of the analogous hydrazones followed by 
hydrolysis with 1 M HCl. Substrate 56 was prepared following a procedure by Chan.39 
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Isoxazolines were prepared by following a literature protocol.35 Substrates that were 
commercially available were obtained from Acros, Lancaster, Aldrich or TCI America 
and used as received. PhI(OAc)2 and Pd(OAc)2 were obtained from Acros and Pressure 
Chemical, respectively, and were used as received. Solvents were obtained from Fisher 
Chemical and used without further purification. Flash chromatography was performed on 
EM Science silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh) and thin layer 
chromatography was performed on Merck TLC plates pre-coated with silica gel 60 F254.  
 
General Procedure for Palladium-Catalyzed Acetoxylation of sp3 C-H bonds: 
3-Methyl-2-butanone O-methyl oxime (200 mg, 1.74 mmol, 1 equiv), PhI(OAc)2 (621 
mg, 1.91 mmol, 1.1 equiv), and Pd(OAc)2 (19 mg, 0.087 mmol, 0.05 equiv) were 
combined in AcOH (7 mL) and Ac2O (7 mL) in a 20 mL vial. The vial was sealed with a 
Teflon lined cap, and the reaction was heated at 100ºC for 3 h. The resulting mixture was 
filtered through a plug of glass wool and diluted with pentane (20 mL), and the pentane 
layer was washed with H2O (2 x 20 mL), saturated NaHCO3 (2 x 20 mL) and brine (2 x 
20 mL).  The organic layer was dried over MgSO4, filtered, and concentrated to afford a 
yellow oil, which was purified by chromatography on silica gel (Rf  = 0.3 in 90% 
hexanes/10% ethyl acetate). The product 9 was obtained as pale yellow oil (222 mg, 74% 
yield), which was a 6:1 mixture of the oxime E/Z isomers. Each substrate was optimized 







The reaction was run with 4.5 equiv of PhI(AcO)2 for 3.5 h in AcOH. Product 33 was 
isolated as a off-white solid (Rf = 0.28 in 70% hexanes/30% ethyl acetate, 62% yield). 1H 
NMR (CDCl3): δ 4.25 (s, 6H), 3.84 (s, 3H), 2.05 (s, 9H), 1.83 (s, 3H), 13C{1H} NMR 
(CDCl3): δ 170.69, 154.34, 62.41, 62.01, 47.50, 20.95, 11.12. Anal. Calcd for 






The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 35 was obtained as 
a viscous oil (75%, Rf  = 0.3 in 90% hexanes/10% ethyl acetate). 1H NMR (CDCl3): δ 
4.32 (d, J = 12 Hz, 1H), 4.19 (d, J = 12 Hz, 1H), 3.74 (s, 3H), 2.44 (m, 1H), 1.99 (s, 3H), 
1.95-1.78 (multiple peaks, 4H), 1.40 (m, 1H), 1.20 (m, 1H), 0.95 (s, 3H), 0.84 (s, 3H). 
13C{1H} NMR (CDCl3): δ 171.18, 165.94, 61.87, 61.59, 54.17, 48.51, 44.82, 33.49, 
28.42, 27.04, 21.12, 20.17, 19.95. Anal. Calcd for C13H21NO3: C, 65.25, H, 8.84, N, 5.85; 






The reaction was run with 2.8 equiv of PhI(OAc)2 in AcOH. Product 37 was obtained as 
a viscous oil  (51% yield). 1H NMR (CDCl3): δ 4.46 (d, J = 11.7 Hz, 2H), 4.07 (d, J = 
11.5 Hz, 2H), 3.79 (s, 3H), 2.50 (m, 2H), 2.05 (s, 3H), 1.68-1.59 (multiple peaks, 6H), 





The reaction was run with 1.1 equiv of PhI(OAc)2 in AcOH. Product 39 was obtained as 
a viscous oil  (61% yield). Unreacted starting material (28 mg, 28% recovered) was also 
isolated. 1H NMR (CDCl3): δ 4.02 (d, J = 11 Hz, 1H), 3.97 (d, J = 11 Hz, 1H), 3.78 (s, 
3H), 2.42 (m, 2H), 2.02 (s, 3H), 1.80-1.64 (multiple peaks, 3H), 1.53 (m, 1H), 1.13 (s, 
3H). 13C{1H} NMR (CDCl3): δ 171.06, 167.11, 69.32, 61.51, 45.37, 36.16, 27.52, 22.48, 
20.99, 20.90. Anal. Calcd for C10H17NO3: C, 60.28, H, 8.60, N, 7.03; Found: C, 60.57, H, 






The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 43 was obtained as 
a viscous oil  (45% yield). 1H NMR (CDCl3): δ 4.78 (m, 1H), 4.19 (s, 4H), 4.09 (m, 2H), 
3.08 (dd, J = 16.5, 10.5 Hz, 1H), 2.77 (dd, J = 16.5, 7.0 Hz, 1H), 2.07 (s, 6H), 2.06 (s, 
3H). 13C{1H} NMR (CDCl3): δ 170.62, 170.48, 170.46, 159.30, 77.32, 40.52, 36.99, 





The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 45 was obtained as 
a viscous oil  (55% yield). 1H NMR (CDCl3): δ 7.09 (s, 1H), 7.04 (s, 1H), 5.05 (s, 2H), 
4.73 (m, 1H), 3.27 (dd, J = 17.0, 10.5, 1H), 2.87 (dd, J = 17.0, 8.5 Hz, 1H), 2.33 (s, 3H), 
2.27 (s, 3H), 2.07 (s, 6H), 1.84 (m, 1H), 1.64 (m, 1H), 1.50 (m, 1H), 1.43-1.37 (multiple 
peaks, 3H), 0.94 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ170.56, 170.22, 156.71, 
64.38, 61.95, 44.41, 37.25, 20.66, 20.63. HRMS (ESI, m/z): [M + Na]+ calcd for 





The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 49 was obtained as 
a viscous oil  (60% yield). 1H NMR (CDCl3): δ 4.79 (m, 1H), 4.27 (s, 6H), 4.08 (m, 2H), 
3.10 (dd, J = 17.0, 10.5 Hz, 1H), 2.79 (dd, J = 17.0, 7.5 Hz, 1H), 2.05 (s, 9H). 13C{1H} 
NMR (CDCl3): δ 170.51, 156.32, 139.08, 136.93, 134.58, 131.15, 127.86, 126.88, 81.04, 
64.28, 44.43, 35.00, 27.84, 22.51, 21.09, 21.02, 19.59, 13.96. HRMS (ESI, m/z): [M + 






The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 51 was 
obtained as a clear oil. The two isomers were isolated as pale yellow oils (major isomer:  
173 mg, 61% yield; minor isomer: 57 mg, 20% yield). Each of the pure isomers was re-
subjected to the reaction conditions and the equilibrium mixture (~3:1) was rapidly 
reestablished in each case. Major Isomer: 1H NMR (CDCl3): δ 4.39 (dd, J = 11.2, 5.9 
Hz, 1H), 3.99 (dd, J = 11.2, 8.1 Hz, 1H), 3.74 (s, 3H), 2.76 (m, 1H), 2.46 (m, 1H), 1.96 
(m, 2H), 1.99 (s, 3H), 1.67 (m, 2H), 1.40 (multiple peaks, 3H). 13C{1H} NMR (CDCl3): δ 
171.24, 158.86, 64.92, 61.39, 41.21, 30.40, 25.98, 24.30, 24.08, 21.13. Minor Isomer: 1H 
NMR (CDCl3): δ 4.17 (dd, J = 10.8, 7.8 Hz, 1H), 4.06  (dd, J = 10.8, 6.4 Hz, 1H), 3.76 (s, 
3H), 3.65 (m, 1H), 2.28 (m, 1H), 2.12 (m, 1H), 1.99 (s, 3H), 1.86 (m, 1H), 1.75 (m, 1H), 
1.57-1.33 (multiple peaks, 4H). Anal. Calcd for C10H17NO3 (mixture of E/Z isomers): C, 





The reaction was run with 1.1 equiv of PhI(OAc)2 in AcOH/Ac2O. The two isomers of 55 
were isolated as pale yellow oils (isomer a:  137 mg, 19.5%; isomer b: 137 mg, 19.5%). 
Each of the pure isomers was re-subjected to the reaction conditions and the equilibrium 
mixture (~1:1) was reestablished rapidly in each case (as determined by gas 
chromatography). Isomer a: 1H NMR (CDCl3): δ 4.20 (t, J = 7.0 Hz, 2H), 3.74 (s, 3H), 
2.42 (t, J = 7.0 Hz, 2H), 2.24, (m, 2H), 1.99 (s, 3H), 1.38 (m, 2H), 1.28 (m, 2H), 0.85 (t, J 
= 7.3 Hz, 3H). 13C{1H} NMR (CDCl3): δ 171.12, 157.84, 61.62, 61.43, 33.27, 28.23, 
27.98, 23.01, 21.10, 13.97. Isomer b: 1H NMR (CDCl3): δ 4.26 (t, J = 6.6 Hz, 2H), 3.76 
(s, 3H), 2.56 (t, J = 6.6 Hz, 2H), 2.13, (m, 2H), 1.99 (s, 3H), 1.38 (m, 2H), 1.28 (m, 2H) 
0.83 (t, J = 7.3 Hz, 3H). Anal. Calcd for C10H19NO3 (mixture of E/Z isomers): C, 59.68, 







The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 49 was obtained as 
a viscous oil  (60% yield). 1H NMR (CDCl3): δ 4.35 (m, 1H), 4.19-4.09 (multiple peaks, 
2H), 2.29 (m, 1H), 2.16-2.12 (multiple peaks, 2H), 2.07 (s, 3H), 1.81 (s, 3H), 1.48 (m, 
2H), 1.35-1.27 (multiple peaks, 4H), 1.25 (d, J = 7.2 Hz, 3H), 0.88 (t, J = 7.5 Hz, 3H). 
13C{1H} NMR (CDCl3): δ 171.02, 158.36, 75.73, 75.69, 66.45, 66.40, 35.84, 31.68, 





The reaction was run with 1.1 equiv of PhI(AcO)2 for 3 h in AcOH/Ac2O. The product 57 
was isolated as a pale yellow oil (Rf  = 0.3 in 90% hexanes/10% ethyl acetate, 222 mg, 
74% yield), which was a 6:1 mixture of the oxime E/Z isomers. Major Isomer: 1H NMR 
(CDCl3): δ 4.10 (dd, J = 10.9, 7.3 Hz, 1H), 3.99 (dd, J = 10.9, 6.9 Hz, 1H), 3.77 (s, 3H), 
2.62 (m, 1H), 1.99 (s, 3H), 1.74 (s, 3H), 1.05 (d, J = 7.2 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 171.10, 157.94, 66.24, 61.45, 39.13, 21.05, 14.95, 11.77. Anal. Calcd for 






The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 61 was 
obtained as pale yellow oil (202 mg, 78% yield). 1H NMR (CDCl3): δ 4.50 (dd, J = 11.0, 
4.4 Hz, 1H), 3.97 (dd, J = 11.0, 8.1 Hz, 1H), 3.75 (s, 3H), 3.27 (m, 1H), 2.39 (m, 1H), 
2.08 (m, 1H), 2.02 (s, 3H), 1.86 (m, 1H), 1.55 (m, 1H), 1.24 (m, 1H), 1.09 (m, 1H), 0.94 
(m, 1H), 0.83 (s, 9H). 13C{1H} NMR (CDCl3): δ 174.09, 158.82, 65.20, 61.45, 47.04, 
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41.63, 32.22, 27.74, 26.98, 24.91, 21.22. Anal. Calcd for C14H25NO3: C, 65.85, H, 9.87, 





The reaction was run with 2.0 equiv of PhI(OAc)2 in AcOH. Product 63 was obtained as 
a viscous oil  (30% yield, 1:1). 1H NMR (CDCl3): δ 4.79 (m, 2H), 4.19-4.06 (multiple 
peaks, 8H), 3.06-2.94 (multiple peaks, 4H), 2.73 (m, 2H), 2.08 (s, 3H), 2.05 (s, 3H), 1.51 
(m, 4H), 1.35 (m, 4H), 0.92 (m, 6H). 13C{1H} NMR (CDCl3): δ 170.75, 64.97, 64.87, 
64.65, 37.71, 31.02, 30.95, 20.82, 20.75, 20.08, 13.87, 13.83. HRMS (ESI, m/z): [M + 





The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 67 was obtained as 
a viscous oil  (47% yield, 1:1). 1H NMR (CDCl3): δ 4.76 (m, 2H), 4.16-4.07 (multiple 
peaks, 8H), 3.04 (dd, J = 17.0, 10.5 Hz, 2H), 2.75-2.70 (multiple peaks, 4H), 2.08 (s, 
12H), 1.18 (d, J = 6.5 Hz, 6H). 13C{1H} NMR (CDCl3): δ 186.65, 170.83, 65.17, 49.66, 





The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 69 was obtained as 
a viscous oil  (25% yield, 1:1). Isomer 1: 1H NMR (CDCl3): δ 7.38-7.29 (multiple peaks, 
5H), 5.55 (dd, J = 11.0, 8.0 Hz, 1H), 4.21 (dd, J = 11.0, 7.0 Hz, 1H), 4.14 (dd, J = 12.0, 
6.0 Hz, 1H), 3.40 (dd, J = 17.0, 11.0, 1H), 3.02 (quin, J = 7.0 Hz, 1H), 2.92 (dd, J = 17.0, 
8.0 Hz, 1H), 2.04 (s, 3H), 1.23 (d, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 170.81, 
159.32, 141.01, 128.68, 128.09, 125.68, 81.46, 65.95, 43.39, 32.83, 20.81, 14.78. Isomer 
1: 1H NMR (CDCl3): δ 7.37-7.30 (multiple peaks, 5H), 5.55 (dd, J = 11.0, 7.5 Hz, 1H), 
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4.20-4.11 (multiple peaks, 2H), 3.40 (dd, J = 17.0, 11.0, 1H), 3.03 (quin, J = 6.5 Hz, 1H), 
2.91 (dd, J = 17.0, 7.5 Hz, 1H), 2.01 (s, 3H), 1.23 (d, J = 7.5 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 170.73, 159.27, 141.11, 128.67, 128.08, 125.65, 81.39, 65.91, 43.16, 32.71, 






The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 72 was 
obtained as a mixture of the two isomers, as pale yellow oils (major isomer: 189 mg, 65% 
yield; minor isomer: 38 mg, 13% yield). Each of the pure isomers was re-subjected to the 
reaction conditions and the equilibrium mixture (~5:1) was reestablished rapidly in each 
case (as determined by gas chromatography). Major Isomer: 1H NMR (CDCl3): δ 4.07 
(pseudo q, J = 13.9, 7.8, 6.4 Hz, 2H), 3.79 (s, 3H), 2.45 (m, 1H), 1.99 (s, 3H), 1.72 (s, 
3H), 1.45 (m, 2H), 0.84 (t, J = 7.4 Hz, 3H). 13C{1H} NMR (CDCl3): δ 171.09, 157.09, 
65.00, 61.46, 46.03, 22.01, 21.07, 11.48, 11.43. Minor Isomer: 1H NMR (CDCl3): 4.16 
(dd, J = 10.9, 5.6 Hz, 1H), 4.04 (dd, J = 10.9, 8.3 Hz, 1H), 3.80, (s, 3H), 3.45 (m, 1H), 
2.03, (s, 3H), 1.80 (s, 3H), 1.49 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H). Anal. Calcd for 




Cyclpropane 79 was reacted with 2.0 equiv Benzoquinone and 5 mol % Pd(OAc)2 in 
AcOH/Ac2O (1:1, 0.12M) in a 20 mL scintillation vial at 100 °C for 12 h. The resulting 
mixture was filtered through a plug of glass wool and diluted with pentane (20 mL), and 
the pentane layer was washed with H2O (2 x 20 mL), saturated NaHCO3 (2 x 20 mL) and 
brine (2 x 20 mL).  The organic layer was dried over MgSO4, filtered, and concentrated 
to afford a yellow oil, which was purified by chromatography on silica gel (Rf  = 0.3 in 
90% hexanes/10% ethyl acetate).  The product 81 was obtained as a mixture of the two 
oxime isomers, as pale yellow oils (44%, 3:1). Major Isomer: 1H NMR (CDCl3): δ 5.89 
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(td, J = 6.4, 1.5 Hz, 1H), 4.76 (d, J = 6.4 Hz, 2H), 3.91 (s, 3H), 2.08 (s, 3H), 1.96 (s, 3H), 
1.90 (br s, 3H). 13C{1H} NMR (CDCl3): δ 170.87, 155.57, 137.09, 124.58, 61.78, 61.33, 






Cyclpropane 82 was reacted with 2.0 equiv Benzoquinone and 5 mol % Pd(OAc)2 in 
AcOH/Ac2O (1:1, 0.12M) in a 20 mL scintillation vial at 100 °C for 12 h. The resulting 
mixture was filtered through a plug of glass wool and diluted with pentane (20 mL), and 
the pentane layer was washed with H2O (2 x 20 mL), saturated NaHCO3 (2 x 20 mL) and 
brine (2 x 20 mL).  The organic layer was dried over MgSO4, filtered, and concentrated 
to afford a yellow oil, which was purified by chromatography on silica gel (Rf  = 0.3 in 
90% hexanes/10% ethyl acetate).  The product 83 was obtained as a mixture of the two 
oxime isomers, as pale yellow oils (47%, 3:1). Major Isomer: 1H NMR (CDCl3): δ 6.32 
(td, J = 16.0, 1.2 Hz, 1H), 6.06 (dt, J = 16.0, 6.0 Hz, 1H), 4.67 (dd, J = 6.0, 1.2 Hz, 2H), 
3.90 (s, 3H), 2.08 (s, 3H), 1.94 (s, 3H). 13C{1H} NMR (CDCl3): δ 170.41, 154.28, 
130.65, 127.72, 64.08, 61.72, 20.72, 9.96. Anal. Calcd for C8H7NO3 (mixture of E/Z 





The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 94 was 
obtained as a pale yellow oil (75%). 1H NMR (CDCl3): δ 7.37 (m, 1H), 7.28-7.23 
(multiple peaks, 2H), 7.14 (d, J = 8.4 Hz, 1H), 3.91 (s, 3H), 3.94 (septet, J = 6.4 Hz, 1H), 






The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 95 was 
obtained as a pale yellow oil (5%). 1H NMR (CDCl3): δ 7.34-7.29 (multiple peaks, 2H), 
7.23-7.15 (multiple peaks, 2H), 7.09 (d, J = 8.4 Hz, 1H), 4.16 (dd, J = 11.2, 7.6Hz, 1H), 
4.04 (dd, J = 11.2, 7.6 Hz, 1H) 3.75 (s, 3H), 2.99 (m, 1H), 1.98 (s, 3H), 1.11 (d, J = 6.4 





The reaction was run with 1.1 equiv PhI(OAc)2 in AcOH/Ac2O. The product 97 was 
obtained as a pale yellow oil (57%). 1H NMR (CDCl3): δ 7.18 (t, J = 7.6 Hz, 1H), 7.00 (d, 
J = 7.2 Hz, 1H), 6.86 (d, J = 8.0 Hz, 1H), 3.91 (s, 3H), 3.45 (sextet, J = 6.8 Hz, 1H) 2.82 




The reaction was run with 1.02 equiv of PhI(OAc)2 in AcOH. Product 100 was obtained 
as a viscous oil  (27% yield). 1H NMR (CDCl3): δ 7.32 (t, J = 8.0 Hz, 1H), 7.13 (d, J = 
8.0 Hz, 1H), 7.00 (d, J = 8.0 Hz, 1H), 4.95 (m, 1H), 4.26-4.18 (multiple peaks, 2H), 3.33 
(dd, J = 17.5, 10.5 Hz, 1H), 3.00 (dd, J = 17.5, 7.5, 1H), 2.36 (s, 3H), 2.28 (s, 3H), 2.11 
(s, 3H). 13C{1H} NMR (CDCl3): δ 170.72, 169.13, 153.61, 148.89, 138.74, 130.07, 
128.04, 122.41, 120.14, 77.62, 64.72, 40.37, 20.95, 20.78, 20.09. HRMS (ESI, m/z): [M 






The reaction was run with 1.02 equiv of PhI(OAc)2 in AcOH. Product 101 was obtained 
as a viscous oil  (34% yield). 1H NMR (CDCl3): δ 7.51 (d, J = 8.0 Hz, 1H), 7.43 (m, 1H), 
7.38-7.37 (multiple peaks, 2H), 5.42 (s, 2H), 4.95 (m, 1H), 4.28 (dd, J = 12.0, 4.0 Hz, 
1H), 4.21 (dd, J = 12.0, 5.5, 1H), 3.53 (dd, J = 17.0, 11.0 Hz, 1H), 3.20 (dd, J = 17.0, 7.0 
Hz, 1H), 2.14 (s, 3H), 2.10 (s, 3H). 13C{1H} NMR (CDCl3): δ 170.82, 170.54, 156.10, 
135.79, 129.80, 128.79, 128.35, 127.84, 127.33, 64.88, 64.85, 39.36, 20.79. HRMS (ESI, 




The reaction was run with 1.02 equiv of PhI(OAc)2 in AcOH. Product 106 was obtained 
as a viscous oil  (65% yield). 1H NMR (CDCl3): δ 8.71 (m, 1H), 7.74 (td, J = 7.5, 2.0 Hz, 
1H), 7.33-7.25 (multiple peaks, 3H), 7.17 (d, J = 8.0 Hz, 1H), 6.98 (d, J = 8.0 Hz, 1H), 
2.15 (s, 3H), 1.94 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.21, 155.56, 149.26, 148.18, 
137.92, 135.86, 133.34, 128.63, 127.76, 124.53, 121.92, 119.76, 20.30, 19.67. HRMS 





The reaction was run with 1.02 equiv of PhI(OAc)2 in AcOH. Product 109 was obtained 
as a viscous oil  (90% yield). 1H NMR (CDCl3): δ 7.73 (d, J = 2.0 Hz, 1H), 7.46 (d, J = 
2.0 Hz, 1H), 7.36 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.04 (d, J = 7.5 Hz, 1H), 
6.42 (t, J = 2.0 Hz, 1H), 2.11 (s, 3H), 2.02 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.21, 
146.87, 140.54, 137.88, 132.80, 131.42, 129.56, 128.33, 120.72, 105.96, 20.38, 17.34. 





The reaction was run with 1.02 equiv of PhI(OAc)2 in AcOH. Product 112 was obtained 
as a viscous oil  (30% yield). 1H NMR (CDCl3): δ 7.50 (dd, J = 8.0, 1.5 Hz, 1H), 7.46 (td, 
J = 8.0, 2.0 Hz, 1H), 7.32 (td, J = 8.0, 1.5 Hz, 1H), 7.15 (d, J = 8.0 Hz), 4.91 (m, 1H), 
4.27 (dd, J = 12.0, 4.0 Hz, 1H), 4.18 (dd, J = 12.0, 6.0 Hz, 1H), 3.47 (dd, J = 16.5, 10.5, 
1H), 3.16 (dd, J = 16.5, 7.0 Hz, 1H), 2.32 (s, 3H), 2.10 (s, 3H). 13C{1H} NMR (CDCl3): δ 
170.70, 169.51, 153.55, 148.32, 130.88, 129.36, 126.17, 123.76, 77.46, 64.69, 38.53, 







The reaction was run with 2.1 equiv of PhI(OAc)2 in AcOH. Product 116 was obtained as 
a viscous oil  (75% yield). 1H NMR (CDCl3): δ 7.25 (t, J = 8.0 Hz, 1H), 6.97 (d, J = 8.0 
Hz, 2H), 4.74 (m, 1H), 4.10 (t, J = 4.4 Hz, 2H), 2.93 (dd, J = 17.2, 10.8 Hz, 1H), 2.76 (t, 
J = 7.6 Hz, 2H), 2.63 (dd, J = 17.2, 6.8 Hz, 1H), 2.48 (t, J = 7.2, 2H), 2.31 (s, 6H), 2.06 
(s, 3H). 13C{1H} NMR (CDCl3): δ 170.68, 169.11, 157.64, 149.70, 127.41, 125.58, 
120.23, 77.32, 64.87, 39.74, 26.88, 21.87, 20.83, 20.68. HRMS (ESI, m/z): [M + Na]+ 






The reaction was run with 2.1 equiv of PhI(OAc)2 in AcOH. Product 126 was obtained as 
a viscous oil  (89% yield). 1H NMR (CDCl3): δ 7.30 (t, J = 8.0 Hz, 1H), 6.98 (d, J = 8.0 
Hz, 2H), 3.83 (s, 3H), 3.39 (s, 2H), 2.31 (s, 6H), 1.64 (s, 3H). 13C{1H} NMR (CDCl3): δ 
 59 
154.98, 150.24, 127.87, 122.08, 120.43, 61.15, 31.04, 20.87, 12.89. HRMS (ESI, m/z): 





The reaction was run with 2.1 equiv of PhI(OAc)2 in AcOH. Product 128 was obtained as 
a viscous oil  (17% yield). 1H NMR (CDCl3): δ 7.27-7.22 (multiple peaks, 2H), 7.18 (t, J 
= 7.5 Hz, 1H), 7.03 (d, J = 7.5 Hz, 1H), 3.84 (s, 3H), 2.73 (t, J = 8.0 Hz, 2H), 2.42 (t, J = 
8.0 Hz, 2H), 2.34 (s, 3H), 1.84 (s, 3H). 13C{1H} NMR (CDCl3): (mixture of oxime 
isomers) δ 169.39, 157.15, 156.47, 148.88, 148.82, 132.94, 132.91, 130.11, 130.06, 
127.37, 127.30, 126.15, 122.28, 61.09, 61.05, 36.17, 29.84, 27.30, 26.27, 20.86, 20.80, 






The reaction was run with 1.1 equiv of PhI(OAc)2 in AcOH. Product 136 was obtained as 
a viscous oil  (56% yield). 1H NMR (CDCl3): δ 7.32-7.23 (multiple peaks, 3H), 7.05 (m,  
1H), 4.47 (m, 1H), 3.93 (q, J = 7.0 Hz, 1H), 2.67 (dd, J = 17.0, 10.0 Hz, 1H), 2.37-2.32 
(multiple peaks, 4H), 1.63 (m, 1H), 1.51 (d, J = 6.5, 3H), 1.44 (m, 1H), 1.34-1.22 
(multiple peaks, 4H), 0.87 (t, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 169.66, 160.54, 
148.60, 133.35, 128.13, 128.00, 126.51, 122.97, 80.63, 40.50, 34.71, 33.54, 27.56, 22.42, 




The reaction was run with 1.1 equiv of PhI(OAc)2 in AcOH. Product 139 was obtained as 
a viscous oil  (60% yield). 1H NMR (CDCl3): δ 7.28-7.17 (multiple peaks, 3H), 7.04 (d, J 
= 8.4 Hz, 1H), 4.73 (m, 1H), 4.13-4.04 (multiple peaks, 2H), 3.98 (dd, J = 12.0, 6.0 Hz, 
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1H), 3.02-2.84 (multiple peaks, 3H), 2.70-2.59 (multiple peaks, 2H), 2.33 (s, 3H), 2.06 (s, 
3H), 1.16 (d, J = 8.0, 3H). 13C{1H} NMR (CDCl3): δ 170.77, 169.37, 161.72, 149.09, 
131.02, 130.86, 127.78, 126.14, 122.58, 122.55, 76.83, 65.02, 64.95, 37.46, 37.53, 35.13, 
35.10, 33.31, 21.01, 20.77, 17.97. HRMS (ESI, m/z): [M + Na]+ calcd for C17H21NO5, 




The reaction was run with 1.1 equiv of PhI(OAc)2 in AcOH. Product 142 was obtained as 
a viscous oil  (10% yield, 1:1). Isomer 1: 1H NMR (CDCl3): δ 7.26-7.12 (multiple peaks, 
4H), 4.72 (m, 1H), 4.17-4.00 (multiple peaks, 2H), 2.90 (m, 1H), 2.73-2.49 (multiple 





The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 145 was obtained as 
a viscous oil  (43% yield, Oxime Isomers 1:1). Oxime Isomer 1: 1H NMR (CDCl3): δ 
7.31-7.21 (multiple peaks, 3H), 7.01 (d, J = 8.0 Hz, 1H), 3.88 (s, 3H), 3.79 (q, J = 7.0 Hz, 
1H), 2.32 (s, 3H), 1.59 (s, 3H), 1.40 (d, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 
169.41, 158.49, 148.94, 133.97, 128.17, 127.74, 126.22, 122.77, 61.33, 61.14, 39.61, 
20.87, 17.25, 12.27. HRMS electrospray (m/z): [M + Na]+ calcd for C13H17NO3, 
258.1106 found, 258.1096. Oxime Isomer 2: 1H NMR (CDCl3): δ 7.34 (dd, J = 7.0, 1.5 
Hz, 1H), 7.29-7.23 (multiple peaks, 2H), 7.01 (dd, J = 7.5, 2.0 Hz, 1H), 4.71 (q, J = 7.5 
Hz, 1H), 3.86 (s, 3H), 2.26 (s, 3H), 1.50 (s, 3H), 1.36 (d, J = 7.5 Hz, 3H). HRMS (ESI, 






The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 146 was obtained as 
a viscous oil  22% yield). 1H NMR (CDCl3): δ 7.28 (t, J = 8.5 Hz, 1H), 6.95 (d, J = 8.5 
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Hz, 2H), 3.88 (s, 3H), 3.68 (q, J = 7.0 Hz, 1H), 2.29 (s, 6H), 1.61 (s, 3H), 1.38 (d, J = 7.0 
Hz, 3H). 13C{1H} NMR (CDCl3): δ 169.12, 157.44, 149.74, 127.60, 127.48, 120.94, 
61.19, 37.66, 20.75, 15.35, 14.03. HRMS (ESI, m/z): [M + Na]+ calcd for C15H19NO5, 




The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 149 was obtained as 
a viscous oil  (83% yield). 1H NMR (CDCl3): δ 7.37 (d, J = 7.6 Hz, 1H), 7.18 (d, J = 7.6 
Hz, 1H), 7.00 (d, J = 8.4 Hz, 1H), 4.96 (m, 1H), 4.27-4.18 (multiple peaks, 2H), 3.32 (dd, 
J = 17.2, 10.8 Hz, 1H), 3.01 (dd, J = 17.2, 6.8, 1H), 2.66 (q, J = 7.6 Hz, 1H), 2.28 (s, 3H), 
2.12 (s, 3H), 1.23 (t, J = 7.6 Hz, 3H). 13C{1H} NMR (CDCl3): δ 170.74, 169.07, 153.51, 
148.83, 144.96, 130.28, 126.37, 121.81, 120.11, 77.65, 64.73, 41.04, 26.51, 20.98, 20.78, 






The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 150 was obtained as 
a viscous oil  (8% yield, 1:1). Isomer 1: 1H NMR (CDCl3): δ 7.44 (d, J = 7.6 Hz, 1H), 
7.38 (d, J = 7.6 Hz, 1H), 7.12 (m, 1H), 5.79 (quin, J = 6.4 Hz, 1H), 5.00 (m, 1H), 4.26-
4.21 (multiple peaks, 2H), 3.50 (dd, J = 17.2, 11.2, 1H), 3.09 (dd, J = 17.2, 7.2 Hz, 1H), 






The reaction was run with 1.5 equiv of PhI(OAc)2 in AcOH. Product 172 was obtained as 
a viscous oil  (6% yield). 1H NMR (CDCl3): δ 8.59 (d, J = 5.5 Hz, 1H), 7.86 (d, J = 8.0 
Hz, 1H), 7.67 (td, J = 9.0, 1.5 Hz, 1H), 7.25 (m, 1H), 5.35 (s, 2H), 4.26 (t, J = 6.0 Hz, 
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2H), 2.01 (s, 3H), 1.70 (m, 2H), 1.41 (m, 2H), 0.93 (t, J = 7.5 Hz, 3H). 13C{1H} NMR 
(CDCl3): δ 170.58, 152.66, 152.58, 148.92, 136.29, 123.63, 120.93, 75.12, 54.84, 31.16, 







Decalone O-methyl oxime (200 mg, 1.11 mmol, 1 equiv), PhI(OAc)2 (539 mg, 1.66 
mmol, 1.5 equiv), and Pd(OAc)2 (12 mg, 0.055 mmol, 0.05 equiv) were combined in 
AcOH (5 mL) and Ac2O (5 mL) in a 20 mL vial. The vial was sealed with a Teflon lined 
cap, and the reaction was stirred at 80ºC for 5 h. The reaction mixture was evaporated to 
dryness and then taken up in 3 mL of pyridine. The pyridine suspension was filtered 
through a short plug of silica, and the silica was washed with copious ethyl acetate to 
remove all of the organic products. The resulting solution was concentrated under 
vacuum to afford a reddish oil, which was purified by chromatography on silica gel (Rf  = 
0.3 in 90% hexanes/10% ethyl acetate). The product 184 was obtained as pale yellow 
crystals (210 mg, 81% yield). 1H NMR (CDCl3): δ 5.03 (ddd, J = 10.9, 10.7, 4.8 Hz, 1H), 
3.69 (s, 3H), 3.24 (br d, J = 13.1, 1H), 2.0 (m, 1H), 1.93 (s, 3H), 1.91 (d, J = 10.9, 1H), 
1.81-0.96 (multiple peaks, 12H). 13C{1H} NMR (CDCl3): δ 170.18, 157.54, 70.42, 61.06, 
51.70, 43.31, 33.32, 32.97, 31.60, 25.59, 25.38, 23.12, 21.09. Anal. Calcd for C13H21NO3: 
C, 65.25, H, 8.84, N, 5.85; Found: C, 65.51, H, 8.79, N, 5.77. 
 
The equatorial stereochemistry of the OAc group of 31 was assigned based on standard 








Product 184 was reacted with 2 equiv TiCl3 and 2 equiv NH4OAc in refluxing degassed 
AcOH:Dioxane:H2O for 2 h. The reaction was extracted with ether. The ethereal layer 
was dried over MgSO4, filtered and concentrated. The resulting oil was was purified by 
chromatography on silica gel (Rf  = 0.3 in 90% hexanes/10% ethyl acetate). Product 185 
was obtained as white crystalline solid. 1H NMR (CDCl3): δ 5.00 (td, J = 11.2, 5.2 Hz, 
1H), 2.38-.2.26(multiple peaks, 2H), 2.19-2.04 (multiple peaks, 2H), 1.98 (s, 3H), 1.87-
1.66 (multiple peaks, 4H), 1.52-1.48 (multiple peaks, 2H), 1.35-1.11 (multiple peaks, 
4H). 
Structure Determination. 
 Colorless needles of 185 were grown from an ether solution at -10 deg. C.  A 
crystal of dimensions 0.50 x 0.10 x 0.04 mm was mounted on a standard Bruker SMART 
CCD-based X-ray diffractometer equipped with a LT-2 low temperature device and normal 
focus Mo-target X-ray tube (λ = 0.71073 A) operated at 2000 W power (50 kV, 40 mA).  
The X-ray intensities were measured at 123(2) K; the detector was placed at a distance 
4.980 cm from the crystal.  A total of 2338 frames were collected with a scan width of 0.3° 
in ω and phi with an exposure time of 60 s/frame. The integration of the data yielded a total 
of 17004 reflections to a maximum 2θ value of 46.76° of which 1704 were independent and 
1325 were greater than 2θ(I).  The final cell constants (Table 1) were based on the xyz 
centroids of 3514 reflections above 10σ(I).  Analysis of the data showed negligible decay 
during data collection; the data were processed with SADABS.  No correction for 
absorption was necessary.  The structure was solved and refined with the Bruker SHELXTL 
(version 6.12) software package, using the space group Pca2(1) with Z = 8 for the formula 
C12H18O3.  All non-hydrogen atoms were refined anisotropically with the hydrogen atoms 
placed in idealized positions.  Full matrix least-squares refinement based on F2 converged at 
R1 = 0.0538 and wR2 = 0.1379 [based on I > 2sigma(I)], R1 = 0.0769 and wR2 = 0.1585 
for all data.   
 
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of Area 
Detector Data, University of Gottingen: Gottingen, Germany, 2003.   
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Decalone oxime was reacted with 1.0 equiv Na2PdCl4 and 1.12 equiv NaOAc in MeOH 
at rt for 3 days.40 The crude reaction was concentrated in vacuum. The crude red brown 
solid was dissolved in CH2Cl2 and filtered through celite. The resulting solution is 
concentrated and dissolved in hot methanol. The crude solid is collected and reacted with 
1.0 equiv pyridine in THF for 10 minutes. The crude reaction is concentrated and purified 
by chromatography on silica gel (50% hexanes/50% ethyl acetate to 35% hexanes/65% 
ethyl acetate). Product 190 was obtained as yellow solid (93% pure). 1H NMR (CDCl3): δ 
9.85 (s, 1H), 8.75 (d, 7.6 Hz, 2H), 7.75 (t, J = 7.6 Hz, 1H), 7.33 (dd, J = 7.6, 6.8 Hz, 2H), 
3.07-3.00 (multiple peaks, 2H), 2.07 (m, 1H), 1.97-1.83 (multiple peaks, 2H), 1.68 (m, 
1H), 1.57-1.52 (multiple peaks, 2H), 1.43-1.32 (multiple peaks, 4H), 1.14-1.02 (multiple 
peaks, 3H). 13C{1H} NMR (CDCl3): δ 169.15, 152.79, 137.49, 125.10, 60.72, 47.14, 
44.06, 33.99, 33.96, 31.18, 28.21, 27.17, 25.34, 23.03, 22.53. 
Structure Determination. 
 Pale yellow needles of 190 were grown from a dichloromethane/pentane solution at 
22 deg. C.  A crystal of dimensions 0.60 x 0.34 x 0.10 mm was mounted on a standard 
Bruker SMART CCD-based X-ray diffractometer equipped with a LT-2 low temperature 
device and normal focus Mo-target X-ray tube (λ = 0.71073 A) operated at 2000 W power 
(50 kV, 40 mA).  The X-ray intensities were measured at 123(2) K; the detector was placed 
at a distance 4.980 cm from the crystal.  A total of 3040 frames were collected with a scan 
width of 0.2° in ω and phi with an exposure time of 10 s/frame. The integration of the data 
yielded a total of 17473 reflections to a maximum 2θ value of 56.64° of which 3703 were 
independent and 3525 were greater than 2σ(I).  The final cell constants (Table 1) were 
based on the xyz centroids of 6708 reflections above 10σ(I).  Analysis of the data showed 
negligible decay during data collection; the data were processed with SADABS and 
corrected for absorption.  The structure was solved and refined with the Bruker SHELXTL 
(version 6.12) software package, using the space group P2(1)/c with Z = 4 for the formula 
C15H21N2OPd.  All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in idealized positions with the exception of the oxime hydrogen which was 
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located on a difference Fourier map.  Full matrix least-squares refinement based on F2 
converged at R1 = 0.0210 and wR2 = 0.0568 [based on I > 2sigma(I)], R1 = 0.0223 and 
wR2 = 0.0576 for all data.   
 
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of Area 
Detector Data, University of Gottingen: Gottingen, Germany, 2003.   









Product 190 was reacted with AgOAc in AcOH at 25°C for 12 h. The reaction was 
filtered through celite and concentrated. Recrystallization of product 191 with CH2Cl2 
and hexanes afforded a yellow solid (93% pure). 1H NMR (CDCl3): δ 8.66 (d, 5.2 Hz, 
2H), 7.75 (t, J = 6.8 Hz, 1H), 7.31 (dd, J = 6.0 Hz, 2H), 3.13 (dd, J = 17.2, 9.2, 1H), 2.80 
(t, J = 9.2 Hz, 1H), 2.00 (t, J = 10.0 Hz, 1H), 1.91-1.76 (multiple peaks, 4H), 1.61-1.44 
(multiple peaks, 3H), 1.34-1.18 (multiple peaks, 4H), 1.05-0.90 (multiple peaks, 3H). 
Structure Determination. 
 Colorless blocks of 191 were grown from a dichloromethane solution at 22 deg. C.  
A crystal of dimensions 0.34 x 0.22 x 0.14 mm was mounted on a standard Bruker 
SMART CCD-based X-ray diffractometer equipped with a LT-2 low temperature device 
and normal focus Mo-target X-ray tube (λ = 0.71073 A) operated at 2000 W power (50 kV, 
40 mA).  The X-ray intensities were measured at 123(2) K; the detector was placed at a 
distance 4.980 cm from the crystal.  A total of 4545 frames were collected with a scan width 
of 0.2° in ω and phi with an exposure time of 10 s/frame. The integration of the data 
yielded a total of 58517 reflections to a maximum 2θ value of 56.80° of which 4660 were 
independent and 4297 were greater than 2σ(I).  The final cell constants (Table 1) were 
based on the xyz centroids of 9446 reflections above 10σ(I).  Analysis of the data showed 
negligible decay during data collection; the data were processed with SADABS and 
corrected for absorption.  The structure was solved and refined with the Bruker SHELXTL 
(version 6.12) software package, using the space group I4(1)/a with Z = 16 for the formula 
C17H24N2O3Pd.  All non-hydrogen atoms were refined anisotropically with the hydrogen 
atoms placed in both idealized and refined positions.  Full matrix least-squares refinement 
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based on F2 converged at R1 = 0.0365 and wR2 = 0.0878 [based on I > 2sigma(I)], R1 = 
0.0390 and wR2 = 0.0887 for all data.   
 
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of Area 
Detector Data, University of Gottingen: Gottingen, Germany, 2003.   
Saint Plus, v. 7.01, Bruker Analytical X-ray, Madison, WI, 2003. 
 
General Procedure for Stoichiometric Reactions of Palladacycle Monomers with Oxidants 
(PhI(OAc)2, PhICl2, MeI): Monomers 190 and 191 were reacted with 1.0 equiv of the 
Oxidant in AcOH at 100 °C for 12 h. The reaction was concentrated and their crude 






Product 192: 1H NMR (CDCl3): δ 4.08 (dt, J = 10.8, 4.0 1H), 2.52-2.41 (multiple peaks, 
3H), 2.30-2.26 (multiple peaks, 2H), 2.13-2.09 (multiple peaks, 2H), 1.84-1.49 (multiple 








 Colorless plates of 193 were grown from an ether solution at 22 deg. C.  A crystal 
of dimensions 0.28 x 0.20 x 0.05 mm was mounted on a standard Bruker SMART CCD-
based X-ray diffractometer equipped with a LT-2 low temperature device and normal focus 
Mo-target X-ray tube (λ = 0.71073 A) operated at 2000 W power (50 kV, 40 mA).  The X-
ray intensities were measured at 123(2) K; the detector was placed at a distance 4.980 cm 
from the crystal.  A total of 3698 frames were collected with a scan width of 0.2° in ω and 
phi with an exposure time of 30 s/frame. The integration of the data yielded a total of 11491 
reflections to a maximum 2θ value of 56.68° of which 2558 were independent and 1864 
were greater than 2σ(I).  The final cell constants (Table 1) were based on the xyz centroids 
of 3409 reflections above 10σ(I).  Analysis of the data showed negligible decay during data 
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collection; the data were processed with SADABS, no correction for absorption was 
necessary.  The structure was solved and refined with the Bruker SHELXTL (version 6.12) 
software package, using the space group P2(1)/n with Z = 4 for the formula C11H19NO.  
All non-hydrogen atoms were refined anisotropically with the hydrogen atoms placed in 
idealized positions.  Full matrix least-squares refinement based on F2 converged at R1 = 
0.0459 and wR2 = 0.1178 [based on I > 2sigma(I)], R1 = 0.0709 and wR2 = 0.1307 for all 
data.   
 
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of Area 
Detector Data, University of Gottingen: Gottingen, Germany, 2003.   
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3.1 Background and Significance 
 
Significant current efforts in the literature are focused on the development of 
“green” catalytic reactions that are safe, scalable, environmentally friendly, and cost 
effective. In particular, such studies have explored the application of practical green 
oxidants, such as organic and inorganic peroxides, in transition metal catalyzed 
transformations. Peroxides are considered practical and green oxidants due to their low 
toxicity and expense. Two of these oxidants – H2O2 and Oxone 
(2KHSO5•KHSO4•K2SO4) – have been especially widely used in the metal catalyzed 
oxidation of alkenes,1, 2 sulfides3 and alcohols.4, 5 We envisioned that we could apply 
these peroxide oxidants in our palladium-catalyzed C–H bond oxygenation reactions.  
Our group has shown that Pd(OAc)2 in conjunction with PhI(OAc)2 serves as an 
efficient catalyst to transform sp2 and sp3 C–H bonds to C–OAc bonds, affording 
acetoxylated products in excellent yield and extremely high selectivity.6-8 As summarized 
in Scheme 3.1, the mechanism of these reactions is proposed to involve initial ligand-
directed C–H activation to provide cyclometalated PdII complex A. Complex A is then 
believed to undergo oxidation by PhI(OAc)2 to afford a Pd
IV intermediate B. Both of the 
acetates from the oxidant are transferred to the metal in this step, and iodobenzene is 
released as a byproduct. Carbon-oxygen bond forming reductive elimination then affords 
the final acetoxylated product. 
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Even though PhI(OAc)2 serves as an effective oxidant to oxygenate a wide range 
of substrates, there are some disadvantages associated with its use. The byproduct from 
these reactions, iodobenzene, is toxic, and, therefore further purification processes are 
required for its usage. As the equivalents of oxidant increase, the accumulation of this 
byproduct increases, which reduces the overall atom economy of the system. 
Additionally, PhI(OAc)2 is relatively expensive, at approximately $1/gram. Based on 
these disadvantages, we desired to replace PhI(OAc)2 with greener and less costly 
oxidants such as peroxides. 
The key intermediate in Pd-catalyzed C–H bond oxygenation transformations is 
the PdIV complex B (Scheme 3.1). We wondered if it would be possible to generate this 
complex using alternative oxidants. While PdIV complexes are plausible intermediates, 
they are typically not easily observed because of their high reactivity. As a result, PtIV 
complexes are often used as models for putative PdIV intermediates, since platinum is in 
the same group as palladium in the periodic table. It is well known in the literature that 
PtII complexes react with oxidants in a very similar fashion to PdII complexes, but the 
resulting products are more stable.9-12 As shown in Scheme 3.2, Jung and coworkers have 
shown that it is possible to oxidize PtII to PtIV, using H2O2 as the oxidant and AcOH as 
the solvent.13 In this reaction, H2O2 serves to oxidize Pt
II to PtIV and AcOH serves as the 
source of acetate in the final product. If platinum is a true model for palladium, then this 
result suggests that peroxides in AcOH could potentially be used as stoichiometric 
oxidants in place of PhI(OAc)2 to generate catalytic intermediate B. 
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(1) (2)  
 
Herrmann and coworkers have reported a rare example where an inorganic 
peroxide – K2S2O8 – was used as the stoichiometric oxidant in a Pd-catalyzed C–H bond 
oxygenation reaction.14 Subjection of a suspension of K2S2O8 in CF3CO2H/(CF3CO)2O to 
20 bar CH4 in the presence of a catalytic amount of PdII catalyst C led to the formation of 
CH3O2CCF3 (Scheme 3.3).  
 













Although the authors do not speculate on the mechanism, we believe that the 
reaction likely proceeds via a high oxidation state PdIV intermediate analogous to 2 
above. Similar to the Jung system, the trifluoroacetic acid is expected to serve as a source 
of trifluoroacetate groups on the metal, which upon reductive elimination form the 
product CH3O2CCF3. Although this reaction is a promising initial lead, the requirement 
of 100 equiv of K2S2O8 as well as the high pressure of methane limits its practical utility.  
 
3.2  Initial Screenings of Peroxides 
 
Initial studies focused on applying peroxides as stoichiometric oxidants in the Pd-
catalyzed directed acetoxylation of m-bromoacetophenone oxime ether. Based on Jung’s 
report, we chose to employ acetic acid as the reaction media and the source of acetate in 
the final product. A variety of peroxides were screened under our previously determined 
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reaction conditions for PhI(OAc)2-mediated acetoxylation reactions (5 mol % Pd(OAc)2, 
2 equiv of oxidant in AcOH at 100 ºC) (Table 3.1). Interestingly, the use of H2O2 in this 
Pd-catalyzed reaction resulted in only 11% of our desired product (entry 1), despite the 
fact that it was a highly effective stoichiometric oxidant for PtII (Scheme 3.2). We 
rationalize this result based on reports that PdII rapidly catalyzes the disproportionation of 
H2O2 to H2O and O2 (Scheme 3.4), and O2 is not capable of oxidizing Pd
II to PdIV in these 
systems.15  
 







Other peroxides such as m-chloroperoxybenzoic acid (m-CPBA) and peracetic 
acid provided slightly higher yields than H2O2 (14% and 34%, respectively – entries 3 
and 4); however, despite attempts to further optimize these reactions, they never afforded 
synthetically useful quantities of the product. The most promising results were obtained 
using the inorganic peroxides Oxone and K2S2O8 as terminal oxidants. These reagents 
afforded the acetoxylated product in comparable yield as PhI(OAc)2 (Table 3.1, entries 7 
and 8). Notably, use of the tetrabutylammounium salt of Oxone substantially lowered the 
yield of the acetoxylated product (entry 5), suggesting that increasing the solubility of the 
oxidant was unfavorable. Importantly, control reactions of substrate 3 with Oxone and 
K2S2O8, in the absence of Pd(OAc)2, did not afford any of the desired acetoxylated 
product 3a. Instead about 25% decomposition of the starting material to a complex 
mixture of unidentified products was observed. 
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Table 3.1: Screen of Peroxide Oxidants for the Pd-Catalyzed Acetoxylation of m-










































Palladium-catalyzed C–H bond acetoxylation with Oxone is an exciting result, 
because this oxidant is environmentally benign, safe (not explosive like many other 
peroxides), and inexpensive. These features make Oxone attractive for large-scale 
applications. We have conducted the reaction of substrate 3 with Oxone effectively at 
scales ranging from 1 mmol to 66 mmol. When we initially executed the 66 mmol scale 
reaction in AcOH, we obtained the desired product, via Kugelrohr distillation, in modest 
45% yield (in contrast, the yield on 1 mmol scale was 68%). This reduction in yield was 
due to competitive formation of the hydrolyzed product 3c (Scheme 3.5). The hydrolysis 
was addressed by addition of 10% acetic anhydride to the reaction mixture, which 
improved the yield of product 3a to 54% on a 66 mmol scale. Importantly, these large 
scale reactions were optimized with 3 mol % of Pd(OAc)2. Further reduction in the 
amount of catalyst was possible; however, longer reaction times were required. 
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(66 mmol) 100% AcOH : 45%










3.3  Scope of Acetoxylation of sp2 C–H Bonds with Oxone and K2S2O8 
 
We next desired to explore the scope of the acetoxylation of substrates with 
Oxone and K2S2O8 in AcOH. This reaction was applied to substrates containing a variety 
of directing groups, including oxime ethers of ketones and aldehydes, amides, and 
isoxazolines (Table 3.2 and 3.3).16 We were delighted to see that substrates that required 
the formation of five (substrates 5-11) and six (substrates 12-13) membered palladacyclic 
intermediates upon C–H activation were all effectively functionalized by Oxone and 
K2S2O8. Both electron rich and poor arenes as well as oxidizable functionalities such as 
benzylic C-H bonds were well tolerated. Notably, substrates 9-13 afforded better yields 
of the desired acetoxylated products with K2S2O8 than Oxone (Table 3.3). Tuning the 
stoichiometry of the oxidant allowed for the formation of mono or diacetoxylated 
products as desired (Scheme 3.6, products 4a and 4b). Acetic anhydride was used in 
conjunction with AcOH in the reaction for some substrates (particularly electron rich 
oxime ethers and oxime ethers derived from aldehydes) to attenuate hydrolysis.  
 
Scheme 3.6: Product Distribution as a Function of Oxidant Stoichiometry 
N
OMe 5 mol % Pd(OAc)2
1-3.5 equiv Oxone or K2S2O8
H
AcOH or AcOH/Ac2O (1:1)








1.2 equiv Oxone  (PhI(OAc)2)   53% (73%) : 18% (9%)
























































Table 3.3: Substrate Scope with K2S2O8 






































Substrate Product Yield with K2S2O8
























In substrates containing substituents meta to the directing group (for example, 5-
10), two different ortho-C–H bonds could potentially be functionalized. In most of these 
reactions, the sterically less hindered C–H bond was acetoxylated selectively (Table 3.1 
and 2, entries 1-4 and 1-2 respectively).8 On the contrary, in the meta-hydroxy substrate 
14, the sterically more hindered C–H bond was acetoxylated (Scheme 3.7). We believe 
that the alcohol and the oxime ether functionalities may chelate to the palladium and 
thereby afford this reversal of selectivity. Importantly, the selectivity of this reaction was 
confirmed by synthesizing authentic samples of products 14a and 14b. 
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Scheme 3.7: Reaction of Substrate 14 with Oxone and PhI(OAc)2 
N




















My colleague Hasnain Malik obtained the corresponding yields of products 3a-
13a from reactions with PhI(OAc)2. In general, yields with Oxone and K2S2O8 were 
comparable to those with PhI(OAc)2. However, two notable exceptions were substrates 
14 and 15. Subjection of substrate 14 under our catalytic conditions using PhI(OAc)2 
resulted in less than 5% of the desired product, presumably due to undesired oxidation of 
14 to the corresponding quinone.17 In contrast, reaction of substrate 14 with Oxone 
afforded 35% of the desired product (Scheme 3.7). The low yield here is due to 
decomposition of the starting material to unidentified products. Similarly, reaction of 
amide 15 with PhI(OAc)2 resulted in decomposition of the starting material, presumably 
via uncatalyzed reaction between the hypervalent iodine oxidant and the amide 
functionality. PhI(OAc)2 has been shown to react with amides to form rearranged 
products via a RCONHI(Ph)OAc intermediate.18, 19 However, reaction of 15 with Oxone 
afforded 38% of the acetoxylated product 15a (Scheme 3.8). In this case, the balance of 
material was accounted for as unreacted substrate 15. 
 
Scheme 3.8: Palladium-Catalyzed Oxidation of m-Chloroacetanilide  
H
N















There are some limitations associated with the use of Oxone and K2S2O8 as 
oxidants in place of PhI(OAc)2. For example, substrates 16-18 resulted in low yields 
and/or reactivity with these peroxides in comparison with PhI(OAc)2. With substrates 16 
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and 17, we believe that these limitations are due to competitive N-oxide formation. For 
example, subjection of quinoxaline 16 to the catalytic reaction conditions with PhI(OAc)2 
resulted in a single acetoxylated product 16a in 65% yield. In contrast, subjection of 16 to 
catalytic conditions with Oxone afforded three products – acetoxylated compound 16a, 
the N-oxide of the acetoxylated product (16a-O), and the N-oxide of the starting material 
(16-O). The assignment of the regioselectivity of N-oxidation was made based on 
comparison of the NMR of 16a to 16a-O following a similar approach taken in 
literature.20 
 
Scheme 3.9: Palladium-Catalyzed Reaction of Quinoxaline with Oxone 




























Similarly, subjection of azobenzene substrate 17 under catalytic conditions with 
PhI(OAc)2 afforded the desired acetoxylated product 17a in 58% yield. On the other 
hand, reaction of azobenzene with Oxone yielded significant quantities of the 
corresponding N-oxide (17-O) along with the acetoxylated product 17a. 
 
Scheme 3.10: Reaction of Azobenzene Substrate 17 with Oxone 
(17a, 39%) (17-O, 36%)
(17)
(17a, 58%)
























The yield of the desired acetoxylated product in reactions of substrates bearing 
pyridine directing groups appears to be hampered by another palladium-catalyzed side 
reaction. For example, reaction of 2-phenylpyridine with Oxone resulted in the formation 
of the desired acetoxylated product 18a, diacetoxylated product 18b, and a new 
compound. As shown in Scheme 3.11, this new compound was identified as the 
homodimer 18c by Kami Hull.21 In contrast, reaction of 18 with PhI(OAc)2 afforded the 
acetoxylated product 18a (52% yield) and the diacetoxylated product 18b (22% yield), 
and none of product 18c was observed.  
 































There were also directing groups that resulted in low yields of the desired 
acetoxylated product with both Oxone and PhI(OAc)2 due to uncatalyzed side reactions 
of the substrate with the oxidant. For example, reaction of oxazoline 19 with both 
PhI(OAc)2 and Oxone afforded <5% of acetoxylated product 19a. This low yield is due 
to uncatalyzed addition of HOAc across the imine. 
 








OAc5 mol % Pd(OAc)2
1 equiv Oxone or PhI(OAc)2
AcOH/Ac2O (1:1)
100 oC
(19) (19a, <5%) (19b, 78%)  
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3.4  Scope of Acetoxylation of sp3 C–H Bonds with Oxone and K2S2O8 
 
Excitingly, sp3 C-H bonds were also effectively functionalized to afford 
acetoxylated products with Oxone and K2S2O8. Reaction of substrate 20 with Oxone is 
particular notable (Scheme 3.13). Even though there are multiple different 1o C–H bonds 
as well as weaker 2o C–H bonds that could undergo oxidation, high selectivity was 
observed for the 1º β-C–H bond. This high selectivity for 1o C–H bonds with Oxone 
suggests strongly against the possibility of radical reaction pathways (common for 
peroxide reagents with weak O–O bonds) and instead is indicative of a ligand-directed 
C–H activation at palladium. Notably, the yield of product 20a with Oxone was low in 
comparison to that with PhI(OAc)2, (45% versus 75%, respectively), and the balance of 
the material was decomposition of the starting material. Similarly, Pd-catalyzed reaction 
of Oxone with camphor substrate 21 also afforded the desired acetoxylated product 
(Scheme 3.13). Finally, the reaction of trans-decalone substrate 22 with Oxone afforded a 
single diastereomeric product (22a) in 23% yield. The same diastereoselectivity was 
observed with PhI(OAc)2 (although the product was obtained in significantly higher 81% 
yield in this case). This result implies that reductive elimination from PdIV under both the 
Oxone and the PhI(OAc)2 proceeds via a similar mechanism – with retention of 
stereochemistry at carbon. The low yields of the desired products with substrates 20-22 
were due to decomposition of the starting material under the oxidative conditions. 
Subjection of the substrate and product individually to the reaction conditions, in the 
absence of palladium, only led to 60% recovery due to the formation of unidentified 
decomposition products.   
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Concurrent to the work described herein, Yu and coworkers reported the use of 
peroxyesters in Ac2O for the Pd-catalyzed oxazoline-directed acetoxylation of sp3 C–H 
bonds (Scheme 3.14).22 They proposed that this reaction proceeds via a PdII/IV catalytic 
cycle, where MeCOOOtBu serves to oxidize PdII to PdIV. The authors also proposed that 
acetic anhydride is essential for catalytic turnover, and state that it is required both to 
introduce acetate ligands at PdIV and to regenerate Pd(OAc)2 by acetylating the Pd-OR 
complex formed at the end of the catalytic cycle. Notably, this is in sharp contrast to what 
is observed in our peroxide-mediated C–H bond acetoxylation reaction. First, Ac2O is 
clearly not required to introduce the OAc group into the products, since high yields of 
acetoxylated products are observed in the absence of this reagent. Second, Ac2O is not 
needed for catalytic turnover in our reactions, since we obtain >10 turnovers without any 
added Ac2O. 
 













In addition, subsequent to the results described herein, Corey reported the use of 
Oxone for the Pd-catalyzed oxidation of C–H bonds in amino acid derivatives.23 This 
report described the installation acetates at 2º positions in 8-aminoquinoline derivatives 
using 20 mol % Pd(OAc)2, 5 equiv Oxone, 1.2 equiv Mn(OAc)2, and 10 equiv Ac2O in 
nitromethane at 80 ºC (Scheme 3.15). Importantly, the products from this reaction were 
obtained with high levels of diastereoselectivity and could allow access to β-hydroxy 
amino acids.  
 


























3.5  Formation of Methyl Ethers with Oxone and K2S2O8 
 
We were next interested in using a similar approach for the conversion of C–H 
bonds to C–OR bonds of ethers, which are also very important and prevalent in 
biologically active molecules.24 A literature search revealed that PtIV alkoxides could be 
generated by oxidizing PtII with H2O2 in methanol.
25 These products were analogous to 
those obtained when the same oxidation was carried out in AcOH (Scheme 3.16)  
 





















Based on this result, we reasoned that by changing the solvent of our reactions 
with Oxone or K2S2O8 to methanol we might be able to install methyl ethers in the final 
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products. We were pleased to find that, using Pd(OAc)2 as the catalyst and Oxone or 
K2S2O8 as oxidants in methanol, we were able to obtain a variety of methoxylated 
products in good yields (Table 3.4).16 The methoxylation reactions also exhibited 
excellent tolerance to benzylic C–H bonds (entries 2, 3 and 6), aryl halides (entries 1 and 
5), and aldehyde oxime ethers (entry 2). Similar to the acetoxylation reactions, higher 
yields of the methoxylated products were obtained when K2S2O8 was used as the oxidant 
for substrates 12, 29 and 30. On the contrary, substrates 3, 27, 11 and 28 showed better 
reactivity with Oxone. 
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5 mol % Pd(OAc)2
1-3.5 equiv Oxone or K2S2O8
Br Br
MeOH































































In the methoxylation reactions with electron rich oxime ethers, we observed 
competing deprotection of the oxime ether. For example, subjection of substrate 6 to 
Oxone in MeOH afforded 18% of the desired product 6b along with 30% of the ketone 6c 
(Scheme 3.17). Unlike the AcOH reactions, neither addition of acetic anhydride nor the 
use anhydrous methanol suppressed the hydrolysis. We believe the hydrolysis reaction 
 87 
also increases the rate of catalyst decomposition. This was determined when subjection of 
the corresponding ketone 6c to the reaction conditions in MeOH resulted in precipitation 
of Pd black within 5 minutes. This may be due to the poor ligand abilities of the ketone 
relative to the oxime ether. Without stabilization by coordination of the substrate, the Pd 
is more likely to undergo decomposition.  
 













10 mol % Pd(OAc)2
1.5 equiv Oxone
MeOH
25 oC to 85 oC
(6)  
 
Unlike the acetoxylation reactions with Oxone and K2S2O8, these methoxylation 
reactions were very sensitive to temperature and reaction time. Each substrate required a 
slow ramp of the temperature from room temperature to 45 ºC. After stirring the reaction 
at 45 ºC for 5 h, the temperature was then slowly ramped to 60 ºC. After another 15 min, 
the temperature was then ramped slowly to 80 ºC. This rigorous care with temperature 
was necessary to limit competing catalyst decomposition. Palladium(II) species are well 
known to react with methanol to form palladium hydrides and formaldehyde.26 These PdII 
hydrides can then undergo reductive elimination of HX to generate Pd0 (Scheme 3.18). 
Catalyst decomposition occurs as Pd0 plates out of the reaction rather than getting 
oxidized to PdII, which is required to initiate the desired PdII/IV catalytic cycle to form 
acetoxylated compounds.  
 

















Due to the increased rate of catalyst decomposition with alcoholic solvents, we 
have thus far been unable to achieve high yielding etherification reactions in other 
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alcohols like isopropanol or ethanol. We believe that as the size of the alcohol increases, 
the rate of etherification slows down and the rate of catalyst decomposition increases. 
Notably, the solvent polarity also changes from MeOH (dielectric constant = 32.6) to 
isopropanol (dielectric constant = 18.3), which could also play a role in the observed 
reactivity differences. Subjection of amide substrate 12 in ethanol with K2S2O8 afforded 
the ethoxy product 12c in modest 28% yield. When the alcohol was changed to 
isopropanol, the yield of the desired isopropoxy product 12d was even lower at 11% 
(Scheme 3.19). 
 






O 5 mol % Pd(OAc)2
2.0 equiv K2S2O8
ROH
25 oC to 85 oC
R = Et : 28%, (12c)




3.6  Introduction of Other Nucleophiles at Carbon with Oxone and 
K2S2O8 
 
As discussed above, we have successfully achieved the Pd-catalyzed conversion 
of C–H bonds to C–OAc and C–OR bonds using Oxone and K2S2O8 as the oxidants in 
the corresponding nucleophilic solvent. Based on these results, we speculated that other 
functionalities could potentially be introduced by using the appropriate nucleophile in an 
inert solvent. Encouragingly, the Pd-catalyzed reaction of 12 with K2S2O8 in CH2Cl2 in 
the presence of 10 equiv of benzoic acid afforded benzoate product 12e in modest 11% 
yield (Scheme 3.20). Similarly, Pd-catalyzed reaction of 12 with K2S2O8 and LiCl in 
CH2Cl2 afforded the chlorinated product 12f, along with three undesired regioisomeric 
chlorinated products. These preliminary results are promising, and we anticipate that after 
further optimization these reactions will prove highly general and effective for converting 
C–H bonds to C–O, C–N, and C–halogen bonds  
 
 89 











(12e, 11% by GC)
















3.7  Conclusions 
 
In summary, this chapter demonstrates the functionalization of sp2 and sp3 C–H 
bonds to C–O bonds using cost effective and environmentally benign oxidants such as 
Oxone and K2S2O8. With AcOH as the reaction medium, acetate functionality can be 
installed at carbon. Changing the reaction medium to MeOH allows formation of methyl 
ether functionalities. These reactions are general across a variety of substrates and 
tolerate most common functional groups. Furthermore, for the most part, yields obtained 
with Oxone and K2S2O8 are comparable to those obtained with PhI(OAc)2. 
 
3.8  Experimental Procedure 
 
General Procedures: NMR spectra were obtained on a Varian Inova 500 (499.90 
MHz for 1H; 125.70 MHz for 13C) unless otherwise noted. 1H NMR chemical shifts are 
reported in parts per million (ppm) relative to TMS, with the residual solvent peak used 
as an internal reference. Multiplicities are reported as follows: singlet (s), doublet (d), 
doublet of doublets (dd), doublet of doublets of doublets (ddd), doublet of triplets (dt), 
triplet (t), quartet (q), quintet (quin), multiplet (m), and broad resonance (br). IR spectra 
were obtained on a Perkin-Elmer Spectrum BX FT-IR spectrometer.  
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Materials and Methods: Oxime substrates 3-11, 14, 20-22, and 27-28 were 
prepared following the procedure described previously.27 The isoxazoline 13 was 
prepared following a procedure by Mapp and coworkers.28 The amide substrates 29-30 
were prepared by palladium-catalyzed arylation of the corresponding lactone.8 Substrate 
17 was prepared following a procedure by Gokel et al.29 Pd(OAc)2 was obtained from 
Pressure Chemical and used as received, and PhI(OAc)2 was obtained from Merck 
Research Laboratories and used as received. Oxone was obtained from Acros and used as 
received, and K2S2O8 was obtained from Fisher Chemical and used as received. Solvents 
were obtained from Fisher Chemical and used without further purification. Flash 
chromatography was performed on EM Science silica gel 60 (0.040–0.063 mm particle 
size, 230–400 mesh) and thin layer chromatography was performed on Merck TLC plates 
pre-coated with silica gel 60 F254. Control reactions (in the absence of Pd catalyst) were 
run for each substrate, and generally showed no reaction. The regioselectivity of 
acetoxylation and etherification was determined based on coupling constant analysis and 










General Procedure for Table 3.1. Peroxide (1.75 mmol, 2.0 equiv) and 
Pd(OAc)2 (9.81 mg, 0.044 mmol, 0.05 equiv) were combined in AcOH (3.7 mL) and 
Ac2O (3.7 mL) in a 20 mL vial. Substrate 3 (200 mg, 0.88 mmol, 1.0 equiv) was then 
added to the mixture. The vial was sealed with a Teflon lined cap, and the reaction was 
heated at 100 oC for 12 h. The reaction mixture was diluted with ethyl acetate, and the 
vial was washed with copious diethyl ether. A 10% aqueous solution of Na2SO3 (450 
mL) was added to the reaction, and the resulting mixture was stirred at 25 ºC for 15 min. 
The organic and the aqueous layers were separated and the organic layer was extracted 
with water (2 x 50 mL), NaHCO3 (1 x 50 mL), and brine (1 x 50 mL). The organic layer 
was dried over MgSO4, filtered, and concentrated. The resulting oil was purified by 
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chromatography on silica gel to afford two oxime (E/Z) isomers (major oxime isomer: Rf 
= 0.25 in 88% hexanes/12% ethyl acetate; minor oxime isomer: Rf = 0.23 in 88% 
hexanes/12% ethyl acetate). The two oxime isomers were isolated as yellow oils in a ratio 
of 5:1. The ratio of regioisomers was >20:1. 
 
Procedure for 66 mmol scale reaction. Oxone (80.79 g, 131.41 mmol, 2.0 equiv) 
and Pd(OAc)2 (441 mg, 1.97 mmol, 0.03 equiv) were combined in AcOH (493 mL) and 
Ac2O (55 mL) in a 1000 mL round bottom flask. Substrate 3 (15 g, 65.7 mmol, 1.0 equiv) 
was then added to the mixture. The reaction was refluxed for 18 h. The reaction mixture 
was diluted with ethyl acetate (500 mL) and filtered through a pad of celite and washed 
with ethyl acetate (1 L). The ethyl acetate, AcOH and Ac2O were removed under reduced 
pressure. The product was obtained as a yellow oil through Kugelrohr distillation (10.15 
g, 54% yield).  
Major Oxime Isomer: 1H NMR (CDCl3): δ 7.56 (d, J = 2.4 Hz, 1Ha), 7.47 (dd, J = 8.6, 
2.4 Hz, 1Hb), 6.98 (d, J = 8.6 Hz, 1Hc), 3.97 (s, 3H), 2.27 (s, 3H), 2.13 (s, 3H). 13C{1H} 
NMR (CDCl3): d 168.82, 152.23, 147.02, 132.49, 132.23, 132.09, 124.87, 119.07, 62.07, 
20.96, 14.89. Minor Oxime Isomer: 1H NMR (CDCl3): δ 7.48 (dd, J = 8.7, 2.4 Hz, 1Hb), 
7.32 (d, J = 2.4 Hz, 1Ha), 7.03 (d, J = 8.7 Hz, 1Hc), 3.79 (s, 3H), 2.25 (s, 3H), 2.12 (s, 
3H). IR (thin film): 2937, 1768 cm-1. HRMS (ESI, m/z): [M+] calcd for C11H12BrNO3, 
285.0000; found, 285.0005. GC analysis (RESTEK Rtx®-5, FID detector): 99% 
integration. Anal. Calcd. for C11H12BrNO2 (mixture of oxime isomers): C, 46.18, H, 4.23, 
N, 4.90; Found: C, 46.20, H, 4.19, N, 4.90. 
 
General Method for Directed C-H Bond Acetoxylation with Oxone: Oxone 
(783 mg, 1.27 mmol, 0.95 equiv) and Pd(OAc)2 (15 mg, 0.07 mmol, 0.05 equiv) were 
combined in AcOH (11.2 mL) in a 20 mL vial. Substrate 3 (200 mg, 1.34 mmol, 1.0 
equiv) was then added to the mixture. The vial was sealed with a Teflon lined cap, and 
the reaction was heated at 100°C for 12 h. The reaction mixture was diluted with ethyl 
acetate (25 mL), and the vial was washed with copious diethyl ether. A 10% aqueous 
solution of Na2SO3 (450 mL) was added to the reaction, and the resulting mixture was 
stirred at 25 ºC for 15 min. The organic and the aqueous layers were separated, and the 
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organic layer was extracted with water (2 x 50 mL), NaHCO3 (1 x 50 mL), and brine (1 x 
50 mL). The organic layer was dried over MgSO4, filtered, and concentrated. The 
resulting oil was purified by chromatography on silica gel. Each substrate was optimized 










The reaction was run for 12 h with 0.95 equiv of Oxone in AcOH. Product 4a was 
obtained as two oxime E/Z isomers (major oxime isomer: Rf = 0.26 in 89% hexanes/11% 
ethyl acetate; minor oxime isomer: Rf = 0.25 in 89% hexanes/11% ethyl acetate). The two 
isomers were isolated as yellow oils (147 mg total, 53% yield, ratio of oxime isomers = 
5:1).  Major Oxime Isomer: 1H NMR (CDCl3): δ 7.43 (dd, J = 7.7, 1.7 Hz, 1H), 7.37 (td, 
J = 7.8, 1.7 Hz, 1H), 7.25 (td, J = 7.5, 1.2 Hz, 1H), 7.10 (dd, J = 8.1, 1.2 Hz, 1H), 3.97 (s, 
3H), 2.29 (s, 3H), 2.16 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.25, 153.44, 147.95, 
130.30, 129.72, 129.45, 126.10, 123.21, 61.94, 21.08, 15.09. Minor Oxime Isomer: 1H 
NMR (CDCl3): δ 7.37 (dd, J = 7.4, 1.8 Hz, 1H), 7.29 (m, 1H), 7.21 (dd, J = 7.6, 1.8 Hz, 
1H), 7.14 (dd, J = 8.1, 1.5 Hz, 1H), 3.79 (s, 3H), 2.26 (s, 3H), 2.14 (s, 3H). IR (thin film): 
2938, 1764 cm-1. Anal. Calcd. for C11H13NO3 (mixture of oxime isomers): C, 63.76, H, 









The reaction was run for 12 h with 1.0 equiv of Oxone in AcOH. Under the reaction 
conditions the OAc of 5a partially hydrolyzed to the corresponding alcohol. The reaction 
mixture was concentrated under vacuum and Ac2O (2.4 mL) and pyridine (0.46 mL) was 
added and the reaction stirred for 18 h. The reaction was stirred in water (5 mL) for 30 
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minutes and then extracted with ether. The ethereal layer was washed with water (2 x 50 
mL), and NaHCO3 (1 x 50 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated. The resulting oil was purified by chromatography on silica gel to afford the 
product as a 2:1 mixture of oxime isomers (major oxime isomer: Rf = 0.25 in 89% 
hexanes/11% ethyl acetate; minor oxime isomer: Rf = 0.20 in 89% hexanes/11% ethyl 
acetate). The two oxime isomers were isolated as yellow oils (192 mg total, 71% yield, 
ratio of oxime isomers = 2:1). The ratio of regioisomers was 11:1. Major Oxime 
Isomer/Major Regioisomer: 1H NMR (CDCl3): δ 7.23 (d, J = 2.2 Hz, 1Ha), 7.16 (dd, J = 
8.2, 2.2 Hz, 1Hb), 6.98 (d, J = 8.2 Hz, 1Hc), 3.97 (s, 3H), 2.34 (s, 3H), 2.26 (s, 3H), 2.15 
(s, 3H). 13C{1H} NMR (CDCl3): δ 169.32, 153.53, 145.66, 135.68, 131.33, 130.22, 
129.75, 122.79, 61.80, 20.95, 20.65, 15.04. Minor Oxime Isomer/Major Regioisomer: 
1H NMR (CDCl3): δ 7.17 (d, J = 8.3, 2.2 Hz, 1Hb), 7.02 (dd, J = 8.3 Hz, 1Hc), 6.99 (d, J 
= 2.2 Hz, 1Ha), 3.79 (s, 3H), 2.35 (s, 3H), 2.24 (s, 3H), 2.12 (s, 3H). Major Oxime 
Isomer/Minor Regioisomer: 1H NMR (CDCl3): δ 7.23 (m, 2H), 7.17 (d, J = 7.6 Hz, 1H), 
3.96 (s, 3H), 2.30 (s, 3H), 2.19 (s, 3H), 2.15 (s, 3H). IR (thin film): 2937, 1765 cm-1. 
HRMS (ESI, m/z): [M+] calcd for C12H15NO3, 221.1047; found, 221.1052. GC analysis 









The reaction was run for 12 h with 1.1 equiv of Oxone in AcOH. Under the reaction 
conditions the OAc of 6a partially hydrolyzed to the corresponding alcohol. The reaction 
mixture was concentrated under vacuum and Ac2O (2.2 mL) and pyridine (0.43 mL) was 
added and the reaction stirred for 18 h. The reaction was stirred in water (5 mL) for 30 
minutes and then extracted with ether. The ethereal layer was washed with water (2 x 50 
mL), and NaHCO3 (1 x 50 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated. The resulting oil was purified by chromatography on silica gel to afford the 
product as a 3:1 mixture of oxime isomers (major oxime isomer: Rf = 0.23 in 85% 
hexanes/15% ethyl acetate; minor oxime isomer: Rf = 0.18 in 85% hexanes/15% ethyl 
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acetate). The two oxime isomers were isolated as yellow oils (180 mg total, 69% yield, 
ratio of oxime isomers = 9:1). The ratio of regioisomers was 18:1. Major Oxime Isomer: 
1H NMR (acetone-d6) (399.97 Hz): δ 7.05 (d, J = 8.7 Hz, 1Hc), 6.99 (d, J = 3.0 Hz, 1Ha), 
6.95 (dd, J = 8.7, 3.0 Hz, 1Hb), 3.90 (s, 3H), 3.81 (s, 3H), 2.22 (s, 3H), 2.11 (s, 3H). 
13C{1H} NMR (acetone-d6) (100.57 Hz): δ 169.87, 158.12, 153.83, 142.69, 132.13, 
125.17, 115.58, 115.06, 62.14, 56.03, 20.99, 15.12. Minor Oxime Isomer: 1H NMR 
(CDCl3): δ 7.05 (d, J = 8.9 Hz, 1Hc), 6.88 (dd, J = 8.9, 3.0 Hz, 1Hb), 6.70 (d, J = 3.0 Hz, 
1Ha), 3.80 (s, 3H), 3.80 (s, 3H), 2.24 (s, 3H), 2.12 (s, 3H).  IR (thin film): 2939, 1764 cm-
1. Anal. Calcd. for C12H15NO4 (mixture of oxime isomers): C, 60.75, H, 6.37, N, 5.90; 









The reaction was run for 12 h with 1.0 equiv of Oxone in AcOH/Ac2O. Product 7a was 
obtained as an inseparable mixture of four products (Rf = 0.27-0.24) – 2 regioisomers and 
2 oxime isomers of each regioisomer – as a clear oil (170 mg total, 63% yield). The 
identity of the major regioisomer and its oxime isomers was confirmed by independent 
synthesis, and the NMR spectra reported below are for this independently synthesized 
product. Gas chromatographic analysis showed that the reaction afforded a 1.6:1 mixture 
of regioisomers and that each of the regioisomers was a 6:1 mixture of oxime isomers. 
Major Oxime Isomer/Major Regioisomer: 1H NMR (C6D6): δ 7.02 (dd, 9.0, 3.0 Hz, 1H), 
6.71 (dd, 8.9, 5.0 Hz, 1H), 6.60 (m, 1H), 3.76 (s, 3H), 1.95 (s, 3H), 1.74 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 169.09, 159.87 (1JCF =  245 Hz), 152.29 (4JCF = 1.7 Hz), 143.74 (4JCF = 
2.9 Hz), 131.66 (3JCF = 8.0Hz), 124.56 (3JCF = 8.7 Hz), 116.16 (2JCF = 23 Hz), 115.93 
(2JCF = 24 Hz), 61.93, 20.80, 14.67. 19F NMR (CDCl3): δ -116.3 - -116.36 (m). Minor 
Oxime Isomer/Major Regioisomer: 1H NMR (C6D6): δ 6.77 (dd, J = 8.9, 5.0 Hz, 1H), 
6.62 (dd, J = 9.0, 3.0 Hz, 1H), 6.61-6.56 (overlapping peaks), 3.64 (s, 3H), 1.90 (s, 3H), 
1.50 (s, 3H). IR (thin film): 2939, 1770 cm-1. HRMS (ESI, m/z): [M+] calcd for 
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C11H12FNO3, 225.0801; found, 225.0797. GC analysis (RESTEK Rtx®-5, FID detector): 











The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH. The product was 
obtained as a yellow oil (143 mg, 53% yield). The ratio of oxime isomers 17:1 and 
regioisomers was >20:1(Rf = 0.28 in 90% hexanes/10% ethyl acetate). 1H NMR (CDCl3): 
δ 8.07 (s, 1H), 7.28 (d, J = 3.0 Hz, 1Ha), 7.01 (d, J = 8.9 Hz, 1Hc), 6.93 (dd, J = 8.9, 3.0 
Hz, 1Hb), 3.99 (s, 3H), 3.82 (s, 3H), 2.31 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.69, 
157.46, 143.95, 142.54, 125.21, 123.95, 117.37, 110.97, 62.30, 55.79, 20.98. IR (thin 
film): 2938, 1763 cm-1. HRMS (ESI, m/z): [M +] calcd for C11H13NO4, 223.0845; found, 
223.0842. GC analysis (RESTEK Rtx®-5, FID detector): 100% integration. 
 
General Method for Directed C-H Bond Acetoxylation with K2S2O8: K2S2O8 
(373 mg, 1.38 mmol, 2.0 equiv) and Pd(OAc)2 (7.7 mg, 0.03 mmol, 0.05 equiv) were 
combined in AcOH (2.88 mL) and Ac2O (2.88 mL) in a 20 mL vial. Substrate 10 (150 
mg, 0.69 mmol, 1.0 equiv) was then added to the mixture. The vial was sealed with a 
Teflon lined cap, and the reaction was heated at 100°C for 12 h. The reaction mixture was 
diluted with ethyl acetate, and the vial was washed with copious diethyl ether. A 10% 
aqueous solution of Na2SO3 (50 mL) was added to the filtrate, and the resulting mixture 
was stirred at 25 ºC for 15 min. The organic and the aqueous layers were separated and 
the organic layer was extracted with water (2 x 50 mL), NaHCO3 (1 x 50 mL), and brine 
(1 x 50 mL). The organic layer was dried over MgSO4, filtered, and concentrated. The 
resulting oil was purified by chromatography on silica gel Each substrate was optimized 












The reaction was run for 12 h with 1.0 equiv of K2S2O8 in AcOH/Ac2O. The product was 
obtained as a mixture of two oxime E/Z isomers (major oxime isomer: Rf = 0.27 in 78% 
hexanes/22% ethyl acetate; minor oxime isomer: Rf = 0.25 in 78% hexanes/22% ethyl 
acetate). The two oxime isomers were isolated as a pale yellow solid (115 mg total, 57% 
yield, ratio of oxime isomers = 6:1). The ratio of regioisomers was 6:1. Major Oxime 
Isomer/Major Regioisomer: 1H NMR (CDCl3): δ 7.78 (d, J = 2.1 Hz, 1Ha), 7.68 (dd, J = 
8.4, 2.1 Hz, 1Hb), 7.27 (d, J = 8.4 Hz, 1Hc), 4.01 (s, 3H), 2.33 (s, 3H), 2.17 (s, 3H). 
13C{1H} NMR (CDCl3): δ 168.26, 151.68, 151.31, 133.65, 133.18, 131.78, 124.51, 
117.80, 110.19, 62.24, 20.98, 14.87. Minor Oxime Isomer/Major Regioisomer: 1H NMR 
(CDCl3): δ 7.66 (dd, J = 8.4, 2.0 Hz, 1Hb), 7.52 (d, J = 2.0 Hz, 1Ha), 7.29 (d, J = 8.5 Hz, 
1Hc), 3.79 (s, 3H), 2.89 (s, 3H), 2.14 (s, 3H). Major Oxime Isomer/Minor Regioisomer: 
1H NMR (CDCl3): δ 7.67 (t, J = 8.8, 7.8 Hz, 2H), 7.37 (t, J = 7.8 Hz, 1H), 3.98 (s, 3H), 
2.38 (s, 3H), 2.16 (s, 3H). IR (thin film): 2230, 1770 cm-1. HRMS (ESI, m/z): [M+] calcd 
for C12H12N2O3, 232.0848; found, 232.0848. GC analysis (RESTEK Rtx®-5, FID 









The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH/Ac2O. The product was 
obtained as a mixture of two oxime (E/Z) isomers (major oxime isomer: Rf = 0.27 in 87% 
hexanes/13% ethyl acetate; minor oxime isomer: Rf = 0.25 in 87% hexanes/13% ethyl 
acetate). The two oxime isomers were isolated as yellow oils (142 mg total, 75% yield, 
ratio of oxime isomers = 5:1). The ratio of regioisomers was >20:1. Major Oxime 
Isomer: 1H NMR (CDCl3): δ 7.71 (d, J = 2.3 Hz, 1Ha), 7.63 (dd, J = 8.5, 2.3 Hz, 1Hb), 
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7.24 (d, J = 8.5 Hz, 1Hc), 3.99 (s, 3H), 2.31 (s, 3H), 2.17 (s, 3H). 13C{1H} NMR (CDCl3): 
δ 168.62, 152.30, 150.49, 131.07, 128.38 (2JCF = 33 Hz), 126.85 (3JCF = 3.8 Hz), 126.62 
(3JCF = 3.6 Hz), 123.60 (1JCF = 272 Hz), 123.91, 62.14, 20.96, 14.93. 19F NMR (CDCl3): 
δ -62.37 (s).  Minor Oxime Isomer: 1H NMR (CDCl3): δ 7.60 (m, 1Hb), 7.43 (d, J = 2.7 
Hz, 1Ha), 7.20 (d, J = 8.5 Hz, 1Hc), 3.76 (s, 3H), 2.25 (s, 3H), 2.12 (s, 3H). IR (thin film): 
2942, 1770 cm-1. HRMS (ESI, m/z): [M+] calcd for C12H12F3NO3, 275.0769; found, 









The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH. The product was 
obtained as a mixture of two oxime (E/Z) isomers (major oxime isomer: Rf = 0.24 in 92% 
hexanes/8% ethyl acetate; minor oxime isomer: Rf = 0.24 in 92% hexanes/8% ethyl 
acetate). The product was isolated as a yellow oil (106 mg total, 53% yield, ratio of 
oxime isomers = 5:1). Major Oxime Isomer: 1H NMR (CDCl3): δ 8.25 (s, 1H), 7.27 (t, J 
= 8.0, 7.5 Hz, 1H), 7.12 (d, J = 7.5 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 3.99 (s, 3H), 2.47 
(s, 3H), 2.33 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.69, 149.12, 144.60, 139.47, 129.93, 
128.84, 123.32, 120.97, 62.19, 21.26, 21.13. Minor Oxime Isomer: 1H NMR (CDCl3): δ 
7.39 (s, 1H), 7.29 (t, J = 7.9, Hz, 1H), 7.10 (d, J = 7.7 Hz, 1H), 6.96 (d, J = 8.1 Hz, 1H), 
3.90 (s, 3H), 2.29 (s, 3H), 2.27 (s, 3H). IR (thin film): 2969, 1769 cm-1. HRMS (ESI, 
m/z): [M+] calcd for C11H13NO3, 207.0895; found, 207.0892. GC analysis (RESTEK 






The reaction was run for 12 h with 1.5 equiv of K2S2O8 in AcOH. The product was 
obtained as a yellow oil (272 mg, 75% yield). (Rf = 0.26 in 15% hexanes/85% ethyl 
acetate). 1H NMR (CDCl3): δ 7.29-7.21 (multiple peaks, 3H), 7.15 (d, J = 7.6 Hz, 1H), 
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3.70 (t, J = 6.9 Hz, 2H), 2.49 (t, J = 8.0 Hz, 2H), 2.24 (s, 3H), 2.13 (quin, J = 7.2 Hz, 
2H). 13C{1H} NMR (CDCl3): δ 173.88, 168.53, 145.64, 130.80, 127.86, 126.89, 126.25, 
123.41, 49.82, 30.94, 20.71, 19.02. IR (thin film): 1766, 1702 cm-1. HRMS (ESI, m/z): 
[M+] calcd for C12H13NO3, 219.0895; found, 219.0894. GC analysis (RESTEK Rtx®-5, 





The reaction was run for 12 h with 3.0 equiv of K2S2O8 in AcOH. The product was 
obtained as a pale yellow viscous oil (79.0 mg, 53% yield) (Rf = 0.26 in 55% 
hexanes/45% ethyl acetate). 1H NMR (CDCl3): δ 7.33 (t, J = 8.1 Hz, 1H), 6.99 (d, J = 8.2 
Hz, 2H), 4.70-4.66 (m, 1H), 4.06-4.05 (multiple peaks, 2H), 3.59 (d, J = 3.3 Hz, 2H), 
2.78 (dd, J = 17.4, 10.8 Hz, 1H), 2.44 (dd, J = 17.4, 7.8 Hz, 1H), 2.32 (s, 6H), 2.04 (s, 
3H). 13C{1H} NMR (CDCl3): δ 170.72, 169.22, 155.92, 150.10, 128.48, 120.89, 120.64, 
77.76, 64.92, 38.22, 23.23, 20.78, 20.69. IR (thin film): 2939, 1769, 1742 cm-1. HRMS 
(ESI, m/z): [M+] calcd for C17H19NO7, 349.1162; found, 349.1160. GC analysis 







The reaction was run for 12 h with 2.0 equiv of Oxone® in AcOH. The product was 
obtained as a mixture of two products (Rf = 0.25 in 90% hexanes/10% ethyl acetate). 
Under the chromatography conditions the OAc underwent partial hydrolysis to the 
corresponding alcohol. The product was isolated as a pale yellow solid (100 mg total, 
37% yield, ratio of OAc to free OH, 2:1); mp = 67–72 °C. The ratio of oxime isomers and 
regioisomers was >20:1. 1H NMR of 14a (CDCl3): δ 11.65 (s, 1H), 7.31 (dd, J = 8.1, 1.5 
Hz, 1H), 7.06 (dd, J = 7.9, 1.5 Hz, 1H), 6.88 (t, J = 8.0 Hz, 1H), 3.99 (s, 3H), 2.35 (s, 
3H), 2.30 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.08, 158.17, 149.79, 139.25, 125.09, 
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123.98, 119.81, 118.49, 62.54, 20.65, 11.61. IR (KBr): 2943, 1760 cm-1. HRMS (ESI, 
m/z): [M+] calcd for C11H13NO4, 223.0844; found, 223.0843. GC analysis (RESTEK 
Rtx®-5, FID detector): 100% integration. Hydrolyzed (OH) product: 1H NMR (CDCl3): δ 







The reaction was run for 12 h with 1.5 equiv of K2S2O8 in AcOH. The product was 
obtained as a pale yellow viscous oil (38% yield) (Rf = 0.26 in 55% hexanes/45% ethyl 
acetate). 1H NMR (C6D6): δ 8.29 (br s, 1H), 7.21 (br s, 1H), 7.07 (br s, 2H), 2.36 (s, 3H), 






Oxone (853 mg, 1.39 mmol, 1.0 equiv) and Pd(OAc)2 (16 mg, 0.07 mmol, 0.05 equiv) 
were combined in AcOH (11.6 mL) in a 20 mL vial. Substrate 16 (200 mg, 1.39 mmol, 
1.0 equiv) was then added to the mixture. The vial was sealed with a Teflon lined cap, 
and the reaction was heated at 100 °C for 12 h. The reaction mixture was diluted with 
chloroform and extracted with water (2 x 50 mL), NaHCO3 (1 x 50 mL), and brine (1 x 
50 mL). The organic layer was dried over MgSO4, filtered, and concentrated. The 
resulting oil was purified by chromatography on silica gel (Rf = 0.18 in 80% 
hexanes/20% ethyl acetate). The product was obtained as a yellow solid (28 mg, 10% 
yield). mp = 86-88 oC. 1H NMR (399.96 Hz) (CDCl3): δ 8.87 (s, 2H), 8.09 (d, J = 8.3 Hz, 
1H), 7.84-7.75 (multiple peaks, 2H), 5.80 (s, 2H), 2.10 (s, 3H). 13C{1H} NMR (100.57 
Hz) (CDCl3): δ 170.85, 145.03, 144.32, 142.83, 141.12, 134.71, 129.71, 129.70, 129.40, 
61.85, 21.03. IR (KBr): 2927, 1739 cm-1. HRMS (ESI, m/z): [M + Na] calcd for 
C11H10N2O2, 202.0742; found, 202.0738. GC analysis (RESTEK Rtx®-5, FID detector): 
99% integration. Along with the product 16a, the N-oxide of the starting material (101 
mg, 46% yield), (Rf = 0.15 in 70% hexanes/30% ethyl acetate) and the N-oxide of 16a 
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(27.0 mg, 9% yield), (Rf = 0.1 in 70% hexanes/30% ethyl acetate) were obtained, whose 










1H NMR (CDCl3): δ 8.70 (d, J = 3.5 Hz, 1Ha), 8.57 (d, J = 8.7 Hz, 1Hc), 8.38 (d, J = 3.5 
Hz, 1Hb), 7.88 (d, J = 7.2 Hz, 1He), 7.75 (t, J = 7.3 Hz, 1Hd), 5.78 (s, 2H), 2.17 (s, 3H). 
13C NMR (CDCl3): δ 170.71, 145.31, 144.05, 137.59, 135.73, 130.83, 129.80, 129.35, 
118.94, 61.78, 20.98. IR (KBr): 1735, 1242 cm-1. mp = 112-113 oC. HRMS (ESI, m/z): 
[M + Na] calcd for C11H10N2O3, 218.0691; found, 218.0689. GC analysis (RESTEK 
Rtx®-5, FID detector): 99% integration. The assignment of the regioselectivity of N-










1H NMR (CDCl3): δ 8.62 (d, J = 3.45 Hz, 1Ha), 8.37 (d, J = 8.2 Hz, 1Hc), 8.31 (d, J = 
3.46 Hz, 1Hb), 7.61-7.55 (multiple peaks, 2Hd, e), 2.73 (s, 3H). 13C{1H} NMR (CDCl3): δ 
145.04, 144.38, 138.65, 137.59, 131.72, 129.77, 128.87, 116.56, 17.66. mp = 132-133 oC. 
IR (KBr): 1501, 1309 cm-1. HRMS (ESI, m/z): [M + Na] calcd for C9H8N2O, 160.0637; 








The reaction was run at rt for 12 h with 1.5 equiv of K2S2O8 in AcOH. The product was 
obtained as a pale yellow oil (Rf = 0.26 in 55% hexanes/45% ethyl acetate) (39% yield). 
1H NMR (C6D6): δ 7.66-7.56 (multiple peaks, 3H), 7.38 (t, J = 7.6 Hz, 1H), 7.31-7.28 
(multiple peaks, 2H), 7.12 (d, J = 8.4 Hz, 1H), 2.45 (s, 3H), 2.41 (s, 3H), 2.39 (s, 3H). 
HRMS (ESI, m/z): [M+] calcd for C10H12ClNO2, 268.1209; found, 268.1209. Along with 
the product 17a, the N-oxide of the starting material (36% yield), (Rf = 0.15 in 70% 







1H NMR (C6D6): δ 7.75-7.66 (multiple peaks, 4H), 7.41 (t, J = 8.0 Hz, 1H), 7.29 (d, J = 







The reaction was run at rt for 12 h with 1.5 equiv of K2S2O8 or Oxone or PhI(OAc)2 in 
AcOH. The product was obtained as a yellow oil (78% yield, Rf = 0.15 in 70% 
hexanes/30% ethyl acetate). 1H NMR (C6D6): δ 7.78 (d, J = 7.0 Hz, 2H), 7.51 (t, J = 7.5 
Hz, 1H), 7.45 (m, 2H) 6.59 (br s, 1H), 4.29 (t, J = 5.0 Hz, 2H), 3.73 (q, J = 5.0 Hz, 2H), 
2.09 (s, 3H). 13C{1H} NMR (CDCl3): δ 171.47, 167.55, 134.18, 131.61, 128.60, 126.91, 








The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH. The product was 
obtained as two oxime (E/Z) isomers (major oxime isomer: Rf = 0.3 in 90% hexanes/10% 
ethyl acetate; minor oxime isomer: Rf = 0.21 in 90% hexanes/10% ethyl acetate). The two 
oxime isomers were isolated as yellow oils (45% yield, ratio of oxime isomers = 5:1). 






The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH. The product was 
isolated as a clear oil (Rf = 0.28 in 90% hexanes/10% ethyl acetate), (63% yield). The 








The reaction was run for 12 h with 2.0 equiv of K2S2O8 in AcOH. The product was 
isolated as a clear oil (Rf = 0.28 in 90% hexanes/10% ethyl acetate), (23% yield). The 
NMR data was identical to that reported previously for this compound.7 
 
General Method for Directed C-H Bond Methoxylation with Oxone: Oxone® 
(808 mg, 1.31 mmol, 2.0 equiv) and Pd(OAc)2 (15 mg, 0.07 mmol, 0.1 equiv) were 
combined in MeOH (5.48 mL) in a 20 mL vial. Substrate 3 (150 mg, 0.66 mmol, 1.0 
equiv) was then added to the mixture. The vial was sealed with a Teflon lined cap, and 
the reaction was stirred at rt for 12 h and then stirred at 80 oC for another 12 h. The 
reaction mixture was diluted with ethyl acetate, and extracted with water (2 x 50 mL), 
NaHCO3 (1 x 50 mL), and brine (1 x 50 mL). The organic layer was dried over MgSO4, 
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filtered, and concentrated. The resulting oil was purified by chromatography on silica gel. 











The reaction was run was stirred at rt for 12 h and then stirred at 80 oC for another 12 h, 
with 2.0 equiv of Oxone®. Product 3b was obtained as two oxime (E/Z) isomers (major 
oxime isomer: 0.28 Rf = 90% in hexanes/10% ethyl acetate; minor oxime isomer: Rf = 
0.26 in 90% hexanes/10% ethyl acetate). The two isomers were isolated as yellow oils. 
Under the reaction conditions oxime 3b underwent partial hydrolysis to the 
corresponding ketone. Isolated product (119 mg total, 70% yield, ratio of oxime isomers 
= 5:1, ratio of oxime to ketone = 4:1). The ratio of regioisomers was >20:1. Major Oxime 
Isomer of 3b: 1H NMR (acetone-d6): δ 7.51 (dd, J = 8.8, 2.6 Hz, 1Hb), 7.38 (d, J = 2.6 
Hz, 1Ha), 7.03 (d, J = 8.8 Hz, 1Hc), 3.90 (s, 3H), 3.87 (s, 3H), 2.10 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 156.64, 155.28, 132.64, 132.16, 128.78, 112.84, 112.69, 61.86, 55.72, 
15.77. IR (thin film): 2932, 1606, 1486 cm-1. HRMS (ESI, m/z): [M+] calcd for 
C10H12BrNO2, 257.0051; found, 257.0045. GC analysis (RESTEK Rtx®-5, FID detector): 
100% integration. Ketone: 1H NMR (CDCl3): δ 7.49 (d, J = 2.4 Hz, 1H), 7.32 (dd, J = 








The reaction was run at rt for 12 h and then stirred at 80 oC for another 12 h with 2.0 
equiv of Oxone®. The two oxime isomers were isolated as clear oils. (E/Z) isomers 
(major oxime isomer: Rf = 0.26 in 97% hexanes/3% ethyl acetate; minor oxime isomer: 
Rf = 0.26 in 97% hexanes/3% ethyl acetate). Under the reaction conditions, oxime 27b 
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underwent partial hydrolysis to the corresponding ketone (102 mg total, 60% yield, ratio 
of oxime isomers = 3:1, Ratio of oxime : ketone = 7:1). Major Oxime Isomer: 1H NMR 
(CDCl3): δ 7.22 (t, J = 8.2 Hz, 1H), 7.02 (dd, J = 8.1, 0.9 Hz, 1H), 6.82 (dd, J = 8.4, 0.9 
Hz, 1H), 4.00 (s, 3H), 3.82 (s, 3H), 2.12 (s, 3H). 13C{1H} NMR (CDCl3): δ 158.39, 
152.81, 133.83, 129.89, 125.97, 121.64, 109.28, 61.80, 55.98, 15.75. Minor Oxime 
Isomer: 1H NMR (CDCl3): δ 7.22 (t, J = 8.2 Hz, 1H), 7.01 (dd, J = 8.1, 0.9 Hz, 1H), 6.82 
(dd, J = 8.1 Hz, 0.9 Hz, 1H), 4.02 (s, 3H), 3.82 (s, 3H), 2.32 (s, 3H). IR of 27b (KBr): 
2936, 1590, 1573 cm-1. HRMS (ESI, m/z): [M+] calcd for C10H12ClNO2, 213.0557; 
found, 213.0554. GC analysis (RESTEK Rtx®-5, FID detector): 99% integration.  
Ketone: 1H NMR (CDCl3): δ 7.13 (t, J = 8.1 Hz, 1H), 6.95 (dd, J = 8.0, 1.1 Hz, 1H), 6.89 
(dd, J = 8.3, 1.1 Hz, 1H), 3.82 (s, 3H), 2.13 (s, 3H). 
 
 
The reaction was run at rt for 12 h and then the temperature was slowly ramped to 80 oC 
over 20  minutes for another 12 h with 2.0 equiv of Oxone in MeOH. The product was 
obtained as two oxime (E/Z) isomers (major oxime isomer: Rf = 0.25 in 95% hexanes/5% 
ethyl acetate; minor oxime isomer: Rf = 0.24 in 95% hexanes/5% ethyl acetate). The two 
oxime isomers were isolated as yellow oils (106 mg total, 59% yield, ratio of oxime 
isomers = 3:1). Major Oxime Isomer: 1H NMR (CDCl3): δ 8.51 (s, 1H), 7.21 (t, J = 8 
Hz, 1H), 6.83 (d, J = 8 Hz, 1H), 6.74 (d, J = 8.5 Hz, 1H), 3.99 (s, 3H), 3.83 (s, 3H), 2.52 
(s, 3H). 13C{1H} NMR (CDCl3): δ 158.48, 146.23, 139.09, 129.73, 123.55, 119.42, 
108.13, 61.89, 55.65, 22.123. Minor Oxime Isomer: 1H NMR (CDCl3): δ 7.52 (s, 1H), 
7.23 (t, J = 7.8 Hz, 1H) 6.84 (d, J = 7.8, 1H), 6.74 (d, J = 8.3 Hz, 1H), 3.93 (s, 3H), 3.80 
(s, 3H), 2.25 (s, 3H). IR (thin film): 2935, 1595 cm-1. HRMS (ESI, m/z): [M+] calcd for 















The reaction was run at rt for 12 h and then stirred at 80 oC for another 12 h with 2.0 
equiv of Oxone in MeOH. The product was obtained as a pale yellow oil (Rf = 0.26 in 
97% hexanes/3% ethyl acetate). 1H NMR (C6D6): δ 6.80-6.73 (multiple peaks, 3H), 3.89 
(s, 3H), 3.67 (s, 3H), 2.69 (t, J = 7.5 Hz, 2H), 2.36 (t, J = 7.5 Hz, 2H), 1.97 (quin, J = 7.5 
Hz, 2H). 13C{1H} NMR (CDCl3): δ174.42, 146.55, 143.78, 127.36, 122.60, 119.47, 
108.74, 56.16, 51.68, 33.71, 29.16, 25.08.  
 
General Method for Directed C-H Bond Methoxylation with K2S2O8: K2S2O8 
(309 mg, 1.14 mmol, 2.0 equiv) and Pd(OAc)2 (12.8 mg, 0.11 mmol, 0.1 equiv) were 
combined in MeOH (4.76 mL) in a 20 mL vial. Substrate 30 (100 mg, 0.57 mmol, 1.0 
equiv) was then added to the mixture. The vial was sealed with a Teflon lined cap, and 
the reaction was stirred at rt for 12 h and then stirred at 40 oC for another 12 h. The 
reaction mixture was diluted with ethyl acetate, and extracted with water (2 x 50 mL), 
NaHCO3 (1 x 50 mL), and brine (1 x 50 mL). The organic layer was dried over MgSO4, 
filtered, and concentrated. Each substrate was optimized for reaction time and equiv of 







The reaction was run at rt for 12 h and then at 40 oC for 12 h with 2.0 equiv of K2S2O8 in 
MeOH. The product was obtained as a yellow oil (85 mg, 72% yield). (Rf = 0.26 in 25% 
hexanes/75% ethyl acetate). 1H NMR (CDCl3): δ 7.29-7.25 (multiple peaks, 2H), 7.01-
6.96 (multiple peaks, 2H), 3.84 (s, 3H), 3.76 (t, J = 7.0 Hz, 2H), 2.56 (t, J = 7.9 Hz, 2H), 
2.19 (quin, J = 7.2 Hz, 2H). 13C{1H} NMR (CDCl3): δ 175.12, 154.80, 128.60, 128.59, 
127.20, 120.85, 111.99, 55.57, 49.90, 31.18, 18.92. IR (thin film): 2945, 1696 cm-1. 
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HRMS (ESI, m/z): [M+] calcd for C11H13NO2, 191.0946; found, 191.0943. GC analysis 









The reaction was run at rt for 12 h and then stirred at 40 oC for another 12 h with 3.0 
equiv of K2S2O8 in MeOH. The product was obtained as a brown solid as a single 
regioisomer (Rf = 0.25 in 25% hexanes/75% ethyl acetate) (67 mg, 61% yield); mp = 95-
110 oC. 1H NMR (CDCl3): δ 7.40 (d, J = 2.5 Hz, 1Ha), 7.37 (dd, J = 9.0, 2.5 Hz, 1Hb), 
6.84 (d, J = 8.5 Hz, 1Hc), 3.83 (s, 3H), 3.74 (t, J = 7.0 Hz, 2H), 2.55 (t, J = 7.9 Hz, 2H), 
2.19 (q, J = 7.7 Hz, 2H). 13C{1H} NMR (CDCl3): δ 175.07, 154.08, 131.460, 131.27, 
128.55, 113.47, 112.35, 55.86, 49.79, 31.04, 18.96. IR (KBr): 2924, 1674 cm-1. HRMS 
(ESI, m/z): [M+] calcd for C11H12BrNO2, 269.0051; found, 269.0046. GC analysis 









The reaction was run at rt for 12 h and then stirred at 40 oC for another 12 h with 2.0 
equiv of K2S2O8 in MeOH. The product was obtained as single regioisomer as a viscous 
pale yellow oil (67.0 mg, 57% yield, Rf = 0.22 in 25% hexanes/75% ethyl acetate). 1H 
NMR (C6D6): δ 7.18 (s, 1Ha), 6.85 (d, J = 8.3 Hz, 1Hb), 6.50 (d, J = 8.3 Hz, 1Hc), 3.39-
3.35 (multiple peaks, 2H), 3.28 (s, 3H), 2.17 (t, J = 7.7 Hz, 2H), 2.10 (s, 3H), 1.47 (quin, 
J = 7.8 Hz, 2H). 13C{1H} NMR (CDCl3): δ 175.19, 152.69, 130.34, 129.14, 129.06, 
126.86, 112.02, 55.75, 50.00, 31.25, 20.39, 18.96. IR (KBr): 2932, 1694 cm-1. HRMS 
(ESI, m/z): [M+] calcd for C12H15NO2, 205.1103; found, 205.1094. GC analysis 









The reaction was run at rt for 12 h and then stirred at 80 oC for another 12 h with 2.0 
equiv of Oxone in MeOH. The product was obtained as a pale yellow oil, mixture of two 
oxime (E/Z) isomers (major oxime isomer: Rf = 0.26 in 97% hexanes/3% ethyl acetate; 
minor oxime isomer: Rf = 0.26 in 97% hexanes/3% ethyl acetate). Under the reaction 
conditions, oxime 6b underwent partial hydrolysis to the corresponding ketone (6c mg 
total, 48% yield, ratio of oxime isomers = 3:1, Ratio of oxime : ketone = 1:1.7). Major 
Oxime Isomer: 1H NMR (C6D6): δ 7.55 (d, J = 8.5 Hz, 1H), 7.50 (m, 1H), 7.13 (dd, J = 
8.5, 3.0 Hz, 1H), 3.88 (s, 3H), 3.80 (s, 3H), 3.79 (s, 3H), 2.62 (s, 3H). Ketone NMR data 





1H NMR (C6D6): δ 6.94-6.90 (multiple peaks, 2H), 6.87 (dd, J = 9, 2.5 1H), 4.00 (s, 3H), 
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Factors Governing the Dominance of a Directing Group 
 
  
4.1  Background and Significance 
 
Palladium-catalyzed ligand directed C–H activation/functionalization has 
emerged as a powerful method for the regioselective conversion of C–H bonds to C–X 
bonds (X = C, O, Cl, Br, I and F).1-10 The ligand directed approach allows for the site 
selective functionalization of the C–H bond proximal to a directing group in molecules 
containing an appropriate chelating functionality (Scheme 4.1).  
 






(1) (2)  
 
Recently, we and others have shown that this methodology is general with respect 
to a wide variety of directing groups such as pyridines, oxime ethers, isoxazolines, 
amides, quinolines, and oxazolines.1-9  Importantly, these functionalities are widely 
prevalent in biologically active molecules.11, 12 Hence, this methodology could potentially 
be used for functionalization of C–H bonds adjacent to chelating groups to generate 
libraries of synthetic analogues of important pharmaceutical targets. 
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The palladium-catalyzed chelate directed functionalization reactions have thus far 
been demonstrated in molecules bearing a single chelating functionality. Hence, they 
could be applicable to molecules such as 3, 4 and 5 that contain only one potential ligand 
(Figure 4.1).13-15 However, the vast majority of biologically active molecules contain 
multiple chelating functionalities (for example, 6, 7, and 8 in Figure 4.2).11, 12 Subjection 
of these molecules to C–H activation/functionalization reactions could possibly lead to 
mixtures of products resulting from functionalization adjacent to the different directing 
groups present in these compounds. In order to enhance the applicability of these ligand-
directed transformations, an understanding of the factors that control functionalization 
adjacent to one chelating moiety over another is essential. Despite the potential synthetic 
utility of this chemistry, to date there has been no systematic study to address this 
important issue. This chapter describes a comprehensive investigation of the factors that 
govern the dominance of a directing group in palladium-catalyzed 
activation/functionalization of C–H bonds to C–OAc bonds. The insights gained from 
this study could ultimately be applied towards transformation of C–H bonds to other C–X 
bonds (X =  Cl, Br, I, F, C, and N) as well. 
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Atherosclerosis Anti-colon cancer Alzheimers  
 
Strategy: Our approach towards elucidating the dominance of a directing group 
involved systematically studying how different directing groups affect the distribution of 
products in Pd-catalyzed C–H bond functionalization with PhI(OAc)2. As shown in 
Scheme 4.2, we designed a series of experiments to compete two directing groups against 
one another in the same reaction flask (mimicking situations where two potential ligands 
are present within the same molecule). In these systems, 1 equiv of substrate A and 1 
equiv of substrate B were subjected to Pd-catalyzed reaction with 1 equiv of PhI(OAc)2. 
The ratio of acetoxylated products (A-OAc/B-OAc) was then determined, and this value 
was taken to represent the relative reaction rates of the two directing groups (kA/kB) under 
a given set of conditions (Scheme 4.2).  
 
Scheme 4.2: Competition Studies Between Multiple Directing Groups 
















A-OAc B-OAc  
 
4.2  Substrate Selection and Optimizations 
 
Our studies began with the synthesis of substrates bearing a variety of different 
directing groups (Figure 4.3). Importantly, the key design elements for these substrates 
include (i) selection of directing groups shown to be effective ligands for palladium and 
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present in biologically active molecules, (ii) installation of a methylene unit between the 
directing ligand and the aryl ring to limit electronic communication between the directing 
group and the arene being functionalized, and (iii) introduction of an electronically 
neutral methyl substituent at the meta-position of the aryl ring being functionalized in 
order to promote selective mono-acetoxylation of the sterically less hindered C-H bond 
(Figure 4.4).4 
 































R = CH3 (11), H (12) R = CH3 (13), H (14)
n
n = 0 (9), 1 (10) (15)
(16) (17) (18) (19)
(20) (21) (22)  
 
 









Next, we conducted studies to obtain reaction conditions for the palladium-
catalyzed C–H activation/acetoxylation of these substrates. A screen of different solvents, 
temperatures and catalyst loadings was performed. A representative set of data for the 
solvent and catalyst loading study is illustrated in Table 4.1. Interestingly, there is a 
significant solvent effect between different directing groups. While 21 lead to excellent 
yields of the acetoxylated product in all solvents, substrate 11 afforded the desired 
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product only in AcOH/Ac2O. The catalyst loading could be reduced to 0.1 mol % for 
substrate 21 and still produce good (47%) yield of acetoxylated product (Table 4.1, entry 
6). However, this low catalyst loading led to diminished reactivity for other substrates 
such as 17 and 11 (entry 6). Hence, we chose to conduct all our further studies with 1 mol 
% Pd(OAc)2. 
 









































Substrates 11, 13, 15-19, and 21 afforded the desired monoacetoxylated products 
23-26 and 30-33 in good to excellent yields under our optimized reaction conditions (1 
mol % Pd(OAc)2, 1.02 – 1.8 equiv PhI(OAc)2 in AcOH/Ac2O at 100 ºC) regardless of the 
nature of the directing group (Table 4.2, entries 1-4 and 8-11). The stronger oxidant 
PhI(OCOCF3)2 was required for substrates 9 and 10, and even then only modest (49-
55%) yields of products 34 and 35 were obtained (Table 4.2, entries 12 and 13). The low 
reactivity of 9 and 10 may be due to the larger seven-membered ring required for 
cyclopalladation with the amide carbonyl in these substrates, since amide substrate 15 
affords the acetoxylated product  33 in good yield (entry 11).  
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Table 4.2: Scope of Substrates Bearing Different Directing Groups 
L
1 mol % Pd(OAc)2
1.02 - 1.8 equiv PhI(OAc)2 L
H OAc
AcOH/Ac2O (1:1)
























































































Substrates 12 and 14 afforded no appreciable amount of the acetoxylated products 
29 and 36 due to their faster relative rate of decomposition under our reaction conditions. 
Additionally, compounds 20 and 22 afforded the desired acetoxylated products 27 and 28 
in low yields due to competing uncatalyzed acetoxylation at other positions in the 
molecule. This was surprising to us because substrates bearing the same directing group, 
but lacking a methylene spacer, afforded good yields of the ortho-acetoxylated products 
along with only trace amounts of the undesired products (Scheme 4.3).1, 2 
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5 mol % Pd(OAc)2
1.5 equiv PhI(OAc)2
AcOH/Ac2O (1:1)
 100 oC, 52%
5 mol % Pd(OAc)2
1.5 equiv PhI(OAc)2
AcOH/Ac2O (1:1)
 100 oC, 69%
(37) (38)
(39) (40)
(41) (42)  
 
4.3  Competition Studies 
 
  The competition experiments depicted in Scheme 4.4 above were conducted in 
two different solvents – an acidic medium (AcOH/Ac2O) and a non-acidic medium 
(benzene). We examined both solvents in order to determine whether the trend of 
dominance observed was not affected by competitive protonation of the basic directing 
groups in AcOH. These studies were performed by subjecting a 1:1 molar ratio of two 
different substrates in either AcOH/Ac2O (1:1) or benzene with 1 equivalent of 
PhI(OAc)2 and 1 mol % Pd(OAc)2. Upon completion of the reaction, the yields and ratios 
of the acetoxylated products were determined by gas chromatography. The ratio of the 
products reflected the relative rates of reaction of the two substrates towards C–H 
activation/acetoxylation. In a representative experiment, the reaction of an equimolar 
quantity of 18 and 17 in the same vessel afforded the acetoxylated products 26 and 25 in 
a ratio of 1:0.4 (kpyrazole/kpyridine = 2/5). The same experiment when conducted in benzene 
also led to 26 as the major product (26:25 = 1:0.06), albeit with greater selectivity than in 
AcOH/Ac2O (Scheme 4.4). 
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Scheme 4.4: Representative Competition Experiment 













AcOH/Ac2O : 1 : 0.4
Benzene : 1 : 0.06
1 equiv 1 equiv
(18) (17) (26) (25)
 
 
Interestingly, competition experiments between pyridine 18 and substrates 
bearing significantly less basic directing groups such as isoxazoline (16), oxime ethers 
(11 and 13), and amide (15) did not afford an appreciable amount of the acetoxylated 
products 24, 30-31, and 33 in either AcOH/Ac2O or benzene. Instead, 26 was formed 
with a selectivity of > 50:1 (Scheme 4.5).  
 











AcOH/Ac2O : 1 : <0.01
Benzene : 1 : <0.01
1 equiv 1 equiv
(18) (11) (26) (30)
 
 
Analogous competition experiments were also conducted between substrates 11, 
13, 15 and 16. Interestingly, the two similar oxime ether derivatives 11 and 13 exhibited 
different reactivity when the solvent was changed from AcOH/Ac2O to benzene (Scheme 
4.6). Methyl oxime ether 11 did not afford any of the acetoxylated product 30 in benzene, 
whilst benzyl oxime ether 13 yielded 28% of product 31.  
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Scheme 4.6: Competition between Oxime Ethers 13 and 11 











AcOH/Ac2O : 1 : 1





1 mol % Pd(OAc)2
1 equiv PhI(OAc)2
80 oC
(13) (11) (31) (30)
 
 
The ratios obtained from all of these competition experiments are compiled in 
Tables 4.3 and 4.4. Based on this data, the reactivity trend depicted in Figure 4.5 was 
obtained for AcOH/Ac2O and benzene, respectively. In general, substrate 18, bearing the 
most basic directing group (pyridine), afforded the predominant acetoxylated product in 
the presence of all other chelating ligands in both AcOH/Ac2O and benzene.  
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1 : 0.4 1 : 0.3 1 : 0.04 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  
- 1 : 3.3 1 : 1.5 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  
1 : 0.3 - n/aa 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  




0.01 : 1 0.01 : 1 0.01 : 1 - 0.01 : 1 0.01 : 1 0.01 : 1 
N
OMe  









0.01 : 1 0.01 : 1 0.01 : 1 1 : 0.01 1 : 0.01 1 : 1 - 
a Ratio not obtained because starting materials and products have identical retention times by GC 
In the ratios depicted above the first number refers to the substrate in the column and the second number to 
the substrate in the row 
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1 : 0.06 1 : 0.2 1 : 0.05 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  - 1 : 4 1 : 2 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  
1 : 0.25 - n/aa 1 : 0.01 1 : 0.01 1 : 0.01 1 : 0.01 
N
N  0.5 : 1 n/a




0.01 : 1 0 : 1 0 : 1 - n/ab 0.01 : 1 0.01 : 1 
N
OMe  









0.01 : 1 0.01 : 1 0.01 : 1 1 : 0.01 1 : 0.01 1 : 1 - 
a Ratio not obtained because starting materials and products have identical retention times by GC 
b Ratio not obtained because starting materials afford trace amounts of products in benzene 
In the ratios depicted above the first number refers to the substrate in the column and the second number to 
the substrate in the row 
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Figure 4.5: Relative Reactivity of Directing Groups from Competition Studies in 















































While the trends in the two solvents varied slightly, in general the results were 
consistent with studies of substituted benzylpyridine derivatives 43a-43f (Scheme 4.7), 
which were conducted by my colleague Kara Stowers. Kara obtained a Hammett ρ value 
of -2.01 when she carried out similar competition experiments with these substrates 
(Scheme 4.7). This ρ value implies that electron rich substrates are dominant in the 
competition studies.  
 

















Hammett ! = -2.01
X = H, Y = OMe (43a),
 CH3 (43b), Cl (43c)
CF3 (43d)
Y = H, X = CH3 (43e), 
F (43f)
(18) X = H, Y = OMe (44a),
 CH3 (44b), Cl (44c)
CF3 (44d)






4.4  Individual Rate Studies 
 
  We next sought to investigate the reasons for predominant product formation by 
substrates bearing an electron rich ligand when substrates containing different directing 
groups were present in the same reaction vessel. In particular, we wondered if 
benzylpyridine substrate 18, which afforded the major product in the presence of other 
directing groups, would also exhibit the fastest rate of acetoxylation. In order to probe 
this, we studied the kinetics of acetoxylation for each substrate individually in separate 
reaction vessels. The initial rate constant for each substrate was obtained under optimal 
conditions (1 mol % Pd(OAc)2, 1.02 equiv PhI(OAc)2, at 80 ºC) in both AcOH/Ac2O and 
in benzene, by monitoring the reaction progress by GC (Table 4.5). The initial rates for 
acetoxylation of substrates 11, 13, 15-19, and 21 ranged from 0.01 to 0.64 mol/(L)(min) 
in AcOH/Ac2O and 0.02 to 0.5 mol/(L)(min) in benzene.  
 































Notably, in AcOH/Ac2O, the three substrates bearing very similar heterocyclic 
nitrogen-containing directing groups – pyridine 18, pyrimidine 21, and pyrazine 19 – 
exhibited very different initial rates. The pyrimidine reacted 60 times faster than the 
pyrazine and 4 times faster than the pyridine (Table 4.5, entries 1, 4, and 8). In contrast, 
substrates bearing two very different directing groups, methyl oxime ether (11) and 
pyridine (18), showed very similar initial rate constants (entries 4-5).  
The solvent had a significant effect on the efficiency of the acetoxylation 
reactions by certain chelating ligands. For example, the isoxazoline and the pyrazole 
underwent reaction at similar rate constants in AcOH/Ac2O, while in benzene the 
isoxazoline substrate 16 was twice as fast as the pyrazole. Notably, methyl oxime ether 
11 and amide 15, which showed good reactivity in AcOH/Ac2O, led to only trace 
amounts of the corresponding acetoxylated products in benzene. Additionally, contrary to 
the competition studies, substrate 18, bearing the most basic directing group – pyridine – 
did not exhibit the fastest rate of acetoxylation. However, these results were consistent 
with the data obtained by Kara Stowers with the substituted benzyl pyridines 43a-43f. 
She obtained a Hammett ρ value of 1.40 when examining the initial rate constants of 
substituted benzyl pyridine derivatives. This implies that, in contrast to the competition 
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studies, electron deficient directing groups accelerate the rate of the reaction in individual 
experiments. 
 
Table 4.5: Initial Rate Constants for Substrates 11, 13, 15-19, and 21 in AcOH/Ac2O and 
Benzene 





























































Conditions a: 1 mol % Pd(OAc)2, 1.02 equiv PhI(OAc)2, (1:1) 0.12M AcOH/Ac2O at 80 °C
Conditions b: 5 mol % Pd(OAc)2, 1.02 equiv PhI(OAc)2,  0.12M Benzene at 80 °C  
 
4.5  Kinetic Isotope Effect Studies 
 
We next desired to determine the kinetic isotope effect (KIE) in the individual 
reactions and competition experiments. In order to elucidate the KIE in the individual 
reactions, the value of kobs with substrate 46 was compared to that of its deuterated 
analogue 45 in both AcOH/Ac2O and benzene (Scheme 4.8). From the initial rates, kH/kD 
was calculated to be 3.54 in AcOH/Ac2O and 1.86 in benzene.  
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kobs = 1.7 x 10
–2 in C6H6
kobs = 3.3 x 10
–2 in AcOH/Ac2O
kobs = 1.0 x 10
–2 in C6H6
kobs = 0.97 x 10
–2 in AcOH/Ac2O
kH/kD = 1.86 in C6H6





We next determined the KIE in the competition experiments. The ratio of 
products at completion was determined when benzylpyridine 47 was subjected to the 
reaction conditions in the presence of either 46 or its deuterated analogue 45 (Scheme 
4.9). The isotope effects obtained from this experiment were 2.32 and 1.65 in 
AcOH/Ac2O and benzene, respectively.  
 



















kH/kD = 1.65 in C6H6































4.6  Order of PhI(OAc)2 
 
In order to gain insight into the relative position of the turnover limiting step in 
the catalytic cycle, we next investigated the order of the reaction in PhI(OAc)2 in both the 
competition studies and the individual reactions. Under our optimal conditions for 
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acetoxylation with the benzylpyridine substrate 18 (Scheme 4.10), the reaction was found 
to be zero order in PhI(OAc)2 in both AcOH/Ac2O and benzene (Figure 4.8 and 4.9).  
 
Scheme 4.10: Reaction Studied for Determining the Order in PhI(OAc)2 








Figure 4.8. Initial Rate Constant as a Function of Oxidant Concentration in AcOH/Ac2O 
 
 




Next, the order of the reaction in PhI(OAc)2 was obtained under the competition 
conditions. Similar to the experiment above, the order of PhI(OAc)2 in the competition 
study between 52 and 18 (Scheme 4.11) was also determined to be zero (Figure 4.10 and 
4.11). Both the order studies were done in collaboration with Kara Stowers. 
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Scheme 4.11: Reaction Studied for Determining the Order in PhI(OAc)2 (Competition) 
(52) (18) (54) (26)













Figure 4.10. Initial Rate Constant of 18 in Presence of 52 as a Function of Oxidant 
Concentration in AcOH/Ac2O 
 
 
Figure 4.11. Initial Rate Constant of 18 in Presence of 52 as a Function of Oxidant 
Concentration in Benzene  
 
 
4.7  Discussion 
 
With all these results in hand we sought to address the key mechanistic steps 
dictating the efficiency of a directing group in palladium-catalyzed ligand directed C–H 
activation/acetoxylation reactions both in the presence and absence of multiple chelating 
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functionalities. The proposed mechanism for these acetoxylation reactions, (Figure 4.12) 
is believed to involve the following steps: (i) ligand coordination to palladium, (ii) C–H 
activation to form palladacycle B, (iii) oxidation of B by PhI(OAc)2 to afford the PdIV 
intermediate C, (iv) C–O bond forming reductive elimination from C to afford complex 
D, and (v) finally ligand exchange whereby a new substrate molecule displaces the 
product from the metal. The mechanistic features/requirements for each of the 
fundamental steps of this catalytic cycle are discussed in detail below. 
 

































Ligand Binding (step i): The equilibrium constant for ligand binding to PdII 
centers is known to be highly dependent on the electronic nature of the coordinating 
group. For example, Craig has studied Keq for the coordination of substituted pyridines to 
PdII pincer complexes (Scheme 4.12).16 The log of Keq obtained for binding of 
differentially substituted pyridines was plotted against the sigma values. These studies 
demonstrated that the Hammett ρ value for this equilibrium is -1.90 in DMSO. The 


























C–H activation (step ii): Ryabov reported the earliest studies on the mechanism of 
electrophilic arene C–H activation by palladium. His group investigated the kinetics of 
stoichiometric cyclopalladation of meta- and para-substituted dimethylbenzylamine 
derivatives with Pd(OAc)2 (Scheme 4.13).17 A Hammett ρ value of –1.6 and a kinetic 
isotope effect of 2.02 were obtained for the reaction in CHCl3. Based on this negative ρ 
value, the authors proposed that cyclopalladation proceeded by a Wheland intermediate 
that transfers a proton to an acetate ligand on the metal via a highly ordered six-
membered transition state (Figure 4.13).  
 

















More recently, computational studies by Macgregor and co-workers provided 
further insights into the transition state for directed C–H activation at PdII.18 They 
obtained theoretical values of 13 kcal/mol for the activation barrier and 1.2 for the kinetic 
isotope effect. Based on this data, along with calculations of the transition state, they 
proposed that the C–H activation reaction proceeds via an agostic C–H complex, rather 
than a Wheland intermediate (Figure 4.13). This would account for the relatively small 
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magnitude of ρ observed experimentally. For comparison, ρ for a typical electrophilic 
aromatic substitution reaction ranges from –6 to –12.19 The agostic complexation is 
followed by an intramolecular hydrogen transfer via a six-membered transition state to a 
coordinated acetate. The authors propose that formation of the agostic complex is rate 
determining in this system; therefore, the small KIE is due to C–H bond elongation, as 
opposed to cleavage, in the transition state. Importantly, a similar mechanism has also 
been proposed by Fagnou20 and by Echavarren21 for other arene activation reactions at 
PdII. 
 














Ryabov's Proposed TS Macgregor's Proposed TS  
 
Based on the aforementioned computational and theoretical studies, it is now 
generally accepted that palladium mediated C–H activation proceeds via interaction of 
electrophilic Pd center with nucleophilic C–H bond. Hence, more electron deficient 
directing groups are expected to accelerate the C–H activation step. For example, 
Funahashi and co-workers have shown that the cyclopalladation of N-benzyltriamines is 
accelerated when the amine nitrogen bears less electron donating substituents.22 As 
shown in Scheme 4.14, the rate of cyclopalladation to form complex 59 increased 
significantly when R was changed from H to Ph in complex 58.  
 













R = H (58a)
R = Ph (58b)
kobs
R = H (59a)
R = Ph (59b)




Oxidation (step iii): Literature precedent suggests that more electron donating 
ligands on palladium will increase the rate of oxidation of PdII complex A to PdIV 
complex B by making the palladium more nucleophilic. For example, van Koten and co-
workers have reported that the reactivity of cyclometalated N,N-dimethylbenzylamine 
complexes towards t-butylhydroperoxide (TBHP) increases as the electron density at the 
metal center increases.23 Cationic complex 60 did not react with TBHP, whilst the more 
electron rich complex 61 reacted to form 62 in 80% yield (Scheme 4.15). These reactions 
were proposed to proceed via rate-limiting oxidation of PdII to a PdIV-oxo species. 
 
























(61) (62)  
 
Reductive elimination (step iv): Reports in literature suggest that electron 
withdrawing ligands accelerate C-O bond forming reductive elimination from PdI1.24 
Based on these reports and the principal of microscopic reversibility with the oxidation 
step, we propose that reductive elimination from PdIV will be similarly accelerated by 
electron deficient ancillary ligands. 
Having this information about the expected trends for the different steps in the 
proposed catalytic cycle, we next sought to speculate on the factors controlling the 
dominance of a directing group based on our experimental results. 
Individual Rate Studies. The kinetic studies of substrates in separate reaction 
vessels showed that, in general, substrates bearing electron deficient or less basic ligands 
react faster in the chelate-directed acetoxylation reaction. This is supported by the 
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positive ρ value (1.4) of the Hammett plot obtained for the acetoxylation of electronically 
differentiated benzylpyridine derivatives. This is further corroborated by the fact that the 
pyridine substrate (which bears the most basic chelating group) did not exhibit the fastest 
initial rate.  
As described above, we would expect that both the C–H activation step and the 
reductive elimination step of the catalytic cycle to be accelerated by electron deficient 
directing groups. Hence, electronic effects alone cannot distinguish between either one of 
these steps being turnover limiting. However, the observed kinetic isotope effects of 1.86 
and 3.45 in benzene and AcOH/Ac2O, respectively, suggests a significant contribution of 
C–H bond breaking to the transition state of this reaction. Importantly, these KIE values 
are similar to those observed by Ryabov (2.02) and Daugulis (4.4)25 for related 
stoichiometric and catalytic reactions, respectively. It is also important to note that 
literature reports have shown that PdIV intermediates analogous to those proposed in our 
reaction are highly unstable, suggesting that rate-limiting reductive elimination is highly 
unlikely. In all, this data suggests that C–H activation is the step controlling the rate of 
these individual reactions. 
However, we note that in contrast to the results with the benzylpyridine 
derivatives, the individual rate studies with substrates 11, 13, 15 and 16 did not show a 
linear correlation between kobs and the basicity of the directing group. For example, 
oxime 11 (pKa ~ –2.90)26 reacted at a similar rate to pyrazole 17 (pKa ~ 2.18)27 in 
benzene, despite a difference of 5 pKa units between the two functional groups. This lack 
of direct correlation likely has both steric and electronic origins. First, unlike 
benzylpyridines 43a-43f, which provide essentially sterically identical coordination 
environments at the Pd center, compounds 11, 13, 15-19 and 21 differ substantially in 
terms of both their steric parameters and their conformational flexibility. Literature 
reports have shown that even relatively subtle steric effects can have a significant 
influence on the relative and absolute rates of cyclopalladation reactions.28 In addition, 
the pKa of the directing group is not an ideal parameter for predicting the subtle 
electronic influence of these ancillary ligands on the C–H activation reaction, as it does 
not take into account the interplay of σ-donor and π-acceptor/donor properties of these 
directing groups. 
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 Competition Studies. The competition studies show that when multiple potential 
chelating functionalities are present in solution, more electron rich/more basic directing 
groups react at faster relative rates. This can be concluded based on three key results: (i) 
the large negative 〉 value from Hammett plots with substituted benzylpyridine 
derivatives, (ii) the observation that the most basic directing group (pyridine in substrate 
18) out-competes all of the other directing groups among substrates 11, 13, 15-19 and 21 
(Figure 4.5) and (iii) the fact that heterocyclic ligands with pKa values greater than zero 
(pyridine, pyrimidine, pyrazine, pyrazole) outcompete all substrates with pKa values less 
than zero (oxime ethers, amides and isoxazolines). Based on the considerations above, 
this suggests that either ligand binding/exchange (steps i and v) or oxidation (step iii) 
controls the relative reactivity of the two substrates under these conditions. We were able 
to rule out the latter based the study of the order of the reaction in PhI(OAc)2. Under our 
optimal conditions for acetoxylation with substrate 18, the reaction was found to be zero 
order in PhI(OAc)2, both in the presence and absence of another substrate (52), (Figures 
4.8-4.11).  
This result led us to propose that selectivity under these competition conditions is 
dictated by Keq for binding of the two substrates to Pd. More specifically, we propose that 
the relative concentrations of the two coordination complexes (A and A’ in Scheme 4.16) 
dictate the observed relative rates of reaction, and that this equilibrium favors binding of 
more electron rich directing group. Literature studies of Keq for coordination of 
substituted pyridines to Pd, discussed above, show Hammett ρ values ranging from –1.7 
to –2.1 in DMSO. These are similar to our results in benzene, where ρ = –2.01. 
 















(A) (A')  
Although ligand binding is the influential step when multiple ligands are present, 
C-H activation is still rate-limiting. This is supported by the significant KIE observed in 
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solvent systems, benzene and AcOH/Ac2O. Relative binding abilities of the competing 
ligands in the reaction mixture will influence the concentration of the palladium bound 
substrate, complex A (Figure 4.12). The concentration of A will in turn affect the rate of 
C-H activation. Since substrates bearing electron rich ligands will bind to the metal 
preferentially over electron deficient ligands, increasing the concentration of coordinated 
complex A, they will exhibit a faster relative rate of reaction. 
The observed effects in the competition studies have important implications for 
future applications of this chemistry. First, the solvent can clearly have a significant 
influence on the selectivity of functionalization in the presence of multiple directing 
groups. Trends for competition studies and rate of reactions were different depending on 
whether the reaction was carried out in a non-acidic solvent such as benzene or an acidic 
solvent such as acetic acid. This suggests that solvent selection could be used to obtain, 
alter, or improve selectivity. Second, these studies can be used to predict relative 
reactivity, even with substrates like 63 (illustrated later in section 4.8) that do not contain 
a methylene spacer between the directing group and the arene ring. Future studies will 
continue to explore how these effects (and the effects of other solvents and additives) 
translate into predicting and controlling the dominant directing group in other more 
complex systems. 
 
4.8  Application 
 
Having explored the factors controlling the dominant directing group in the 
presence of several chelating functionalities, our efforts focused towards applying the 
insights gained from our study towards selective palladium-catalyzed ligand mediated 
acetoxylation adjacent to one ligand in a substrate bearing multiple directing groups. In 
order to do this, substrate 63 containing an amide and a methyl oxime ether was 
synthesized. Based on the competition studies between substrates 11 and 15, we expected 
the oxime ether to outcompete the amide, resulting in products of acetoxylation ortho to 
the oxime ether. We were pleased to find that, consistent with our hypothesis, the 
reaction of substrate 63 in the presence of 3 mol % Pd(OAc)2 and 2.0 equiv  PhI(OAc)2 in 
AcOH/Ac2O afforded the di-acetoxylated product 64 in 72% isolated yield (Scheme 
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4.17). Importantly, none of the product derived from acetoxylation of the C–H bond 
ortho to the amide directing group was observed. The acetoxylated product 64 was 
further elaborated to diverse compounds 65, 66 and 67 employing Pd-catalyzed chelate-
directed, chlorination,29 phenylation,3 and acetoxylation methodologies, respectively 
(Scheme 4.18).  
 
Scheme 4.17. Highly Selective Oxime Ether-Directed C–H Acetoxylation of Substrate 63 











OAc(63) (64)  
 











































The results in Scheme 4.18 show that even though the oxime ether is dominant, if 
the ortho sites are blocked then the amide can direct functionalization. Hence, we next 
wondered if we could employ a similar strategy towards functionalizing the C–H bond 
adjacent to the oxime ether in a substrate like 68, which contains both a pyridine and an 
oxime ether, by blocking the sites ortho to the pyridine moiety. Subjection of substrate 68 
to standard reaction conditions with 2.0 equivalents of PhI(OAc)2 afforded the 
 136 
diactoxylated product 69 in 79% (Scheme 4.19). However, disappointingly, subjection of 
69 to catalytic Pd and PhI(OAc)2 did not afford an appreciable amount of acetoxylated 
product 70. This may be due to the fact that the C–H bonds at the site ortho to the oxime 
ether are very sterically hindered. 
 
Scheme 4.19: Intramolecular Competition Between a Pyridine and an Oxime Ether 






















(68) (69) (70)  
 
Next, substrate 71 was synthesized bearing an oxime ether directing group with 
the ability to direct C–H activation at two different aryl rings (Scheme 4.20). Based on 
the competition studies conducted with substrates 11 and 13 in benzene and AcOH/Ac2O, 
we predicted a greater selectivity in benzene than AcOH. Excitingly, subjection of 
substrate 71 under the optimized conditions of 5 mol % Pd(OAc)2, 1.02 equiv PhI(OAc)2 
in benzene/Ac2O afforded a single acetoxylated product 72. In contrast, subjection of the 
same molecule in AcOH/Ac2O afforded a 1:1 ratio of products 72 and 73 (Scheme 4.20).  
 

























(71) (72) (73)  
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4.9  Conclusions 
 
In summary, we have conducted detailed studies on elucidating the electronic 
requirements of a directing group in Pd-catalyzed directed C–H functionalization 
reactions. Through mechanistic studies we have determined that the rate-limiting step is 
C–H activation. However, when multiple ligands are present, the equilibrium of ligand 
coordination appears to control the relative rate of reaction. Interestingly, there is not a 
direct correlation between the intrinsic rate and the dominance of a directing group. 
These important findings allow for the further development of selective and effective 
transformations.  
 
4.10  Experimental Procedure 
 
General Procedures: NMR spectra were obtained on a Varian Inova 400 (399.96 
MHz for 1H; 100.57 MHz for 13C; 376.34 MHz for 19F) unless otherwise noted. 1H NMR 
chemical shifts are reported in parts per million (ppm) relative to TMS, with the residual 
solvent peak used as an internal reference. Multiplicities are reported as follows: singlet 
(s), doublet (d), doublet of doublets (dd), doublet of doublets of doublets (ddd), doublet 
of triplets (dt), triplet (t), quartet (q), quintet (quin), multiplet (m), and broad resonance 
(br). IR spectra were obtained on a Perkin-Elmer spectrum BX FT-IR spectrometer 
 
Materials and Methods: Pd(OAc)2 was obtained from Pressure Chemical and 
used as received, and PhI(OAc)2 was obtained from Merck Research Laboratories and 
used as received. Solvents were obtained from Fisher Chemical and used without further 
purification unless otherwise noted. THF was purified using an Innovative Technology 
(IT) solvent purification system composed of activated alumina, copper catalyst, and 
molecular sieves.  Flash chromatography was performed on EM Science silica gel 60 
(0.040–0.063 mm particle size, 230–400 mesh) and thin layer chromatography was 
performed on Merck TLC plates pre-coated with silica gel 60 F254. Melting points were 
determined with a Mel-Temp 3.0, a Laboratory Devices Inc, USA instrument and are 
uncorrected. HRMS data were obtained on a Micromass AutoSpec Ultima Magnetic 
 138 
Sector mass spectrometer. Gas chromatography was carried out on a Shimadzu 17A 
using a Restek Rtx®-5 (Crossbond 5% diphenyl – 95 % dimethyl polysiloxane; 15 m, 
0.25 mm ID, 0.25 µm df) column. 
 
Synthesis of Substrates 18, 19, 21, 45-47 and 52 
Substrates 18, 19, 21, 45-47 and 52 were prepared via Pd-catalyzed Negishi 
coupling of (3-methylbenzyl)zinc(II) bromide with the corresponding halopyridine 
derivative using a modification of a literature procedure. 30 
Synthesis of Zn reagent: A three-necked flask was charged with purified zinc dust  
(1.2 equiv) and anhydrous THF. The mixture was heated to reflux, and 1,2-
dibromoethane (0.04 equiv) was added. After heating at reflux for 15 min, the reaction 
was cooled to room temperature and TMSCl (0.05 equiv) was added. The resulting 
mixture was stirred at room temperature for 30 min, and then a solution of m-
bromoxylenes (1 equiv) in anhydrous THF was added dropwise over a period of 2 h. 
Negishi coupling. In a Schlenk flask, Pd(OAc)2 (0.05 equiv) and P(o-tolyl)3 (0.1 
equiv) were dissolved in anhydrous THF, and this mixture was stirred for 10 min. The 
halopyridine (1.0 equiv) was then added, and the resulting mixture was cooled to 0 ºC. 
The aryl zinc reagent (2.0 equiv) was added dropwise to this solution over the course of 
15 min, and the reaction was allowed to warm to room temperature and stirred overnight. 





Substrate 18 was obtained as a clear oil (Rf = 0.28 in 70% hexanes/30% ethyl acetate). 1H 
NMR (CDCl3): δ 8.56 (dd, J = 4.4, 1.2 Hz, 1H), 7.56 (dt, J = 7.6 Hz, 2.0 Hz, 1H), 7.20 (t, 
J = 7.6 Hz, 1H), 7.13-7.03 (multiple peaks, 5H), 4.13 (s, 2H), 2.33 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 161.02, 149.23, 139.30, 138.06, 136.40, 129.78, 128.34, 127.03, 126.02, 
122.99, 121.08, 44.59, 21.30. HRMS electrospray (m/z): [M-H]+ calcd for C13H13N, 






Substrate 21 was obtained as a pale yellow oil (Rf = 0.28 in 70% hexanes/30% ethyl 
acetate). 1H NMR (CDCl3): δ 8.66 (d, J = 4.8 Hz, 1H), 7.21-7.15 (multiple peaks, 3H), 
7.08 (t, J = 4.8 Hz, 1H), 7.02 (d, J = 6.8 Hz, 1H), 4.26 (s, 2H), 2.31 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 170.02, 157.17, 138.00, 129.76, 128.32, 127.26, 126.02, 118.48, 45.92, 





Substrate 19 was obtained as a clear oil (Rf = 0.28 in 75% hexanes/25% ethyl acetate). 1H 
NMR (CDCl3): δ 8.50- 8.47 (multiple peaks, 2H), 8.40 (d, J = 2.8 Hz, 1H), 7.21 (t, J = 
7.6 Hz, 1H), 7.08-7.04 (multiple peaks, 3H), 4.13 (s, 2H), 2.32 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 156.53, 144.70, 144.00, 142.24, 138.34, 137.93, 129.67, 128.57, 127.44, 
125.94, 41.84, 21.28. HRMS (ESI, m/z): [M-H]+ calcd for C12H12N2, 183.0922; found, 





Substrate 52 was obtained as a colorless oil (Rf = 0.26 in 90% hexanes/10% ethyl 
acetate). 1H NMR (CDCl3): δ 8.74 (d, J = 4.4 Hz, 1H), 7.36-7.34 (multiple peaks, 2H), 
7.23 (t, J = 1.9 Hz, 1H), 7.11-7.07 (multiple peaks, 3H), 4.21 (s, 2H), 2.35 (s, 3H). 
13C{1H} NMR (CDCl3):  δ 162.68, 150.29, 138.71 (q, 2JCF = 33.7 Hz), 138.40, 138.28, 
129.80, 128.63, 127.50, 126.04, 122.80 (q, 1JCF = 271 Hz), 118.56 (q, 3JCF  = 3.6 Hz), 
116.84 (q, 3JCF  = 2.9 Hz), 44.58, 21.32. 19F{1H} NMR (CDCl3): δ –64.78. HRMS (ESI, 
m/z): [M-H]+ Calcd for C14H12F3N, 250.0843; Found, 250.0842. 
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Substrate 16 was prepared from 2-m-tolylacetaldehyde according to a literature 
procedure. 31Substrate 16 was obtained as a yellow oil (Rf = 0.28 in 70% hexanes/30% 
ethyl acetate). 1H NMR (CDCl3): δ 7.21 (t, J = 7.4 Hz, 1H), 7.09-7.01 (multiple peaks, 
3H), 4.76 (m, 1H), 4.08 (qd, J = 12.0, 4.8 Hz, 2H), 3.64 (q, J = 14.8 Hz, 2H), 2.93 (dd, J 
= 17.2, 11.2 Hz, 1H), 2.60 (dd, J = 17.2, 6.8 Hz, 1H), 2.33 (s, 3H), 2.02 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 170.77, 157.56, 138.57, 135.36, 129.49, 128.72, 127.91, 125.72, 77.36, 
65.04, 38.56, 33.85, 21.32, 20.07. IR (thin film): 1742 (br) cm-1. HRMS (ESI, m/z): [M]+ 





Substrate 17 was prepared from pyrazole and α-bromoxylenes according to a literature 
procedure.32 Substrate 17 was obtained as a red oil (Rf = 0.24 in 90% hexanes/10% ethyl 
acetate). 1H NMR (CDCl3): δ 7.56 (d, J = 1.6 Hz, 1H), 7.38 (d, J = 2.4 Hz, 1H), 7.24 (t, J 
= 7.6 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 7.04-7.01 (multiple peaks, 2H), 6.28 (t, J = 2.0 
Hz, 1H), 5.28 (s, 2H), 2.33 (s, 3H). 13C{1H} NMR (CDCl3): δ 139.41, 138.45, 136.47, 
129.11, 128.69, 128.62, 128.34, 124.67, 105.82, 55.85, 21.31. HRMS (ESI, m/z): [M-H]+ 





Substrate 11 was prepared from 3-methylphenylacetone and methoxylamine 
hydrochloride according to a literature procedure.33 Substrate 11 was obtained as a clear 
oil as a 1 : 0.4 mixture of oxime isomers. Major oxime isomer: 1H NMR (CDCl3): δ 7.20 
(m, 1H), 7.07-6.99 (multiple peaks, 3H), 3.91 (s, 3H), 3.44 (s, 2H), 2.35 (s, 3H), 1.75 (s, 
3H). 13C{1H} NMR (CDCl3): δ 156.62, 138.16, 136.78, 129.73, 128.39, 127.44, 126.04, 
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61.23, 41.97, 21.34, 13.52 . HRMS (ESI, m/z): [M]+ calcd for C11H15NO3, 177.1153; 





Substrate 12 was prepared from 2-heptanone, hydroxylamine hydrochloride, and α-
bromoxylenes according to a literature procedure.34 Substrate 12 was obtained as a clear 
oil as a 1 : 0.9 mixture of oxime isomers (Rf = 0.26 in 97% hexanes/3% ethyl acetate). 
Major oxime isomer: 1H NMR (CDCl3): δ 7.27 (t, J = 7.6 Hz, 1H), 7.20-7.17 (multiple 
peaks, 2H), 7.12 (d, J = 7.2 Hz, 1H), 5.07 (s, 2H), 2.40-2.38 (s, 3H), 2.19 (dd, J = 8.0, 7.6 
Hz, 2H), 1.89 (s, 3H), 1.56-1.48 (multiple peaks, 2H), 1.37-1.27 (multiple peaks, 4H), 
0.91 (m, 3H). 13C{1H} NMR (CDCl3): δ 158.92, 138.18, 137.77, 128.61, 128.25, 128.12, 
124.83, 75.15, 35.75, 31.30, 26.15, 22.38, 21.36, 14.07, 13.92. HRMS (ESI, m/z): [M]+ 




Substrate 13 was prepared from m-tolylaceticacid and dimethylamine according to a 
literature procedure. The 1H NMR and 13C NMR data for 13 were identical to those 





This compound was prepared via the Cu-catalyzed reaction of pyrrolidinone with 1-(4'-
bromobiphenyl-4-yl) ethanone according to a literature procedure.36 The product was 
obtained as a yellow solid. 1H NMR (CDCl3): δ 8.02 (d, J = 8.0 Hz, 2H), 7.73 (d, J = 8.8 
Hz, 2H), 7.69-7.63 (multiple peaks, 4H), 3.92 (t, J = 6.8 Hz, 2H), 2.67-2.63 (multiple 
peaks, 5H), 2.20 (quin, J = 7.6 Hz, 2H). 13C{1H} NMR (CDCl3): δ 197.70, 174.37, 
144.97, 139.52, 135.64, 135.60, 128.95, 127.58, 126.84, 120.07, 48.65, 32.76, 26.66, 
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17.97. IR (thin film): 1694, 1682 cm-1. HRMS (ESI, m/z): [M]+ calcd for C18H17NO2, 





Substrate 63 was prepared from the corresponding ketone (above) and methoxylamine 
hydrochloride according to a literature procedure.33 Substrate 63 was obtained as a yellow 
solid. 1H NMR (CDCl3): δ 7.73-7.69 (multiple peaks, 4H), 7.63-7.57 (multiple peaks, 
4H), 4.02 (s, 3H), 3.90 (t, J = 6.8 Hz, 2H), 2.64 (t, J = 8.0 Hz, 2H), 2.24 (s, 3H), 2.19 (m, 
2H). 13C{1H} NMR (CDCl3): δ 174.25, 154.21, 140.94, 138.86, 136.37, 135.33, 127.27, 
126.73, 126.41, 120.09, 61.93, 48.68, 32.72, 17.97, 12.51. IR (thin film): 1685 cm-1. 
HRMS (ESI, m/z): [M]+ calcd for C19H20N2O2, 308.1525; found, 308.1518.  
General Procedure for Directed C-H Bond Acetoxylation: In a 20 mL vial, 
PhI(OAc)2 (0.49-0.86 mmol, 1.02-1.80 equiv) and Pd(OAc)2 (1.08 mg, 0.0048 mmol, 
0.01 equiv) were combined in a mixture of AcOH (2.0 mL) and Ac2O (2.0 mL).  
Substrate (0.48 mmol, 1.0 equiv) was added, the vial was sealed with a Teflon-lined cap, 
and the resulting solution was heated at 100 ºC for 3-24 h. The reaction was cooled to 
room temperature, and the solvent was removed under vacuum. The resulting brown oil 
was purified by chromatography on silica gel. Each substrate was optimized for reaction 




The reaction was run for 6 h with 1.02 equiv of PhI(OAc)2. The product 26 was obtained 
as a yellow oil (86.9 mg, 75% yield, Rf = 0.27 in 70% hexanes/30% ethyl acetate). 1H 
NMR (CDCl3): δ 8.52 (dd, J = 4.8, 1.6 Hz, 1H), 7.54 (dt, J = 7.6, 1.6 Hz, 1H), 7.11-7.02 
(multiple peaks, 3H), 6.94 (d, J = 8.0 Hz, 1H), 4.06 (s, 2H), 2.30 (s, 3H), 2.16 (s, 3H), 
2.58 (m, 1H), 0.88 (d, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 169.37, 159.88, 149.03, 
146.79, 136.44, 135.78, 131.72, 130.83, 128.38, 122.85, 122.24, 121.24, 39.21, 20.78, 
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20.69. IR (thin film): 1759 cm-1. HRMS (ESI, m/z): [M+H]+ calcd for C15H15NO2, 





The reaction was run for 3 h with 1.02 equiv of PhI(OAc)2. The product 23 was obtained 
as a yellow oil (104.7 mg, 90% yield, Rf = 0.28 in 55% hexanes/45% ethyl acetate). 1H 
NMR (CDCl3): δ 8.62 (d, J = 1.6 Hz, 2H), 7.20 (s, 1H), 7.08-7.04 (multiple peaks, 2H), 
6.92 (d, J = 8.4 Hz, 1H), 4.19 (s, 2H), 2.31 (s, 3H), 2.18 (s, 3H). 13C{1H} NMR (CDCl3): 
δ 169.28, 169.14, 157.01, 146.73, 135.60, 131.84, 129.86, 128.47, 122.12, 118.51, 40.88, 
20.72. IR (thin film): 1757 cm-1. HRMS (ESI, m/z): [M+H]+ calcd for C14H14N2O2, 




The reaction was run for 6 h with 1.1 equiv of PhI(OAc)2. The product 24 was obtained 
as a yellow oil (96.5 mg, 69% yield, Rf = 0.28 in 70% hexanes/30% ethyl acetate). 1H 
NMR (CDCl3): δ 7.09 (dd, J = 8.0, 2.0 Hz, 1H), 7.06 (s, 1H), 6.91 (d, J = 8.0 Hz, 1H), 
4.71 (m, 1H), 4.10-4.01 (multiple peaks, 2H), 3.56 (s, 2H), 2.84 (dd, J = 17.2, 10.8 Hz, 
1H), 2.51 (dd, J = 17.2, 7.6 Hz, 1H), 2.31 (s, 3H), 2.28 (s, 3H), 2.02 (s, 3H). 13C{1H} 
NMR (CDCl3): δ 170.61, 169.68, 156.63, 146.98, 136.14, 131.18, 129.21, 127.10, 
122.57, 77.48, 64.86, 38.38, 29.01, 20.69, 20.57. IR (thin film): 1746 (br) cm-1. HRMS 





The reaction was run for 10 h with 1.02 equiv of PhI(OAc)2. The product 25 was 
obtained as a yellow oil (97.3 mg, 88% yield, Rf = 0.28 in 75% hexanes/25% ethyl 
acetate). 1H NMR (CDCl3): δ 7.53 (d, J = 1.6 Hz, 1H), 7.32 (d, J = 2.4 Hz, 1H), 7.14 (dd, 
J = 8.4, 1.6 Hz, 1H), 6.98 (d, J = 8.4 Hz, 1H), 6.95 (d, J = 1.6 Hz, 1H), 6.26 (t, J = 2.0 
Hz, 1H), 5.23 (s, 2H), 2.30 (s, 3H), 2.26 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.07, 
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146.32, 139.18, 136.04, 130.11, 129.85, 129.14, 128.08, 122.34, 105.90, 50.73, 20.57, 
20.50. IR (thin film): 1760 cm-1. HRMS (ESI, m/z): [M+Na]+ calcd for C13H14N2O2, 





The reaction was run for 4.5 h with 1.1 equiv of PhI(OAc)2. The product 30 was obtained 
as a yellow oil as a 1 : 0.42 mixture of oxime isomers (89.2 mg, 79% yield, Rf = 0.28 in 
89% hexanes/11% ethyl acetate). Major oxime isomer: 1H NMR (CDCl3): δ 7.06 (d, J = 
8.4 Hz, 1H), 7.01 (s, 1H), 6.92 (d, J = 8.4 Hz, 1H), 3.88 (s, 3H), 3.57 (s, 2H), 2.32 (s, 
3H), 2.28 (s, 3H), 1.71 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.45, 155.09, 146.92, 
135.95, 131.52, 128.53, 128.42, 122.12, 61.21, 29.85, 20.86, 20.73, 19.37. IR (thin film): 
1763 cm-1. HRMS (ESI, m/z): [M+Na]+ calcd for C13H17NO3, 258.1106; found, 
258.1100. Minor oxime isomer: 1H NMR (CDCl3): δ 7.08-7.05 (multiple peaks, 2H), 6.92 
(d, J = 8.0 Hz, 1H), 3.87 (s, 3H), 3.37 (s, 2H), 2.32 (s, 3H), 2.30 (s, 3H), 1.70 (s, 3H). 
13C{1H} NMR (CDCl3): δ 169.60, 155.70, 147.18, 135.90, 131.52, 128.74, 128.47, 





The reaction was run for 8 h with 1.1 equiv of PhI(OAc)2. The product 31 was obtained 
as a yellow oil as a 1 : 0.39 mixture of oxime isomers (97.9 mg, 70% yield, Rf = 0.28 in 
90% hexanes/10% ethyl acetate). Major oxime isomer: 1H NMR (CDCl3): δ 7.23 (d, J = 
1.6 Hz, 1H), 7.11 (dd, J = 8.0, 1.6 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 4.99 (s, 2H), 2.34 (s, 
3H), 2.28 (s, 3H), 2.14 (t, J = 7.6 Hz, 2H), 1.83 (s, 3H), 1.48 (m, 2H), 1.34-1.24 (multiple 
peaks, 4H), 0.88 (t, J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 169.33, 158.35, 146.63, 
135.40, 130.40, 129.70, 129.24, 121.97, 70.47, 35.63, 31.23, 26.05, 22.29, 20.80, 20.73, 
13.85. IR (thin film): 1757 cm-1. HRMS (ESI, m/z): [M+Na]+ calcd for C17H25NO3, 
314.1732; found, 314.1729. Minor oxime isomer: 1H NMR (CDCl3): δ 7.23 (d, J = 1.6 
Hz, 1H), 7.11 (dd, J = 8.0, 1.6 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 4.96 (s, 2H), 2.34-2.28 
(multiple peaks, 8H), 1.84 (s, 3H), 1.47 (m, 2H), 1.34-1.26 (multiple peaks, 4H), 0.88 (t, 
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J = 7.2 Hz, 3H). 13C{1H} NMR (CDCl3): δ 169.54, 159.15, 146.54, 135.55, 130.50, 





The reaction was run for 24 h with 1.8 equiv of PhI(OAc)2. The product 32 was obtained 
as a yellow oil (86.1 mg, 74% yield, Rf = 0.28 in 60% hexanes/40% ethyl acetate). 1H 
NMR (CDCl3): δ 8.38 (s, 2H), 8.30 (s, 1H), 7.05 (s, 1H), 7.00 (d, J = 8.0 Hz, 1H), 6.89 
(d, J = 9.5, 8.0 Hz, 1H), 3.99 (s, 2H), 2.23 (s, 3H), 2.13 (s, 3H). 13C{1H} NMR (CDCl3): 
δ 168.79, 155.19, 146.43, 144.30, 143.59, 142.01, 135.54, 131.24, 129.44, 128.42, 
122.06, 36.39, 20.41, 20.38. IR (thin film): 1760 cm-1. HRMS (ESI, m/z): [M+H]+ calcd 





The reaction was run for 10 h with 1.1 equiv of PhI(OAc)2. The product 33 was obtained 
as a yellow oil (87 mg, 77% yield, Rf = 0.28 in 30% hexanes/60% ethyl acetate). 1H 
NMR (CDCl3): δ 7.07-7.06 (multiple peaks, 2H), 6.93 (d, J = 8.8 Hz, 1H), 3.52 (s, 2H), 
2.96 (s, 3H), 2.93 (s, 3H), 2.30 (s, 3H), 2.29 (s, 3H). 13C{1H} NMR (CDCl3): δ 170.16, 
169.45, 146.49, 135.98, 130.63, 128.64, 127.00, 122.09, 37.55, 35.82, 35.57, 20.84. IR 
(thin film): 1759, 1645 cm-1. HRMS (ESI, m/z): [M+Na]+ calcd for C13H17NO3, 





The reaction was run for 5 h with 0.10 equiv of Pd(OAc)2 and 2.02 equiv of 
PhI(OCOCF3)2 in AcOH (4 mL). The product 34 was obtained as a yellow oil (69 mg, 
55% yield, Rf = 0.24 in 15% hexanes/85% ethyl acetate). 1H NMR (CDCl3): δ 7.09 (dd, J 
= 8.0, 2.0 Hz, 1H), 7.07 (br s, 1H), 6.91 (d, J = 8.0 Hz, 1H), 4.55 (s, 2H), 3.08 (t, J = 5.6 
Hz, 2H), 2.42 (t, J = 6.4 Hz, 2H), 2.32 (s, 3H), 2.30 (s, 3H), 1.77-1.71 (multiple peaks, 
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2H). 13C{1H} NMR (CDCl3): δ 169.93, 169.51, 147.14, 135.88, 131.07, 129.42, 128.54, 
122.43, 46.88, 44.87, 32.49, 23.03, 21.25, 21.00, 20.90. IR (thin film): 1759, 1639 cm-1. 





The reaction was run for 5 h with 0.10 equiv of Pd(OAc)2 and 2.02 equiv of 
PhI(OCOCF3)2 in AcOH (4 mL). The product 35 was obtained as a yellow oil (58 mg, 
49% yield, Rf = 0.24 in 15% hexanes/85% ethyl acetate). 1H NMR (CDCl3): δ 7.09 (dd, J 
= 8.0, 2.0 Hz, 1H), 7.06 (br s, 1H), 6.89 (d, J = 8.0 Hz, 1H), 4.34 (s, 2H), 3.13 (t, J = 7.2 
Hz, 2H), 2.35 (t, J = 8.0 Hz, 2H), 2.30 (s, 3H), 2.27 (s, 3H), 1.91 (t, J = 8.0 Hz, 2H). 
13C{1H} NMR (CDCl3): δ174.42, 169.91, 146.99, 135.83, 131.19, 129.60, 127.76, 
122.45, 46.23, 41.73, 30.74, 20.87, 20.71, 17.57, 17.44. IR (thin film): broad strong peak 





The reaction was run for 12 h with 2.0 equiv PhI(OAc)2. The product 40 was obtained as 
a yellow oil (140 mg, 52% yield, Rf = 0.24 in 75% hexanes/25% ethyl acetate). 1H NMR 
(CDCl3): δ 9.29 (d, J = 1.2 Hz, 1H), 8.77 (d, J = 5.6 Hz, 1H), 7.80 (dd, J = 8.0, 1.6 Hz, 
1H), 7.60 (dd, J = 6.4, 1.6 Hz, 1H), 7.51 (td, J = 8.0, 1.6 Hz, 1H), 7.40 (td, J = 8.0, 1.6 
Hz, 1H), 7.21 (d, J = 8.0 Hz, 1H), 2.24 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.18, 





The reaction was run for 4.5 h with 1.02 equiv of PhI(OAc)2. The product 53 was 
obtained as a colorless oil (135.1 mg, 91% yield, Rf = 0.27 in 79% hexanes/21% ethyl 
acetate). 1H NMR (500 MHz, CDCl3): δ 8.71 (d, J = 5.5 Hz, 1H), 7.34 (d, J = 5.0 Hz, 
1H), 7.29 (s, 1H), 7.11-7.09 (multiple peaks, 2H), 6.96 (d, J = 8.5 Hz, 1H), 4.12 (s, 2H), 
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2.33 (s, 3H), 2.19 (s, 3H). 13C{1H} NMR (CDCl3): δ 169.26, 161.59, 150.22, 146.82, 
138.66 (q, 2JC-F  = 33.7 Hz), 136.06, 131.71, 129.95, 128.88, 122.76 (q, 1JC-F  = 271.7 Hz), 
122.43, 118.47 (q, 3JC-F  = 3.7 Hz), 116.96 (q, 3JC-F  = 3.7 Hz), 39.47, 20.82, 20.71. 
19F{1H} NMR (CDCl3): δ –64.85. IR (thin film): 1753 cm-1. HRMS (ESI, m/z): [M+Na+] 







Substrate 63 (308 mg, 1.0 mmol, 1.0 equiv), Pd(OAc)2 (6.7 mg, 0.03 mmol, 0.03 equiv), 
and PhI(OAc)2 (902 mg, 2.8 mmol, 2.8 equiv) were combined in a 20 mL vial and were 
dissolved in a 1 : 1 mixture of AcOH and Ac2O (8 mL). The vial was sealed with a 
Teflon-lined cap, and the mixture was heated at 100 ºC for 12 h. The reaction was cooled 
to room temperature, the solvent was removed under vacuum, and the resulting brown oil 
was purified by column chromatography. The product 64 was obtained as a yellow solid 
(318 mg, 75% yield, Rf = 0.30 in 20% hexanes/80% ethyl acetate, mp =  234-237 °C). 1H 
NMR (CDCl3): δ 7.72 (d, J = 8.8 Hz, 2H), 7.57 (d, J = 8.8 Hz, 2H), 7.28 (s, 2H), 3.95 (s, 
3H), 3.92 (t, J = 7.6 Hz, 2H), 2.66 (t, J = 8.0 Hz, 2H), 2.31 (s, 6H), 2.21 (quin, J = 7.6 
Hz, 2H),  2.07 (s, 3H). 13C{1H} NMR (CDCl3): δ 174.30, 168.74, 149.90, 149.23, 142.09, 
139.48, 134.50, 127.33, 122.82, 119.88, 118.58, 62.03, 48.57, 32.72, 20.87, 17.88, 15.50. 
IR (thin film): 1769, 1686 cm-1. HRMS (ESI, m/z): [M+H]+ calcd for C23H24N2O6, 







Substrate 64 (51 mg, 0.12 mmol, 1.0 equiv), Pd(OAc)2 (1.3 mg, 0.006 mmol, 0.03 equiv) 
and PhI(OAc)2 (121 mg, 0.24 mmol, 2.0 equiv) were combined in a 20 mL vial and were 
dissolved in a 1:1 mixture of AcOH and Ac2O (1 mL). The vial was sealed with a Teflon-
lined cap, and the mixture was heated at 100 ºC for 12 h. The reaction was cooled to 
room temperature, the solvent was removed under vacuum, and the resulting brown oil 
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was purified by column chromatography. The product 65 was obtained as a yellow solid 
as a 1 : 0.2 mixture of oxime isomers (34 mg, 59% yield, Rf = 0.25 in 10% hexanes/90% 
ethyl acetate,  mp =  64.5-70.1 °C).  Major oxime isomer: 1H NMR (CDCl3): δ 7.43 (dd, J 
= 8.0, 2.0 Hz, 1H), 7.36-7.34 (multiple peaks, 2H), 7.21 (s, 2H), 3.95 (s, 3H), 3.76 (t, J = 
6.8 Hz, 2H), 2.54 (t, J = 8.0 Hz, 2H), 2.28-2.22 (multiple peaks, 9H), 2.18 (m,  2H), 2.06 
(s, 3H). 13C{1H} NMR (CDCl3): δ 174.12, 168.64, 149.76, 149.27, 147.68, 145.93, 
141.03, 138.87, 130.92, 128.25, 127.31, 125.04, 123.55, 122.51, 122.40, 118.95, 118.80, 
62.05, 49.91, 31.10, 20.91, 20.83, 19.93, 19.24, 15.46. IR (thin film): 1770, 1700 cm-1. 







Substrate 64 (51 mg, 0.12 mmol, 1.0 equiv), Pd(OAc)2 (1.3 mg, 0.006 mmol, 0.05 equiv) 
and N-chlorosuccinimide (32 mg, 0.24 mmol, 2.0 equiv) were combined in a 20 mL vial 
and were dissolved in AcOH (1 mL). The vial was sealed with a Teflon-lined cap, and the 
mixture was heated at 100 ºC for 12 h. The reaction was cooled to room temperature, the 
solvent was removed under vacuum, and the resulting brown oil was purified by column 
chromatography. The product 66 was obtained as a yellow solid as a 1 : 0.5 mixture of 
oxime isomers (47 mg, 81% yield, Rf = 0.28 in 15% hexanes/85% ethyl acetate, mp =  
66.8–73.2 °C). Major oxime isomer: 1H NMR (CDCl3): δ 7.64 (dd, J = 5.2, 1.6 Hz, 1H), 
7.47 (m, 1H), 7.34 (s, 1H), 7.25 (s, 1H), 7.2 (s, 1H), 3.94 (s, 3H), 3.79 (t, J = 6.8 Hz, 2H), 
2.58 (t, J = 8.0 Hz, 2H), 2.28-2.22 (multiple peaks, 8H), 2.06 (s, 3H). 13C{1H} NMR 
(CDCl3): δ 175.00, 168.57, 149.79, 149.29, 147.59, 141.21, 139.84, 136.19, 132.51, 
129.65, 128.98, 128.20, 126.44, 123.80, 118.94, 62.89, 49.84, 32.71, 36.34, 30.91, 20.93, 
19.06, 15.41. IR (thin film): 1773, 1694 cm-1. HRMS (ESI, m/z): [M+Na]+ calcd for 









Substrate 64 (51 mg, 0.12 mmol, 1.0 equiv), Pd(OAc)2 (1.3 mg, 0.006 mmol, 0.03 equiv) 
and [(m-CF3C6H4)2I]BF4 (32 mg, 0.24 mmol, 2.0 equiv), NaHCO3 (15 mg, 0.18 mmol, 
1.5 equiv) were combined in a 20 mL vial and were dissolved in a toluene (1 mL). The 
vial was sealed with a Teflon-lined cap, and the mixture was heated at 100 ºC for 12 h. 
The reaction was cooled to room temperature, the solvent was removed under vacuum, 
and the resulting brown oil was purified by column chromatography. The product 67 was 
obtained as a yellow solid as a 1:0.3 mixture of oxime isomers (53 mg, 78% yield, Rf = 
0.28 in 25% hexanes/75% ethyl acetate, mp = 62.2-65.8 °C). Major oxime isomer: 1H 
NMR (CDCl3): δ 7.66-7.57 (multiple peaks, 4H), 7.53-7.49 (multiple peaks, 2H), 7.30 (s, 
1H), 7.22 (s, 1H), 7.19 (s, 1H), 3.91 (s, 3H), 3.83 (t, J = 6.8 Hz, 1H), 3.25 (t, J = 6.8 Hz, 
1H), 2.57 (t, J = 8.0 Hz, 1H), 2.36 (t, J = 8.0 Hz, 1H), 2.23 (s, 6H), 2.12 (t, J = 7.4 Hz, 
1H), 2.03 (s, 3H), 1.88 (t, J = 7.4 Hz, 1H). 13C{1H} NMR (CDCl3): δ175.46, 168.54, 
168.48, 149.87, 149.31, 149.21, 141.45, 139.47, 138.62, 136.37, 131.81, 130.75 (q, 2JC-F 
= 32.2 Hz), 129.25, 129.10, 128.82, 128.23, 127.31, 124.93 (q, 3JC-F = 3.7 Hz), 124.45 (q, 
3JC-F = 3.8 Hz), 123.90 (q, 1JC-F = 271 Hz), 119.86, 118.98, 118.55, 61.99, 48.54, 32.69, 
20.81, 18.85, 17.85, 15.46. 19F{1H} NMR (CDCl3): δ –62.57. IR (thin film): 1771, 1694 






Pyridyl oxime ether substrate (250 mg, 1.11 mmol, 1.0 equiv), Pd(OAc)2 (7.5 mg, 0.03 
mmol, 0.03 equiv) and PhI(OAc)2 (715 mg, 2.22 mmol, 2.0 equiv) were combined in a 20 
mL vial and were dissolved in a 1 : 1 mixture of AcOH and Ac2O (9.25 mL). The vial 
was sealed with a Teflon-lined cap, and the mixture was heated at 100 ºC for 12 h. The 
reaction was cooled to room temperature, the solvent was removed under vacuum, and 
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the resulting brown oil was purified by column chromatography. The product 68 was 
obtained as a pale yellow solid (299 mg, 79% yield, Rf = 0.26 in 55% hexanes/45% ethyl 
acetate). 1H NMR (CDCl3): δ 8.73 (m, 1H), 7.74 (m, 1H), 7.42 (m, 2H), 7.35 (m, 1H), 





Substrate 70 (200 mg, 0.75 mmol, 1.0 equiv), Pd(OAc)2 (8 mg, 0.04 mmol, 0.05 equiv) 
and PhI(OAc)2 (247 mg, 0.766 mmol, 1.02 equiv) were combined in a 20 mL vial and 
were dissolved in Benzene (6.3 mL). The vial was sealed with a Teflon-lined cap, and the 
mixture was heated at 100 ºC for 12 h. The reaction was cooled to room temperature, the 
solvent was removed under vacuum, and the resulting brown oil was purified by column 
chromatography. The product 71 was obtained as a yellow oil as a 1 : 0.6 mixture of 
oxime isomers (73 mg, 30% yield, Rf = 0.22 in 91% hexanes/9% ethyl acetate).  Major 
oxime isomer: 1H NMR (CDCl3): δ 7.25 (m, 1H) 7.18 (t, J = 7.0 Hz, 1H), 7.13 (dd, J = 
8.0, 2.0 Hz, 1H), 7.04 (d, J = 7.0 Hz, 1H), 7.00 (br s, 1H), 6.97 (d, J = 7.5 Hz, 1H), 5.07 
(s, 2H), 3.42 (s, 2H), 2.35 (s, 3H), 2.32 (s, 3H), 2.28 (s, 3H), 1.75 (s, 3H). Minor oxime 
isomer: 1H NMR (CDCl3): δ 7.24 (br s, 1H), 7.18-7.12 (multiple peaks, 2H), 7.04-6.96 
(multiple peaks, 3H), 5.05 (s, 2H), 3.66 (s, 2H), 2.33 (s, 3H), 2.31 (s, 3H), 2.28 (s, 3H), 





Substrate 70 (200 mg, 0.75 mmol, 1.0 equiv), Pd(OAc)2 (8 mg, 0.04 mmol, 0.05 equiv) 
and PhI(OAc)2 (247 mg, 0.766 mmol, 1.02 equiv) were combined in a 20 mL vial and 
were dissolved in a 1:1 mixture of AcOH and A2O (6.3 mL). The vial was sealed with a 
Teflon-lined cap, and the mixture was heated at 100 ºC for 12 h. The reaction was cooled 
to room temperature, the solvent was removed under vacuum, and the resulting brown oil 
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was purified by column chromatography. The product was obtained as a yellow oil as a 
1:1 mixture of regio isomers 71 and 72. Characterization for the oxime isomers for 
regioisomer 71 is shown above. Regioismer 72 was obtained in a 1:0.4 mixture of oxime 
isomers (134 mg, 55% yield, Rf = 0.22 in 91% hexanes/9% ethyl acetate). Major oxime 
isomer: 1H NMR (CDCl3): δ 7.24 (d, J = 7.0 Hz, 1H) 7.18-7.17 (multiple peaks, 2H), 
7.11 (d, J = 7.0 Hz, 1H), 7.06 (d, J = 7.5 Hz, 1H), 7.01 (br s, 1H), 6.91 (d, J = 8.0 Hz, 
1H), 5.08 (s, 2H), 3.37 (s, 2H), 2.36 (s, 3H), 2.31 (s, 3H), 2.21 (s, 3H), 1.75 (s, 3H). 
Minor oxime isomer: 1H NMR (CDCl3): δ 7.23 (d, J = 7.5 Hz, 1H), 7.18-7.16 (multiple 
peaks, 2H), 7.11 (d, J = 7.0 Hz, 1H), 7.05 (d, J = 8.0 Hz, 1H), 7.00 (br s, 1H), 6.92 (d, J 
8.5 Hz, 1H), 5.08 (s, 2H), 3.62 (s, 2H), 2.36 (s, 3H), 2.29 (s, 3H), 2.22 (s, 3H), 1.73 (s, 
3H). 
 
General Procedure for Kinetics Experiments. Kinetics experiments were run in 
two dram vials sealed with Teflon-lined caps. Each data point represents a reaction in an 
individual vial, with each vial containing an identical concentration of oxidant, catalyst, 
and substrate. The vials were charged with PhI(OAc)2 (0.0158 g, 0.049 mmol, 1.02 equiv, 
added as a solid), substrate (0.048 mmol, 1.0 equiv, added as a 0.96 M stock solution in 
AcOH), and Pd(OAc)2 (0.11 mg, 0.00048 mmol, 0.01 equiv, added as a 0.0096 M stock 
solution in AcOH), and the resulting mixtures were diluted to a total volume of 400 mL 
of a 1 : 1 mixture of AcOH and Ac2O. The vials were then heated at 80 ºC for various 
amounts of time. Reactions were quenched by cooling the vial at 0 ºC for 5 min, followed 
by the addition of a 2% solution of pyridine in CH2Cl2 (2 mL). An internal standard 
(pyrene) was then added, and the reactions were analyzed by gas chromatography. Each 
reaction was monitored to ~10% (8.6-11.0%) conversion, and rate constants were 
calculated for each reaction using the initial rates method. Each kinetics experiment was 
run in triplicate, and the data shown in the Hammett plots represent an average of these 
three runs. 
 
General Procedure for Competition Experiments. A two dram vial was 
sequentially charged with PhI(OAc)2 (0.0158 g, 0.049 mmol, 1.02 equiv, added as a 
solid), substrate A (0.048 mmol, 1.0 equiv, added as a 0.96 M stock solution in AcOH), 
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substrate B (0.048 mmol, 1.0 equiv, added as a 0.96 M stock solution in AcOH), and 
Pd(OAc)2 (0.11 mg, 0.00048 mmol, 0.01 equiv, added as a 0.0096 M stock solution in 
AcOH), and the resulting mixtures were diluted to a total volume of 400 mL of a 1 : 1 
mixture of AcOH and Ac2O. The reaction was heated at 80 ºC for 12 h, and then cooled 
to room temperature. A GC standard (pyrene) was added, and the reaction was analyzed 
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Palladium-Catalyzed 1,2-Difunctionalization of Alkenes 
 
 
5.1  Background and Significance 
 
Oxidative amination reactions have been an important area of research in organic 
chemistry.1-4 In particular, aminooxygenation reactions of alkenes, leading to vicinally 
difunctionalized products, with two distinct carbon-heteroatom bonds, provide an 
attractive route towards the synthesis of small molecules of synthetic and pharmaceutical 
interest.  
The development of a PdII/IV catalyzed method to form aminooxygentated 
products could allow access to β-amino alcohols (via intermolecular reactions) and 
nitrogen containing heterocycles (via intramolecular reactions).5, 6 Some of the most 
common alternative approaches to vicinal amino alcohols involve: (i) functional group 
manipulations of imine or carbonyl groups via reduction or nucleophilic addition,5 (ii) 
ring opening reactions of epoxides and aziridines,5 (iii) aminohydroxylation of olefins,5 
and (iv) aldol or pinacol-type coupling reactions.5 Hydroxyamination of alkenes is the 
most staightforward route for vicinal amino alchohol synthesis, and the Sharpless Os-
catalyzed asymmetric aminohydroxylation reaction (Scheme 5.1) is probably the most 
widely used of these reactions.7 
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64%, 81% ee 













We hope to access vicinal aminooxygenated compounds by developing a PdII/IV 
catalyzed route. The two key steps of the proposed reaction involve (i) aminopalladation 
followed by (ii) oxidative cleavage of the resultant carbon-palladium bond (Scheme 5.2, 
pathway a).  
 




















pathway b  
 
In order to achieve the desired aminooxygenation transformation, the key 
challenge that needs to be addressed is competing β-hydride elimination from the Pd-
alkyl intermediate A (Scheme 5.2, pathway b). Importantly, several research groups have 
recently demonstrated that the undesired aminopalladation/β-hydride elimination 
sequence can be a useful and efficient synthetic transformation.2 Stahl and co-workers 
have developed the most effective of these systems.8 They have demonstrated the 
oxidative amination of activated and unactivated olefins with nitrogen nucleophiles 
including carboxamides, carbamates and sulfoamides via a PdII/0 reaction manifold 
(Scheme 5.3). A representative example is illustrated in Scheme 5.4, and involves the 
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synthesis of enamide 5 from octene and phthalimide in the presence of 5 mol % 
Pd(OAc)2 and O2 as the oxidant. 
 


























5 mol % Pd(OAc)2
PhCN, O2,




In 1980, Backvall demonstrated that Pd-alkyl intermediates generated upon 
aminopalladation can be intercepted by strong oxidants at –40 ºC without competing β-
hydride elimination.9 For example, the reaction of trans-butene with stoichiometric 
Pd(PhCN)2Cl2 and dimethylamine afforded the Pd-alkyl intermediate 7, and subsequent 
addition of Pb(OAc)4 led to the formation of aminooxygenated product 8. As shown in 
Scheme 5.5, this reaction was proposed to proceed via trans-aminopalladation followed 
by oxidative cleavage of the palladium-carbon bond with inversion of stereochemistry at 
the carbon. The mechanism of aminopalladation was elucidated by trapping the PdII 
intermediate 7 with LiAlD4 at –70 ºC to form deuterated amino butane. Cope elimination 
of the amine then allowed stereochemical analysis of the deuterated butene. Although this 
reaction illustrates the feasibility of aminooxygenation, it is limited by the need for a 
stoichiometric amount of palladium. The electron rich amines used in this reaction (for 
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example, dimethylamine) coordinate more strongly to palladium than alkenes and 
therefore inhibit catalytic turnover. 
 














As described in Chapter 1, we have been able to successfully out-compete β-hydride 
elimination and intercept cyclopalladated Pd-alkyl intermediates with PhI(OAc)2 via a 
PdII/IV catalytic cycle. Based on this and on Backvall’s precedent,9 we envisioned the 
development of a Pd-catalyzed aminooxygenation reaction using a PdII catalyst and 
PhI(OAc)2 as a strong oxidant. As shown in Scheme 5.6, we speculated that the use of 
PhI(OAc)2 might allow us to oxidatively intercept the intermediate A (illustrated in 
Scheme 2). Additionally, the use of moderately nucleophilic phthalimide might attenuate 
its binding to Pd, hence allowing for catalytic turnover.  
 












Palladium alkyl intermediates generated upon aminopalladation, such as A, have been 
previously shown to undergo a number of reactions, including olefin insertion,8 
carbonylation,10, 11 and oxidative cleavage with CuCl2 or CuBr2 to form C–C, C–Cl and 
C–Br bonds, respectively. For example, Chemler has demonstrated the intramolecular 
aminochlorination of substrate 9 using 5 mol % Pd(OAc)2 and 4 equiv of CuCl2 (Scheme 
5.7).12 Interestingly, competing β-hydride elimination products such as 12 were not 
observed in this reaction. Two possible mechanisms have been proposed, and both 
initiate with an intramolecular aminopalladation to afford intermediate 13 (Scheme 5.8) 
The first (Scheme 5.8, path a) involves oxidative cleavage of the Pd–C bond in 13 with 
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CuCl2 via a PdIV intermediate. The second (Scheme 5.8, path b) proposes a copper 
assisted ligand transfer to form the C–Cl bond, without a change in oxidation state at PdII.  
 
















(9) (10) (11) (12)
 
 





















As we began this project, several groups reported Pd-catalyzed intramolecular olefin 
aminoacetoxylation and diamination reactions similar to the transformation that we 
proposed. For example, Sorensen demonstrated intramolecular aminopalladation with 
substrates such as N-tosylamide 16 to form oxazolidinone 17.13 The use of Pd(OAc)2 as a 
catalyst resulted in significant quantities of β-hydride product 18. However, this pathway 
could be suppressed by employing a chloride-based catalyst. Hence, using 10 mol % 
Pd(PhCN)2Cl2 and 2 equiv PhI(OAc)2 led to the formation of 17 in 65% yield (Scheme 
5.9). Reaction of cinnamyl alcohol-derived N-tosyl carbamate 19 proceeded 
stereospecifically to afford product 22, which led to speculation that the mechanism 
involved trans-aminopalladation followed by C–O bond-forming reductive elimination 
with inversion of stereochemistry at the carbon (Scheme 5.10). However, no other 
mechanistic experiments were conducted to support this claim. Later reports by Muniz 
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suggest that cis-aminopalladation followed by reductive elimination with inversion of 
stereochemistry is more likely. 
 
Scheme 5.9. Palladium-Catalyzed Intramolecular Aminoacetoxylation with PhI(OAc)2  
(16)











not isolated  
 


































(20) (21) (22)  
 
A later report by Muniz and co-workers demonstrated the Pd-catalyzed oxidative 
intramolecular diamination of olefins.14, 15 They were able to efficiently generate bicyclic 
and tricyclic substituted urea derivatives through diamination of substrates such as 23, 
using 5 mol % Pd(OAc)2 and 2.2 equiv PhI(OAc)2 (Scheme 5.11). The authors did not 
observe products such as 25, resulting from competing β-hydride elimination. A 
mechanism involving: (i) rate-limiting cis-aminopalladation to form 27, (ii) oxidation to 
PdIV complex 28, (iii) amide dissociation, and (iv) SN2-type reductive elimination with 
inversion of stereochemistry at carbon was proposed (Scheme 5.12). Experiments 
including deuterium labeling, kinetics, solvent effects, electronic substitution effects, and 
in situ NMR investigation were used to elucidate this mechanism.  
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Scheme 5.11. Palladium-Catalyzed Intramolecular Diamination Reactions 
(23) (24) (25)
NHTs











not observed  
 




























(29) (30)  
 
As discussed above, we desired to develop an intermolecular aminoacetoxylation 
reaction. Concurrent to our work, Stahl and co-workers published the intermolecular 
variant of oxidative aminoacetoxylation of olefins.16 Using phthalimide as the nitrogen 
nucleophile, they showed high yielding aminoacetoxylation of allyl ether substrates such 
as 31. They also observed the formation of β-hydride elimination products such as 33, 
albeit in low yield. They proposed that coordination of the metal with the oxygen in the 
ether linkage suppressed β-hydride elimination. Through detailed mechanistic 
experiments, they proposed a mechanism involving cis-aminopalladation followed by 
SN2-type C–O bond-forming reductive elimination at PdIV with inversion of 
stereochemistry at carbon.  
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10 mol % PdCl2(CH3CN)2 
or Pd(OAc)2
2.5 equiv PhI(OAc)2










(32, 78%) (33, 16%)(4)  
 
5.2  Initial Investigation 
 
Our initial studies focused on the reaction between 1-octene and phthalimide. 
These substrates were chosen because Stahl had demonstrated their ability to undergo 
efficient aminopalladation (Scheme 5.4).8 Gratifyingly, subjection of 1-octene and 
phthalimide to 5 mol% Pd(OAc)2 and 1.5 equiv PhI(OAc)2 in AcOH at 100 ºC afforded 
the 1,2-aminooxygenated product 34 in 21% isolated yield. This low yield was due to 
competitive formation of two side products: (i) olefin 5 (generated via termination of the 
reaction by β-hydride elimination) and (ii) diacetoxylated product 35. Notably, Stahl 
obtained similar results with substrate 3. 
 
Scheme 5.14. Palladium-Catalyzed Reaction of 1-Octene with Phthalimide and 
PhI(OAc)2  





















Optimization Studies. Several reaction parameters such as solvent, catalyst, and 
temperature were screened in order to increase the yield of the desired product 34. 
Solvents such as AcOH led to increased yields of the undesired diacetoxylated product 
35, while dichloroethane, CH3CN, and CH2Cl2 were most effective in affording 34. 
Interestingly, reactions in THF only afforded the β-hydride elimination product 5. 
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A survey of various catalysts revealed that Pd(PhCN)2Cl2 and Pd(CH3CN)2Cl2 
(which were found to decrease β-hydride elimination in Sorensen’s system) led to similar 
yields of products 34 and 5 as Pd(OAc)2. In an attempt to suppress β-hydride elimination, 
we investigated palladium catalysts containing bidentate and tridendate ligands (Figure 
5.1). We thought that having a multicoordinated ligand on the metal would limit vacant 
cis coordination sites, which are required for β-hydride elimination. Consistent with this 
hypothesis, Pd(CC)Br2, Pd(CNC)Br2, and Pd(PNP)Cl2 (Figure 5.1) afforded only trace 
amounts of the β-hydride products; however, the desired product 34 was also obtained in 
low yield with these catalysts. We next attempted to increase catalyst reactivity by 
moving to Pd(O2CCF3)2, which contains a more electrophilic Pd center. However, with 
this catalyst we observed an increase in the relative rate of decomposition of the olefins. 
Lowering the temperature of the reaction from 100 ºC to 60 ºC did slow down the rate of 
Pd-catalyzed olefin decomposition.  
 


























Based on all of these studies, the final optimized conditions for this reaction were 
5 mol % Pd(OAc)2 and 2 equiv PhI(OAc)2 in CH2Cl2 at 60 ºC, which afforded 41% yield 
of the desired product 34. Despite these optimization studies, the relative rate of β-
hydride elimination versus oxidation was still competitive, and 41% yield of 1,2-
difunctionalized product 34 was obtained under these conditions. 
Exploration of Different Olefin and Nucleophile Partners. We wondered if a 
different nucleophile partner would provide higher yields in this reaction. As such, a 
series of carboxamides, carbamates and sulfonamides were investigated; however, only 
p-toluenesulfonamide (TsNH2) and p-nitrobenzenesulfonamide (NsNH2) afforded the 
desired aminoacetoxylated product in greater than 5% yield under the optimized reaction 
 164 
conditions from above (5 mol % Pd(OAc)2, 2 equiv PhI(OAc)2 in CH2Cl2 at 60 °C). We 
next attempted to increase the yield of the desired product with these nucleophiles 
through the addition of bases. Strong bases such as NaOtBu and Cs2CO3 either led to 
decomposition of 1-octene or resulted in greater quantities of the β-hydride elimination 
product (37). Weak bases such as Na2SO4 and MgO did not hamper the reaction, but also 
did not improve the yield of 38. However, interestingly, the addition of acetate sources 
such as NaOAc and LiOAc increased the yield of the desired product 38 to 10%. We 
believed that solubility was a limitation with using these bases. Hence, 
tetrabutylammonium acetate was examined as a soluble acetate source, and was found to 
be optimal for reactions with TsNH2 and NsNH2.  With optimal conditions of 5 mol % 
Pd(OAc)2, 2 equiv PhI(OAc)2, 1 equiv Bu4NOAc, in CH2Cl2 at 60 °C, 1-octene reacted 
with TsNH2 and NsNH2 to provide 38 and 41 in 18% and 25% yield, respectively, 
(Scheme 5.15). 
 
Scheme 5.15. Palladium-Catalyzed Reaction of 1-Octene with Tosylamine or 
Nosylamine and PhI(OAc)2 
NHTs NHTs
OAc
(37, 15% by GC) (38, 18%)
























Mechanistic studies by Stahl have shown that aminopalladation of norbornene 
with TsNH2 occurs in a syn fashion.8 Hence, we decided to screen the reactions with 
norborylene as the olefin partner, since we expected β-hydride elimination to be 
attenuated in this system due to conformational constraints. Consistent with this 
hypothesis, reaction of norbornene and TsNH2 (with 5 mol % Pd(OAc)2, 2 equiv 
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PhI(OAc)2, 1 equiv Bu4NOAc, in CH2Cl2 at 60 °C) did not afford any of the β-hydride 
elimination product 44. However, due to low reactivity of the aminoacetoxylation 
reaction and formation of the undesired diacetoxylation product 45, we obtained the 
desired product 43 in only 38% yield (Scheme 5.16). 
 


















We next explored the reactivity of norbornene with phthalimide as the 
nucleophile. Reaction of norbornene and phthalimide in CH2Cl2 with 5 mol % Pd(OAc)2, 
2.0 equiv PhI(OAc)2 at 60 °C afforded the aminoacetoxylated product 46 and 
diacetoxylation product 45 in 41% and 23% yield respectively. Optimization reactions 
screening various solvents, temperatures, bases and catalysts did not improve the yield of 
46.  
 
Scheme 5.17: Palladium-Catalyzed Reaction of Norbornene with Phthalimide and 












(46, 42%)  
 
Interestingly, when the reaction of norborylene and phthalimide with 5 mol % 
Pd(OAc)2 and 2 equiv PhI(OAc)2 was conducted in nitromethane, a new compound (47) 
was obtained along with the expected 1,2-aminoacetoxylated product 46. 
Characterization of 47 by NMR spectroscopy and X-ray crystallography revealed that a 
molecule of nitromethane and a molecule of phthalimide had been incorporated to afford 
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an unexpected 2,7-disubstituted norbornane derivative. When the solvent was changed 
from nitromethane to nitroethane, similar reactivity was observed to afford compound 48, 
albeit in lower yield. In this case, the balance of the material was unreacted starting 
material (~41%) and the aminoacetoxylated product 46 (22%). 
 
Scheme 5.18. Palladium-Catalyzed Reaction of Norbornene with Phthalimide and 






























Similar connectivity as product 47 and 48 has been observed by Heck in the Pd-
catalyzed reaction of phenylmercuric chloride with norbornene.17 Reaction of PhHgCl 
and norbornene with catalytic Li2PdCl4 and stoichiometric CuCl2 afforded exo-2-chloro-
7-phenylnorbornene (49) (Scheme 5.19). The authors did not speculate on a possible 
mechanism for the formation of 49. 
 
Scheme 5.19: Halophenylation of Norbornene 
(42)









Substrates with Directing Groups. A substrate design strategy was next employed 
in an attempt to avoid competitive formation of β-hydride elimination products. In 
Chapter 2, we proposed that β-hydride elimination in the sp3 C–H functionalization 
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reactions was attenuated by the formation of a cyclopalladated intermediate. In such an 
intermediate, coordination of the chelating functionality to the metal provides a cyclic 
structure, which renders β-hydride elimination conformationally unfavorable. Based on 
these systems, we reasoned that tethering a chelating group to the nucleophile of the 
alkene could have a similar effect.  
We first explored nucleophile 50, which contains two basic functional groups, an 
amide and a pyridine. We anticipated that the former could undergo aminopalladation 
while the latter could subsequently bind to the metal to generate chelated intermediate 51 
(Scheme 5.20). However, when reactions of 50 with 1-octene were explored under our 
optimized conditions (5 mol % Pd(OAc)2, 2 equiv PhI(OAc)2 and 1 equiv Bu4NOAc in 
CH2Cl2 at 60 °C), 50 and the starting olefin were recovered quantitatively. Despite 
screening various solvents, temperatures, and bases, we did not observe any reactivity. 
We believe that the nucleophile may coordinate tightly with the metal and thereby 
prevent further reaction. 
 

















(50) (51) (52)(3)  
 
We next explored alkene substrates that contain either a quinoline or an oxime 
ether functionality, as these are both known to bind readily to PdII. We envisioned that 
interaction between the quinoline or oxime ether and palladium would bring the metal in 
the proximity of the olefin. Subsequent aminopalladation would then result in a cyclic 
Pd-alkyl intermediate like 54 or 57 (Scheme 5.21), which would be less susceptible to β-
hydride elimination than their acyclic analogues. However, subjection of substrates 53 
and 56 to phthalimide with 5 mol % Pd(OAc)2 and 2 equiv PhI(OAc)2 in different 
solvents at 60 °C, with and without Bu4NOAc, afforded unreacted starting material (with 
53) or undesired side reactions of the olefin (with 56).  
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(4) (53) (54) (55)
(4) (56) (57) (58)  
 
We hypothesized that 50, 53 and 56 did not exhibit any reactivity towards 
oxidative amination because the directing group bound tightly to the PdII catalyst and 
thereby prevented coordination of the olefin and/or nucleophile. Hence, our next 
approach was to examine tethering a weaker ligand such as an alcohol to the olefin. In 
this system, the alcohol could chelate to the palladium and aminopalladation could occur 
followed by oxidation to produce the desired product (Scheme 5.22).  
 




















Initial studies focused on the Pd-catalyzed reaction of 3-buten-1-ol (59) and 
phthalimide with PhI(OAc)2 (Scheme 5.22). Consistent with our hypothesis, when 59 was 
subjected to the optimized reaction conditions with 1-octene (Scheme 5.23), none of the 
β-hydride elimination product 64 was observed, which was confirmed by synthesizing an 
authentic sample. However, surprisingly, none of desired product 61 was observed either. 
Instead, the reaction afforded two tetrahydrofuran products - one incorporating the 
phthalimide (62) and the second incorporating an acetate (63).  
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Scheme 5.23: Palladium-Catalyzed Reaction of 3-Butene-1-ol with Phthalimide and 





















In order to explore the origin of products 62 and 63, we next probed the scope and 
mechanism of this transformation. These studies are discussed below and divided into 
four sections. The first two sections describe the scope and mechanism for the formation 
of product 63. The last two sections focus on efforts towards understanding the generality 
and mechanistic details of formation of product 62. 
 
5.3  Cyclization of Alcohols 
 
We believed that PhI(OAc)2 was the source of acetate in product 63 (Scheme 
5.23). Hence, benzoate derivatives of PhI(OAc)2 were screened in order to add molecular 
weight to the products and facilitate isolation. Subjection of 3-buten-1-ol to 5 mol % 
Pd(OAc)2 and 2 equiv PhI(OCOPh)2 in CH3CN at 60 ºC afforded the cyclized product 65 
in 41% yield (Scheme 5.24).  
 
Scheme 5.24. Palladium-Catalyzed Cyclization of 3-Buten-1-ol 
(59)



























The modest yield of this cyclization reaction is believed to be due to side 
reactions of the 3-butene-1-ol starting material under the reaction conditions. Consistent 
with this hypothesis, traces of diacetoxylated aldehyde 67, epoxide containing product 
68, and Heck side product 66 were isolated from the reaction. Notably, approximately 5% 
of product 65 and <5% of products 66 and 68 were observed when the reactions were run 
in the absence of Pd(OAc)2. The formation of Heck product 66 could be suppressed 
through the use of (Mesityl)I(CO2Ph)2 in place of PhI(CO2Ph)2. However, this oxidant 
exhibited lower reactivity for the desired transformation (Scheme 5.25).   
 

















We speculated that the formation of the diacetoxylated aldehyde product 67 and 
epoxide product 68 would be increased by employing more reactive oxidants. Consistent 
with our hypothesis, when various electronically different iodosobenzoate derivatives 
were explored, the electron deficient oxidants (para-NO2, CF3, and Br substituted 
benzoates) led to greater quantities of products 67 and 68. However, the yields obtained 
with the electron rich benzoate oxidants (para-OMe and CH3 substituted benzoates) were 
similar to those obtained with PhI(CO2Ph)2. We believe Pd(OAc)2 acts as a Lewis acid to 
catalyze the formation of  the epoxide product 68 and diacetoxylated product 67 via a 
mechanism similar to epoxide formation with m-CPBA (Scheme 5.26). Subsequent 
reaction of product 71 with Pd, through β-hydride elimination, would form aldehyde 67. 
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The scope of this reaction with respect to the alcohol substrate was next 
examined. In a representative example, 2-phenyl-l-butenol reacted under the optimal 
conditions (5 mol % Pd(OAc)2 and 2 equiv of PhI(OAc)2 in CH3CN at 60 ºC) to afford 
35% of the desired substituted THF ring 73, along with significant amounts of epoxide 74 
(Scheme 5.27). Similar yields of THF products were obtained with a variety of other 
alcohol substrates 75-85 (Table 5.1), and in all cases, analogous epoxide side products 
were observed. Notably, the THF rings were formed with modest levels of 
diastereoselectivity, with dr ranging from 1:1 to 2:1.  
 
Scheme 5.27: Alcohol Cyclization Reactions  



















Table 5.1: Substrate Scope for Alcohol Cyclization Reactions  
































































5.4  Cyclization of Amines 
 
Analogous cyclization reactions of amino olefins were next examined. Amino 
olefin substrates containing various protecting groups (Cbz, Ts, Ns, Boc, and urea) were 
subjected to our optimal reaction conditions (5 mol % Pd(OAc)2 and 2 equiv of 
PhI(OAc)2 in CH3CN at 60 ºC ). Only amines with Ns and Ts protecting groups exhibited 
trace reactivity towards the cyclization reaction (Scheme 5.28). Upon screening bases 
with substrates 87 and 90, we determined that NaHCO3 allowed us to access the 
pyrrolidine products 88 and 91 in about 20% yield. Diacetoxylation of the starting olefin, 
similar to that observed with 1-octene (Scheme 5.14), was again a competitive pathway 




Scheme 5.28: Amine Cyclization Reactions 
NHNs



















(91, 19%) (92, 26% by GC)








We next synthesized protected amines 93 and 94, which contain a phenyl 
substituent in the backbone (Figure 5.2). We anticipated that this group would facilitate 
cyclization via a Thorpe-like effect. In addition, we synthesized amides 95-97, which we 
expected to be conformationally biased to undergo cyclization. However, in the reaction 
of substrates 93-94 and 96-97 under our optimal conditions (5 mol % Pd(OAc)2 and 2 
equiv of PhI(OAc)2 in CH3CN at 60 ºC with and without NBu4OAc or NaHCO3) we 
either observed unreacted starting material (with 93-97), diacetoxylation of the olefin 
(with 93 and 94), Heck products (with 96 and 97) or decomposition (with 95). 
 




R = H (95)
R = Ts (96)
R = CONHTs (97)
Ph
R = CBz (93)
R =  Ns (94)



















5.5  Cyclization of Acids 
 
In order to further explore the scope of these cyclization reactions, we studied 
substrates containing carboxylic acids as the intramolecular nucleophile. Gratifyingly, 
subjection of 3-butenoic acid to our reaction conditions (5 mol % Pd(OAc)2, 2 equiv of 
PhI(OCOPh)2 and 2 equiv NaHCO3 in CH3CN at 60 ºC ) afforded the cyclized lactone 
product 100 in 56% yield (Scheme 5.29). As shown in Table 5.2, the scope of this 
cyclization was general for various different substituted acids. Substrates 101-111 
cyclized to form lactones in better yields than the alcohols and amines. However, we still 
obtained low diastereoselectivity with substrates such as 101. The diastereoselectivity did 
not improve upon addition of Pd catalysts containing various bidentate and tridentate 
ligands. 
 
Scheme 5.29. Carboxylic Acid Cyclization Reactions 
OH
O










(100, 56%)(99)  
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Conditions: 5 mol % Pd(OAc)2, 2 equiv PhI(OCOPh)2, 2 equiv NaHCO3, CH2Cl2, 60 °C  
 
Reaction of substituted internal olefins did occur with high levels of 
stereospecificity. For instance, trans-4-ethylbutenoic acid 107 preferentially formed the 
trans-4,5-substituted lactone 108 with 13:1 selectivity (Table 5.2, entry 4), while cis-4-
ethylbutenoic acid 109 preferentially afforded the cis-4,5-substituted lactone 110 with 9:1 
selectivity (entry 5).  
 
5.6  Mechanistic Investigations of the Cyclization Reactions 
 
We next explored the role of palladium in these alcohol, amine and acid 
cyclization reactions. We speculated that there were at least two possible mechanisms: (i) 
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a PdII/IV-catalyzed pathway involving 5-endo-trig cyclization followed by oxidation 
(Scheme 5.30) or (ii) a mechanism involving PdII acting as a Lewis acid to promote the 
formation of iodonium ring 115, that subsequently undergoes cyclization (Scheme 5.31). 
 
















(113) (114)  
 













(115) (116)  
 
 Importantly, there is limited literature precedent for PdII-promoted 5-endo trig 
cyclization reactions. As shown in Scheme 5.32, one example involved an alcohol and 
one involved an amine nucleophile.18, 19 In both cases, the final fate of the palladium alkyl 
intermediate, generated upon cyclization, was β-hydroxy elimination. There is literature 
precedent for Bronsted acid promoted cyclization of acids with hypervalent iodine 
oxidants. Butenoic acid was cyclized with PhI(OAc)2 in AcOH in the presence of a 
strong acid, HBF4 (Scheme 5.33).20 Notably, PdII complexes have been used as Lewis 
acid catalysts in Baeyer Villiger oxidations, Diels Alder reactions, and the acetalization 
of aldehydes and ketones.21 Hence, we wondered if the role of palladium in these 
cyclization reactions was that of a Lewis acid. 
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(119) (120)  
 































 In order to distinguish between the two mechanisms, a number of control 
experiments were executed. First, the reactions were conducted with as PhI(O2CCF3)2, 
which is a stronger oxidant and more electrophilic reagent than PhI(O2CPh)2. As shown 
in Scheme 5.34, similar reactivity was observed with PhI(O2CCF3)2 in the presence and 
absence of the Pd catalyst. In both cases, the THF product 124 was obtained in 41-54% 
yield as an approximately 1:1 ratio of diastereomers. 
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With Pd: Overall yield 41%, 1:1






Secondly, Lewis acids such as BF3•Et2O were screened in the reactions in place 
of the PdII catalyst. The desired cyclized products were again observed in the presence of 
BF3•Et2O, albeit in lower yield (Scheme 5.35). Our results and literature precedent led us 
to hypothesize that the cyclized products are likely forming through a Lewis acid 
mechanism and not a PdII/IV cycle.  
 














5 mol % Pd(OAc)2
11%








10 mol % BF3•Et2O





5.7  Aminooygenation Cyclization Reactions with 3-Alken1-ols 
 
Initial Results. We sought to optimize for the THF ring 62 that had incorporated 
the nucleophile. Subjection of 3-buten-1-ol and phthalimide to 5 mol % Pd(OAc)2 and 2 
equiv PhI(OAc)2 in CH3CN at 60 ºC afforded the aminooygenated THF product 62 in 
27% isolated yield. This low yield was due to two major side reactions: (i) the 
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concomitant formation of tetrahydrofuran 63 discussed above (Scheme 5.23) and (ii) 
competitive undesired side reactions of the alcohol substrate 59 (Scheme 5.24). Notably, 
no products resulting from β-hydride elimination were observed, presumably due to the 
formation of a cyclic intermediate. We thought that using additives that can promote 
formation of free sites at the metal, might facilitate coordination of the nucleophile and 
the alcohol to the catalyst. Hence we studied the effect of the addition of 10 mol % of 
various additives to our reaction. Interestingly, additives containing potentially 
coordinating couterions such as AgI, ZnCl2, and AuCl3 led to decreased reactivity, whilst 
additives with non-coordinating counterions, such as AgBF4, AgOTf and SbF5 
significantly improved the yield (Table 5.3). Further optimizations showed that two 
sequential additions of catalyst, silver salt, oxidant and alcohol further increased the yield 
of this reaction to 45%.  
 
Table 5.3: Addition of Additives to the Palladium-Catalyzed Reaction of 3-Butene-1-ol 
with Phthalimide and PhI(OAc)2 



































5 mol % Pd(OAc)2






















Scope of Aminooxygenation Reactions. With optimal conditions in hand, the 
scope of this transformation was next studied. We reasoned that a substituent at the 
allylic position might accelerate the cyclization due to a Thorpe-like effect. We were 
delighted to find that substrate 72, bearing a phenyl group in the allylic position, afforded 
the desired product in 77% yield and 10:1 diastereoselectivity. The stereochemistry was 
confirmed via NMR analysis and an x-ray crystal structure. Electron donating (Table 5.4, 
entries 2-4 and 8-9) and electron withdrawing (entries 5-7) substituents as well as 
halogens were tolerated on the phenyl ring.22 Tertiary alcohols also afforded the desired 
products in modest yield (entry 13).  
 
Table 5.4: Substrate Scope of Aminooxgenation Reactions 






























































R = benzyl (125a)
R = i-propyl (125b)
(75)
(83)
Conditions: 10 mol % Pd(OAc)2, 20 mol % AgBF4, 2.0 equiv PhI(OAc)2, CH3CN, 60 °C  
 
While similar yields of products were obtained with different electronically and 
sterically substituted aryl rings at the allylic position, the diastereoselectivities were 
affected by the nature of the allylic substituent. In general, the diastereoselectivities were 
higher for electron withdrawing substituents in the para-position of the aryl ring and for 
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less sterically hindered aryl substituents. Interestingly, reduced yields and 
diastereoselectivities were obtained with substrates bearing non-aromatic substituents 
such as benzyl, methyl or isopropyl groups at the allylic position (Table 5.4, entries 10-
12). 
In contrast to the reactivity of substrate 83, the reaction of substituted tertiary 
alcohols such as 143-145, and 147 resulted in either unreacted starting material, 
decomposition, or the formation of Heck products. Similar reactivity was observed with 
substrates 139-141 and 143-144 that contained functionalities with the ability to 
coordinate to the metal, such as another olefin, a carbonyl, or an oxime ether, creating the 
possibility of dual chelation. Conformationally constrained substrate 148 also afforded 
only trace amounts of products under our standard conditions.  
 
Scheme 5.36. Alkenol Substrates that Exhibited Low Reactivity 
OH
R
R = H (139), 












R1 = H, R2 = Ph, (146)
R1 = CH3, R
2 = Ph, (147)
R1 = CH3, R





Other nitrogen nucleophiles were also examined in this reaction. However, we 
were surprised to find that p-toluenesulfonamide, p-nitrophenylsulfonamide, 
oxazolidinone, pyrrolidinone, and succinimide did not react to form even traces of 
cyclized products under our optimal reaction conditions.  
 
5.8  Mechanistic Investigations of Aminooxygenation Cyclization 
 
With the aforementioned results in hand, we were interested in investigating the 
mechanism of the aminooxygenation transformation. There are at least six distinct 
mechanistic possibilities for the Pd-catalyzed formation of the phthalimide substituted 
tetrahydrofuran rings: (i) SN2 reaction of phthalimide with THF 65 (Scheme 5.37), (ii) 
iodocyclization to form product 149 followed by subsequent intermolecular SN2 reaction 
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with phthalimide (Scheme 5.38), (iii) Lewis acid catalyzed cyclization (Scheme 5.39), 
(iv) Pd-catalyzed 1,2-aminoacetoxylation of the olefin to form product 150 followed by a 
subsequent intramolecular SN2 reaction (Scheme 5.40), (v) 5-endo-trig oxypalladation to 
form intermediate 151 followed by oxidatively induced C–N bond forming reductive 
elimination (Scheme 5.41), and (vi) aminopalladation of the olefin followed by oxidative 
cyclization and C–O bond formation (Scheme 5.42).  
 









(65) (62)  
 










(115) (149)  
 
























































In order to examine the viability of the first mechanism, compound 65 was 
synthesized via the previously discussed cyclization reaction (Scheme 5.24). Subjection 
of product 65 and phthalimide to the standard reaction conditions (10 mol % Pd(OAc)2, 
20 mol % AgBF4, 2 equiv PhI(OAc)2 in CH3CN at 60 °C) did not afford any of the 
aminooxygenated product 62 (Scheme 5.43). This result suggested strongly that product 
62 was not formed by mechanism i. 
 










10 mol % Pd(OAc)2
20 mol % AgBF4
2.0 equiv PhI(OAc)2
CH3CN, 60 °C
not observed  
 
The viability of mechanism ii was examined by preparing an authentic sample of 
the iodo-substituted THF 149 (Scheme 5.38). Substrate 72 was chosen instead of 59 due 
to ease of isolation. Compound 153 was treated under the standard reaction conditions 
with phthalimide (10 mol % Pd(OAc)2, 20 mol % AgBF4, 2 equiv PhI(OAc)2 in CH3CN 
at 60 °C), and again, we did not observe the formation of product 126. Based on this 




Scheme 5.44. Possible SN2 Reaction between Phthalimide and Iodide Product 153 
10 mol % Pd(OAc)2
20 mol % AgBF4
1.0 equiv NHPhth
2.0 equiv PhI(OAc)2













The third possible route to 126 would involve Pd acting as a Lewis acid to promote 
cyclization. In order to probe for this, we examined the reaction in the absence of 
palladium catalyst and in the presence of BF3•Et2O. Substrate 72 was subjected to 10 mol 
% BF3•Et2O with 2 equiv PhI(OAc)2 in CH3CN at 60 °C, and as shown in Scheme 5.45, 
product 126 was again not observed in this control reaction.  
 















In order to determine if mechanism iv was occurring, we synthesized 154 by 
subjecting benzyl-protected 3-butenol and phthalimide to our reaction conditions 
followed by DDQ deprotection (Scheme 5.46). Subjection of 61 to the reaction 
conditions (10 mol % Pd(OAc)2, 20 mol % AgBF4, 2 equiv PhI(OAc)2 in CH3CN at 60 
°C) did not afford even traces of product 62. This result suggested that mechanism iv was 
not operational.   
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1. 10 mol % Pd(OAc)2




2.  DDQ, CH2Cl2
OMe
10 mol % Pd(OAc)2






If the reaction were proceeding via 5-endo trig cyclization (mechanism v), then 
we would expect that conducting the reaction of 4-phenyl-1-butenol and phthalimide in 
the presence of oxygen instead of PhI(OAc)2 would form product 157 or its isomers, 
resulting from β-hydride elimination from intermediate 156 (Scheme 5.47). As seen 
earlier in examples by Stahl and co-workers (Scheme 5.4) in the absence of a strong 
oxidant that can intercept the PdII intermediate, β-hydride elimination is the most 
favorable pathway. Hence, substrate 155 and phthalimide were subjected to 5 mol % 
Pd(OAc)2, 10 mol % AgBF4 in CH3CN at 60 °C under 1 atm of O2. However, this 
reaction did not provide even traces of 157 or its isomers, suggesting against mechanism 
v.  
 







5 mol % Pd(OAc)2


















With these results in hand, we surmised that the formation of product 62 was 
catalyzed by palladium through the PdII/IV amination/oxidation pathway vi.22 As shown in 
Scheme 5.48, we envisioned four different pathways for the desired aminooxygenation 
reactions. The first step of the reaction might involve cis- or trans-aminopalladation. 
Upon aminopalladation, the reaction could then proceed via two different routes: (i) 
oxidation to PdIV followed by reductive elimination via an SN2 pathway leading to 
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inversion of configuration at carbon or (ii) chelation of the tethered alcohol to the 
palladium followed by oxidation to PdIV and then direct reductive elimination with 
retention of stereochemistry. Importantly, in the latter case, chelation/oxidation could 
occur in the opposite order. As mentioned in the background section, both cis and trans 
aminopalladation have been observed previously.9, 13, 15, 16, 23 Additionally, reductive 
elimination at PdIV has been shown to occur with either retention or inversion of 
stereochemistry at carbon, depending on the substrate and the reaction conditions.  
 





























































In order to distinguish between these four mechanistic possibilities, the deuterium 
labelled substrate 157 was synthesized (Scheme 5.49). Subjection of substrate 157 and 
phthalimide to our reaction conditions afforded the aminoacetoxylated product 158 along 
with product 159, resulting from β-hydride elimination. The deuterium had scrambled in 
products 158 and 159. We speculated that the deuterium scrambling in the products might 
be due to the isomerization of the olefin in the starting material, rather than an inherent 
lack of stereospecificity of the reaction. Indeed, this hypothesis was confirmed when 157 
was subjected to our reaction in the absence of phthalimide and PhI(OAc)2. This reaction 
provided a 1:1 mixture of the cis and trans isomers of 157. 
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D 10 mol % Pd(OAc)2












Because the deuterium-labelled substrate 157 did not provide the desired 
mechanistic information, we next explored the reactivity of trans- and cis-4-
phenylbutenol, 155, with phthalimide, 10 mol % Pd(OAc)2, 20 mol % AgBF4, and 2 
equiv PhI(OAc)2 in CH3CN at 60 ºC. In this case, the cis substrate 155 afforded a single 
diastereomeric product (160) that had a trans relationship between the phenyl ring and 
the phthalimide (Scheme 5.50). The stereochemistry was confirmed via NMR analysis 
and an x-ray crystal structure. In contrast, the trans substrate did not afford any of the 
desired aminooxygenated product under our reaction conditions. This result shows that 
even if isomerization between cis and trans phenyl butenols occurred under our reaction 
conditions, only the cis-isomer reacts to form the product. The trans relationship between 
the phenyl ring and the phthalimide in product 160 led us to believe that either 
mechanistic pathway a or d (Scheme 5.48) was operational in these reactions.  
 











10 mol % Pd(OAc)2





(155) (160)  
 
In order to distinguish between mechanisms a and d, we needed to determine the 
mechanism of aminopalladation. A prior study by Stahl suggested that the geometry of β-
hydride elimination products from PdII intermediate A or D would provide this 
information.16 As shown in Scheme 5.51, if cis-aminopalladation were operational, then 
PdII intermediate 151 would have to undergo σ-bond rotation to achieve the required syn 
relationship between the Pd and the β-hydrogen to achieve β-hydride elimination. As 
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such, this reaction would afford the Z-substituted olefin 163 (Scheme 5.51). In contrast, 
the PdII product of trans-aminopalladation can undergo direct β-hydride elimination, 
leading to the E-substituted olefin 165.  
 

































Subjection of substrate 155 to our optimized reaction conditions in the presence of 
O2 instead of PhI(OAc)2 (to promote termination of the reaction via β-hydride 
elimination) afforded the β-hydride elimination product 163, albeit in low 3% yield 
(Scheme 5.52). This result suggests that our reaction goes through a cis-aminopalladation 
pathway. The low yield in this reaction is due to competitive olefin isomerization of the 
starting material, which yields the unreactive trans isomer. Interestingly, when the 
reaction shown in Scheme 5.52, was conducted in the absence of AgBF4, we obtained 4% 
yield of a 1:1 ratio of Z and E substituted β-hydride elimination products (Scheme 5.52), 
suggesting that cis and trans aminopalladation are competitive under these conditions. 
Importantly, control experiments showed that neither product 163 nor product 165 
isomerized under either set of reaction conditions.  
 
 189 






















with AgBF4 :  (3%) >15 : 1
without AgBF4: (4%) 1 : 1  
 
Analyzing all the mechanistic data allowed us to conclude that mechanistic pathway 
a is governing the reaction (Scheme 5.48). It is notable that during reductive elimination 
from PdIV, there exists a choice for either reductive elimination of the acetate, to form 
aminoacetoxylated product 168, or the alkoxide to form the THF ring 160 (Scheme 5.53). 
As discussed above, we obtain the THF ring product exclusively. Notably, C–OAc 
reductive elimination at PdIV is certainly possible, as it was observed in the C–H 
activation/acetoxylation reactions. We believe the preference for reductive elimination of 
the alkoxide over the acetate in the current systems can be attributed to the greater 
nucleophilicity of the alkoxide as discussed in chapter 2.24  
As discussed above, we observe reductive elimination with retention at the carbon. 
This is in sharp contrast to what was reported by Muniz (Scheme 5.12)15 and Stahl 
(Scheme 5.13)16 for related aminopalladation/oxidation reactions. However, other reports 
have suggested that reductive elimination from high oxidation state Pd complexes can 
occur with retention at carbon.25, 26 We believe that pre-coordination of the alkoxide is a 
likely reason for reductive elimination occurring with retention in our system. 
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Origin of Diastereoselectivity. We next sought to rationalize the observed 
diastereoselectivity and the role of silver in the aminooxygenation reaction. Silver is 
known to facilitate the dissociation of acetate from group 10 metal centers through 
coordination.27 Based on the results from Scheme 5.52 and Table 5.3, we propose that 
silver reacts to produce a vacant coordination site on the palladium by promoting 
dissociation of an acetate ligand. This vacant coordination site allows the palladium to 
bind to the phthalimide nucleophile, facilitating cis-aminopalladation.  
Substrates 169 and 170, where the alcohol had been replaced with a carbon, were 
chosen to elucidate the origin of diastereoselectivity. Subjection of substrate 170 to our 
reaction conditions did not lead to any observable reactivity (Scheme 5.54). This was in 
contrast to substrate 75, which yielded 30% of product 135. Substrate 169 underwent 
aminoacetoxylation to afford product 172 in 4 : 1 diastereoselectivity along with the β-
hydride elimination product 171 (Scheme 5.54). The diastereoselectivity observed with 
substrate 72 is significantly greater than the dr observed with substrate 169. This implies 
that there exists some interaction between the palladium and the alcohol in the transition 
state for aminopalladation.  
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10 mol % Pd(OAc)2









(172, 25%, 4.5 : 1)R = Ph (171, 10%)





10 mol % Pd(OAc)2






(126) R = Ph 77%, 10:1
(135) R = CH3 30% 1:1.4
(72) R = Ph
(75) R = CH3
(169) R = Ph
(170) R = CH3  
 
These results can be rationalized based on the proposed transition state in Figure 5.3. 
Here the palladium is interacting with the nitrogen of the nucleophile, the tethered 
alcohol, and the olefin in a cyclic transition state. In order to avoid unfavorable steric 
interactions with the coordinated phthalimide, the allylic substituent assumes a pseudo-
equatorial position, resulting in a trans delivery of the phthalimide. However, this 
transition state does not completely explain the observed steric and electronic effects on 
the diastereoselectivity, particularly with the methyl, benzyl, and mesityl substituted 
substrates 75, 125a, and 72h. It is possible that alternative and/or competing transition 
states are accessed in these systems.  
 
















(i) Favored (ii) Unfavored  
 
 192 
5.9  Conclusion 
 
In summary, palladium alkyl intermediates generated via nucleopalladation were 
intercepted to form carbon-oxygen bonds. Aminopalladation reactions, using 
nucleophiles such as phthalimide, p-toluenesulfonamide, and p-nitrophenylsulfonamide 
and olefins such as octene and norbornene were explored to form 1,2-aminoacetoxylated 
products. These products were obtained in low yields due to competitive undesired β-
hydride elimination. This undesired pathway was attenuated by tethering chelating 
functionalities, such as alcohols, amines and acids, to the olefin. Reaction of the tethered 
olefin in the absence of amine nucleophiles led to formation of acetate substituted cyclic 
compounds. We propose that these cyclization reactions occur via a Lewis acid catalyzed 
mechanism to form the tetrahydrofuran, pyrrolidinone, or lactone products, respectively. 
Reaction of the alkenols in the presence nucleophiles such as phthalimide afforded 
phthalimide-substituted THF rings. Mechanistic experiments have shown that this 
aminooxygenated compound is formed by cis-aminopalladation followed by oxidative 
cleavage with PhI(OAc)2 to afford the final product with retention of stereochemistry at 
the carbon.  
 
5.10  Experimental Procedure 
 
General Procedures: NMR spectra were obtained on a Varian Inova 500 (499.90 
MHz for 1H; 125.70 MHz for 13C) unless otherwise noted 19F NMR spectra were 
obtained on Varian Inova 300 (282 MHz for 19F). 1H NMR chemical shifts are reported in 
parts per million (ppm) relative to TMS, with the residual solvent peak used as an internal 
reference. Multiplicities are reported as follows: singlet (s), broad singlet (br, s), doublet 
(d), doublet of doublets (dd), doublet of doublets of doublets (ddd), doublet of triplets 
(dt), triplet (t), quartet (q), quintet (quin), multiplet (m), and broad resonance (br). IR 
spectra were obtained on a Perkin-Elmer Spectrum BX FT-IR spectrometer. 
 
Materials and Methods: Alcohol substrates 77, 72, 72a-72h, and 155 were 
prepared according to literature procedures. Substrate 125a was synthesized by alkylation 
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of 3-butenoic acid with benzyl bromide followed by LiAlH4 reduction of the acid to 
afford the alcohol. PhI(O2CPh)2 was prepared according to a literature procedure. 
Pd(OAc)2 was obtained from Pressure Chemical and used as received, and PhI(OAc)2 
was obtained from Merck Research Laboratories and used as received. Solvents were 
obtained from Fisher Chemical. Acetonitrile was freshly distilled from calcium hydride 
under a nitrogen atmosphere. Dichloromethane, tetrahydrofuran, and diethyl ether were 
purified using a an Innovative Technology (IT) solvent purification system composed of 
activated alumina, copper catalysts and molecular sieves. Flash chromatography was 
performed on EM Science silica gel 60 (0.040–0.063 mm particle size, 230–400 mesh), 
and thin layer chromatography was performed on Merck TLC plates pre-coated with 
silica gel 60 F254. HPLC was performed on a Varian Prostar 210 HPLC using Waters 
µPorasil® 10 µm silica (19 x 300 mm) columns. Melting points were determined with a 
Mel-Temp 3.0, a Laboratory Devices Inc, USA instrument and are uncorrected. HRMS 
data were obtained on a Micromass AutoSpec Ultima Magnetic Sector mass 
spectrometer. The geometries of the diastereomeric tetrahydrofuran products were 
determined based on 1H NMR nOe studies (substrates 5a-14a) and by X-ray 
crystallography (3a and 4a). 
 
Typical Procedure for Olefin reaction with Nucleophile: Phthalimide (100 mg, 
0.68 mmol, 1 equiv), PhI(OAc)2 (0.440 g, 1.36 mmol, 2 equiv), and Pd(OAc)2 (8 mg, 
0.034 mmol, 0.05 equiv) were combined in CH2Cl2 (1.4 mL) in a 20 mL vial. Octene (98 
mg, 1.36 mmol, 2.0 equiv) was added to the reaction, the vial was sealed with a Teflon-
lined cap, and the reaction was heated at 60 ºC for 12 h. The reaction mixture was 
evaporated to dryness and then taken up in diethyl ether (10 mL). The ether layer was 
washed with 10% aqueous Et3N (10 mL), H2O (2 x 20 mL), saturated aqueous NaHCO3 
(20 mL), and saturated aqueous NaCl (20 mL). The ether extracts were dried over 
MgSO4, filtered, and concentrated to afford a red oil, which was purified by 









Product 38 was obtained as a yellow oil (18%). 1H NMR (CDCl3): δ 7.75 (d, J = 8.0 Hz, 
2H), 7.29 (d, J = 8.5 Hz, 2H), 4.77 (m, 1H), 3.97 (dd, J = 10.8, 5.2 Hz, 1H), 3.89 (dd, J = 
10.8, 3.6 Hz, 1H), 2.42 (s, 3H), 1.94 (s, 3H), 1.47-1.13 (multiple peaks, 8H), 0.84 (t, J = 








Product 41 was obtained as a yellow oil (25%). 1H NMR (CDCl3): δ 8.34 (d, J = 7.2 Hz, 
2H), 8.07 (d, J = 7.2 Hz, 2H), 3.99 (dd, J = 9.2, 4.0 Hz, 1H), 3.95 (dd, J = 9.2, 4.0 Hz, 







Product 43 was obtained as a yellow oil (38%). 1H NMR (CDCl3): δ 7.74 (d, J = 8.0 Hz, 
2H), 7.29 (d, J = 8.5 Hz, 2H), 5.11 (d, J = 9.0 Hz, 1H), 4.68 (d, J = 7.5 Hz, 1H), 3.37 (d, 
J = 8.5 Hz, 1H), 2.42 (s, 3H), 2.10 (m, 1H), 2.04 (s, 3H), 1.98 (d, J = 4.5 Hz, 1H), 1.84 





Product 45 was obtained as a yellow oil (29%). 1H NMR (CDCl3): δ 4.72, (br s, 1H), 4.62 
(br s, 1H), 2.48 (m, 1H), 2.42 (m, 1H), 2.29 (m, 1H), 2.04 (s, 3H), 1.94 (s, 3H), 1.94 (m, 






Product 46 was obtained as a yellow oil (42%). 1H NMR (CDCl3): δ 7.81 (m, 2H), 7.69 
(m, 2H), 4.73 (d, J = 8.0 Hz, 1H), 3.59-3.57 (multiple peaks, 2H), 3.47 (d, J = 4.5 Hz, 
1H), 1.92 (dd, J = 14.0, 7.0, 1H), 1.81 (m, 1H), 1.74 (m, 1H), 1.64 (m, 1H), 1.54 (s, 3H), 






Product 47 was obtained as a yellow oil (47%). 1H NMR (CDCl3): δ 7.67 (d, J = 8.0 Hz, 
1H), 7.54-7.51 (multiple peaks, 2H), 7.43 (m, 1H), 4.88 (d, J = 11.0 Hz, 1H), 4.75 (d, J = 
11.0 Hz, 1H), 4.15 (d, J = 6.4 Hz, 1H), 4.09 (br s, 1H), 2.95 (br s, 1H), 2.87 (d, J = 5.2 
Hz, 1H), 1.79 (m, 1H), 1.53 (m, 1H), 1.45 (m, 1H), 1.18-1.10 (multiple peaks, 2H). 13C 
{1H} NMR (CDCl3): δ 169.28, 145.79, 132.98, 130.24, 129.77, 128.29, 123.72, 122.38, 
85.46, 82.50, 78.97, 59.35, 38.58, 38.08, 37.40, 25.24, 21.36. IR (thin film): 1711, 1552, 








Product 48 was obtained as a yellow oil (14%). 1H NMR (CDCl3): δ 7.79-7.76 (multiple 
peaks, 2H), 7.61 (t, J = 7.0 Hz, 1H), 7.53 (t, J = 7.5 Hz, 1H), 5.23 (q, J = 6.5 Hz, 1H), 
4.22 (d, J = 6.5 Hz, 1H), 4.13 (br s, 1H), 3.11 (d, J = 4.5 Hz, 1H), 3.00 (br s, 1H), 1.84 
(m, 1H), 1.61 (m, 1H), 1.51 (dd, J = 14.0, 6.5 Hz, 1H), 1.32-1.20 (multiple peaks, 2H), 
1.04 (d, J = 6.5 Hz, 3H). 13C {1H} NMR (CDCl3): δ 169.77, 144.15, 133.69, 132.67, 
130.33, 129.98, 124.11, 123.45, 122.85, 89.00, 87.91, 78.52, 59.50, 38.69, 37.83, 37.48, 
25.19, 21.36, 15.12. IR (thin film): 1711, 1552, 1377 cm–1. HRMS (ESI, m/z): [M + H]+ 
calcd for C16H16N2O4, 301.1188; found, 301.1188. 
 
Typical Procedure for Alcohol cyclization: PhI(O2CPh)2 (90 mg, 2.77 mmol, 
2.0 equiv) and Pd(OAc)2 (15 mg, 0.069 mmol, 0.05 equiv) were combined in CH3CN 
(2.8 mL) in a 20 mL vial. 3-Buten-1-ol (100 g, 1.39 mmol, 1.0 equiv) was added, the vial 
was sealed with a Teflon-lined cap, and the reaction was stirred at 60 °C for 18 h. The 
resulting mixture was evaporated to dryness and then taken up in diethyl ether (10 mL). 
The ether layer was washed with H2O (2 x 20 mL), saturated aqueous NaHCO3 (10 mL), 
and saturated aqueous NaCl (10 mL). The ether layer was then dried over MgSO4, 
filtered, and concentrated to afford a red oil, which was purified by chromatography on 






The product 65 was obtained as a clear oil (113 mg, 42% yield). 1H NMR (CDCl3): δ  
8.03 (d, J = 8.4 Hz, 2H), 7.56 (m, 1H), 7.43 (t, J = 7.9 Hz, 2H), 5.54 (m, 1H), 4.00-3.88 
(multiple peaks, 4H), 2.26 (m, 1H), 2.15 (m, 1H). 13C {1H} NMR (CDCl3): δ 166.24, 
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133.07, 129.92, 129.56, 128.32, 75.34, 73.15, 67.09, 32.89. IR (thin film): 1717 cm–1. 





The product 68 was obtained as a clear oil (10% yield). 1H NMR (CDCl3): δ  8.06-8.03 
(multiple peaks, 2H), 7.58 (m, 1H), 7.46-7.42 (multiple peaks, 2H), 4.36 (t, J = 6.8 Hz, 






The product 73 was obtained as a clear oil (35%, 2:1 dr). 1H NMR (CDCl3): δ  7.35-
7.28(multiple peaks, 5H), 5.19 (quin, J = 2.5 Hz, 1H), 4.28 (dd, J = 9.0, 7.0 Hz, 1H), 4.17 
(dd, J = 10.5, 5.0 Hz, 1H), 3.96 (dd, J = 9.0, 5.0 Hz, 1H), 3.89 (dd, 10.5, 2.0 Hz, 1H), 
3.47 (m, 1H), 2.10 (s, 3H). 13C {1H} NMR (CDCl3): δ 170.73, 168.30, 128.82, 127.40, 
127.11, 81.37, 73.08, 72.76, 51.18, 29.60. HRMS (ESI, m/z): [M + Na]+ calcd for 





The product 74 was obtained as a clear oil (23%). 1H NMR (CDCl3): δ 7.37-
7.25(multiple peaks, 5H), 4.45 (m, 2H), 3.21 (m, 1H), 2.76 (m, 2H), 2.56 (dd, J = 4.5, 3.0 
Hz, 1H), 2.04 (s, 3H). 13C {1H} NMR (CDCl3): δ 170.90, 137.89, 128.72, 127.94, 127.45, 
65.46, 53.31, 47.64, 46.03, 20.85. IR (thin film): 1740 cm–1. HRMS (ESI, m/z): [M + 






The product 76 was obtained as a clear oil (22%, 1.4:1 dr). 1H NMR (CDCl3): δ 8.05 (m, 
2H), 7.57 (m, 1H), 7.44(m, 2H), 5.15 (m, 1H), 4.19-4.15 (multiple peaks, 2H), 3.98 (d, J 







The product 78 was obtained as a clear oil (30%, 1:1 dr). 1H NMR (CDCl3): δ  7.99 (d, J 
= 8.5 Hz, 2H), 7.86 (d, J = 8.5 Hz, 2H), 7.55-7.42 (multiple peaks, 5H),  5.41 (m, 1H), 
4.35 (dd, J = 9.5, 6.0 Hz, 1H), 4.29 (dd, J = 11.0, 5.0 Hz, 1H), 4.08-4.05 (multiple peaks, 






The product 78’ was obtained as a viscous oil (10%). 1H NMR (CDCl3): δ  8.13 (d, J = 
7.0 Hz, 2H), 7.99 (d, J = 8.0 Hz, 2H), 7.50-7.41 (multiple peaks, 3H), 7.22 (d, J = 8.0 Hz, 
2H), 4.66 (d, J = 6.5 Hz, 2H), 3.28 (m, 1H), 2.93 (q, J = 7.0 Hz, 1H), 2.81 (t, J = 4.5 Hz, 








Mixture of cis and trans Isomers in a 1.0:1.8 ratio. 1H NMR (CDCl3): δ 8.08-8.04 
(multiple peaks, 4H), 7.68-7.27 (multiple peaks, 2H), 7.48-7.43 (multiple peaks, 4H), 
5.50 (m, 1H), 5.37 (m, 1H), 4.42-4.39 (multiple peaks, 2H), 4.10-4.04 (multiple peaks, 
4H), 1.78-1.71 (multiple peaks, 2H), 1.66-1.62 (multiple peaks, 2H), 1.39 (d, J = 86.5 Hz, 








Product 82 was obtained as a yellow oil (37%, 2:1 dr). Isomer 1: 1H NMR (CDCl3): δ 
7.49-7.43 (multiple peaks, 5H), 7.45-7.38 (multiple peaks, 2H), 7.29-7.25 (multiple 
peaks, 3H), 5.64 (m, 1H), 4.43 (dd, J = 10.5, 5.5 Hz, 1H), 4.08 (dd, J = 10.5, 0.5 Hz, 1H), 
2.68 (d, J = 14.0, 1H), 2.41 (dd, J = 14.0, 5.5 Hz, 1H), 1.63 (s, 3H). 13C {1H} NMR 
(CDCl3): δ165.96, 147.25, 132.84, 129.75, 129.45, 128.04, 126.29, 124.69, 84.74, 75.92, 
72.77, 45.83, 30.23, 29.68. Isomer 2: 1H NMR (CDCl3): δ 8.10 (dd, J = 8.0, 1.0 Hz, 2H), 
7.61 (t, J = 7.5 Hz, 1H), 7.49 (t, J = 8.0 Hz, 2H), 7.44 (dd, J = 8.5, 1.0 Hz, 2H), 7.38 (t, J 
= 8.0 Hz, 2H), 7.27 (t, J = 7.5 Hz, 1H), 5.51 (m, 1H), 4.22 (d, J = 11.0 Hz, 1H), 4.15 (dd, 
J = 11.0, 5.0 Hz, 1H), 2.75 (dd, J = 14.0, 7.0 Hz, 1H), 2.45 (dd, J = 14.0, 2.5 Hz, 1H), 
1.71 (s, 3H). 13C {1H} NMR (CDCl3): δ 166.25, 147.25, 133.16, 129.99, 129.63, 128.43, 







Product 83 was obtained as a yellow oil (40%). 1H NMR (CDCl3): δ 7.97 (d, J = 8.0 Hz, 
2H), 7.52 (t, J = 7.5 Hz, 1H), 7.40 (t, J = 8.0 Hz, 2H), 5.54 (m, 1H), 4.19 (dd, J = 11.0, 
5.0 Hz, 1H), 4.03 (d, J = 11 Hz, 1H), 2.18 (dd, J = 14.0, 7.0, 1H), 2.04 (d, J = 14.0 Hz, 







Product 86 was obtained as a yellow oil (29%, 2:1 dr). Cis Isomer: 1H NMR (CDCl3): δ 
7.90 (dd, J = 7.5, 1.6 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.44-7.30 (multiple peaks, 7H), 
5.63 (m, 1H), 5.02 (t, J = 8.0 Hz, 1H), 4.30 (d, J = 11.0 Hz, 1H), 4.11 (dd, J = 11.0, 5.0 
Hz, 1H), 2.84 (m, 1H), 2.18 (m, 1H). Trans Isomer: 1H NMR (CDCl3): δ 7.39-7.29 
(multiple peaks, 10H), 5.62 (t, J = 6.0 Hz, 1H), 5.11 (dd, J = 10.5, 5.0 Hz, 1H), 4.44 (dd, 
J = 11.0, 5.0 Hz, 1H), 4.04 (dd, J = 11.0, 2.0 Hz, 1H), 2.54 (dd, J = 14.5, 6.0 Hz, 1H), 







Product 124 was obtained as a yellow oil (29%, 2:1 dr). Trans Isomer: 1H NMR 
(CDCl3): δ 7.39-7.29 (multiple peaks, 5H), 5.62 (t, J = 5.0 Hz, 1H), 5.11 (dd, J = 10.0, 
5.0 Hz, 1H), 4.44 (dd, J = 11.5, 5.0 Hz, 1H), 4.05 (dd, J = 11.5, 3.0 Hz, 1H), 2.54 (dd,  J 
= 14.0, 5.5 Hz, 1H), 2.17 (ddd, J = 14.0, 10.0, 5.5 Hz, 1H). Cis Isomer: 1H NMR 
(CDCl3): δ 7.38-7.31 (multiple peaks, 5H), 5.56 (m, 1H),  4,93 (t, J = 9.0 Hz, 1H), 4.29 
(d, J = 14.0 Hz, 1H), 4.01 (dd, J = 14.0, 6.0 Hz, 1H), 2.86 (quin, J = 9.0 Hz, 1H), 2.08 
(m, 1H). 
 
Typical Procedure for Amine cyclization: PhI(O2CH3)2 (90 mg, 2.77 mmol, 2.0 
equiv), NaHCO3 (90 mg, 2.77 mmol, 2.0 equiv) and Pd(OAc)2 (15 mg, 0.069 mmol, 0.05 
equiv) were combined in CH3CN (2.8 mL) in a 20 mL vial. Amine (1.0 equiv) was 
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added, the vial was sealed with a Teflon-lined cap, and the reaction was stirred at 60 °C 
for 18 h. The resulting mixture was evaporated to dryness and then taken up in diethyl 
ether (10 mL). The ether layer was washed with H2O (2 x 20 mL), saturated aqueous 
NaHCO3 (10 mL), and saturated aqueous NaCl (10 mL). The ether layer was then dried 
over MgSO4, filtered, and concentrated to afford a red oil, which was purified by 






Product 88 was obtained as a yellow oil (20%). 1H NMR (CDCl3): δ 8.40 (d, J = 8.8 Hz, 
2H), 8.03 (d, J = 8.8 Hz, 2H), 5.17 (m, 1H), 3.57 (q, J = 4.8 Hz, 1H), 3.52 (d, J = 4.8 Hz, 






Product 91 was obtained as a yellow oil (19%). 1H NMR (CDCl3): δ 7.72 (d, J = 8.0 Hz, 
2H), 7.33 (d, J = 8.0 Hz, 2H), 5.10 (m, 1H), 3.53 (dd, J = 8.8, 5.0 Hz, 1H), 3.46 (dd, J = 
12.0, 5.0 Hz, 1H), 3.42 (m, 1H), 4.31 (m, 1H), 2.42 (s, 3H), 1.95-1.93 (multiple peaks, 
2H), 1.80 (s, 3H). 
 
Typical Procedure for Acid cyclization: PhI(O2CPh)2 (90 mg, 2.77 mmol, 2.0 
equiv), NaHCO3 (90 mg, 2.77 mmol, 2.0 equiv)  and Pd(OAc)2 (15 mg, 0.069 mmol, 0.05 
equiv) were combined in CH2Cl2 (2.8 mL) in a 20 mL vial. 3-Butenoic Acid (100 g, 1.39 
mmol, 1.0 equiv) was added, the vial was sealed with a Teflon-lined cap, and the reaction 
was stirred at 60 °C for 18 h. The resulting mixture was evaporated to dryness and then 
taken up in diethyl ether (10 mL). The ether layer was washed with H2O (2 x 20 mL), 
saturated aqueous NaHCO3 (10 mL), and saturated aqueous NaCl (10 mL). The ether 
layer was then dried over MgSO4, filtered, and concentrated to afford a red oil, which 
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Product 100 was obtained as a yellow oil (56%). 1H NMR (CDCl3): δ 8.03 (d, J = 8.0 Hz, 
2H), 7.61 (t, J = 8.0 Hz, 1H), 7.47 (t, J = 7.5 Hz, 2H), 4.63 (dd, J = 11.1, 4.8 Hz, 1H), 







Product 102 was obtained as a yellow oil (65%, 1:1 dr). Cis Isomer: 1H NMR (CDCl3): δ 
8.03 (d, J = 7.5 Hz, 2H), 7.61 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 2H), 5.76 (m, 1H), 
4.51 (dd, J = 11.0, 4.5 Hz, 1H), 4.45 (d, J = 11.0 Hz, 1H), 2.91 (quin, J = 7.5 Hz, 1H), 
1.34 (d, J = 7.5 Hz, 3H). Trans Isomer: 1H NMR (CDCl3): δ 8.04 (d, J = 7.0 Hz, 2H), 
7.61 (t, J = 7.0 Hz, 1H), 7.46 (t, J = 7.5 Hz, 2H), 5.32 (m, 1H), 4.70 (dd, J = 11.0, 5.5 Hz, 






Product 104 was obtained as a yellow oil (60%). 1H NMR (CDCl3): δ 8.03 (dd, J = 8.0, 
1.5 Hz, 2H), 7.59 (t, J = 8.0 Hz, 1H), 7.46 (t, J = 8.0 Hz, 2H), 4.88 (m, 1H), 4.54 (dd, J = 
12.0, 3.0 Hz, 1H), 4.44 (dd, J = 12.0, 5.0 Hz, 1H), 2.69-2.56 (multiple peaks, 2H), 2.43 







Product 106 was obtained as a yellow oil (66%). 1H NMR (CDCl3): δ 8.05 (dd, J = 8.1, 
1.2 Hz, 2H), 7.59 (t, J = 8.1 Hz, 1H), 7.46 (t, J = 8.1 Hz, 2H), 4.79 (m, 1H), 4.57 (dd, J = 
12.0, 3.3 Hz, 1H), 4.37 (dd, J = 12.0, 6.3 Hz, 1H), 2.22 (dd, J = 12.9, 6.3 Hz, 1H), 1.95 







Product 108 was obtained as a yellow oil (65%, 13:1 dr). 1H NMR (CDCl3): δ 8.03 (d, J 
= 7.5 Hz, 2H), 7.61 (t, J = 8.0 Hz, 1H), 7.47 (t, J = 8.0 Hz, 2H), 5.37 (dt, J = 7.5, 2.0 Hz, 
1H), 4.58 (td, J = 7.0, 2.0 Hz, 1H), 3.04 (dd, J = 20.0, 7.5 Hz, 1H), 2.72 (dd, J = 20.0, 2.0 







Product 110 was obtained as a yellow oil (56%, 9:1 dr). 1H NMR (CDCl3): δ 8.02 (dd, J 
= 8.0, 1.5 Hz, 2H), 7.61 (t, J = 7.5 Hz, 1H), 7.50-7.46 (multiple peaks, 2H), 5.74 (t, J = 
5.0 Hz, 1H), 4.57 (m, 1H), 3.02 (dd, J = 8.5, 5.5 Hz, 1H), 2.73 (d, J = 18.5 Hz, 1H), 1.95 









Product 112 was obtained as a yellow oil (48%, >50:1 dr). 1H NMR (CDCl3): δ 8.08 (dd, 
J = 8.4, 1.6 Hz, 2H), 7.64 (t, J = 7.2 Hz, 1H), 7.52-7.38 (multiple peaks, 8H), 5.75 (br s, 
1H), 5.54 (dt, J = 6.4, 1.5 Hz, 1H), 3.01 (dd, J = 18.4, 6.4 Hz, 1H), 2.78 (dd, J = 18.4, 
1.5, 1H). 
 
Typical Procedure for Formation of Amino-Tetrahydrofurans: Phthalimide 
(100 mg, 0.68 mmol, 1 equiv), PhI(OAc)2 (0.440 g, 1.36 mmol, 2 equiv), AgBF4 (13 mg, 
0.068 mmol, 0.10 equiv), and Pd(OAc)2 (8 mg, 0.034 mmol, 0.05 equiv) were combined 
in CH3CN (1.4 mL) in a 20 mL vial. 3-Buten-1-ol (98 mg, 1.36 mmol, 2.0 equiv) was 
added to the reaction, the vial was sealed with a Teflon-lined cap, and the reaction was 
heated at 60 ºC for 1 h. The reaction was cooled to room temperature and additional 
PhI(OAc)2 (0.22 g, 0.68 mmol, 1.0 equiv) along with a solution of Pd(OAc)2 (8 mg, 
0.034 mmol, 0.05 equiv) and AgBF4 (13 mg, 0.068 mmol, 0.10 equiv) in CH3CN (0.4 
mL) was added to the reaction. Another equivalent of the alcohol (49 mg, 0.68 mmol) 
was also added, and the reaction was heated at 60 ºC for an additional 8 h. The resulting 
mixture was evaporated to dryness and then taken up in diethyl ether (10 mL). The ether 
layer washed with 10% aqueous Et3N (10 mL), H2O (2 x 20 mL), saturated aqueous 
NaHCO3 (20 mL), and saturated aqueous NaCl (20 mL). The ether extracts were dried 
over MgSO4, filtered, and concentrated to afford a red oil, which was purified by 






Product 61 was obtained as a yellow viscous oil (Rf = 0.22 in 50% hexanes/50% ethyl 
acetate). 1H NMR (CDCl3): δ 7.85 (dd, J = 5.6, 3.1 Hz, 2H), 7.74 (dd, J = 5.3, 3.1 Hz, 
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2H), 4.70 (m, 1H), 4.59 (dd, J = 11.2, 9.3 Hz, 1H), 4.46 (dd, J = 11.2, 4.9 Hz, 1H), 3.71 
(m, 1H), 3.59 (m, 1H), 2.26 (m, 1H), 2.03 (m, 1H), 1.98 (s, 3H), 1.74 (br s, 1H). 13C {1H} 
NMR (CDCl3): δ 170.63, 168.61, 134.16, 131.67, 123.39, 63.51, 59.12, 47.77, 31.42, 






The second addition of catalyst, oxidant, and alcohol was after 1 h. Product 62 was 
isolated as a white solid (66 mg, 45% yield, Rf = 0.10 in 70% hexanes/30% ethyl 
acetate). mp = 81.4-84.6  oC. 1H NMR (CDCl3): δ 7.83 (dd, J = 5.5, 3.1 Hz, 2H), 7.71 
(dd, J = 5.4, 3.1 Hz, 2H), 4.91 (m, 1H), 4.22 (q, J = 8.4 Hz, 1H), 4.04 (t, J = 8.7 Hz, 1H), 
3.98 (td, J = 8.4, 5.2 Hz, 1H), 3.91 (dd, J = 8.8, 6.9 Hz, 1H), 2.39 (m, 1H), 2.25 (m, 1H). 
13C {1H} NMR (CDCl3): δ 167.99, 134.05, 131.77, 123.21, 69.40, 68.34, 49.55, 29.72. IR 







1. 5 % PdCl2(CH3CN)2 
Phthalimide





3-Buten-1-ol was treated with acetic anhydride in pyridine to protect the alcohol 
functionality. This alkene was then treated with phthalimide and Pd(OAc)2 in PhCN 
under an oxygen atmosphere at 60 oC for 24 h.8 The resulting product was deprotected 
with K2CO3 in MeOH to afford an authentic sample of 64. Product 64 was obtained as a 
pale yellow viscous oil (Rf = 0.15 in 65% hexanes/35% ethyl acetate). 1H NMR (CDCl3): 
δ 7.89 (dd, J = 5.2, 3.3 Hz, 2H), 7.77 (dd, J = 5.3, 3.1 Hz, 2H), 5.58 (s, 1H), 5.30 (s, 1H), 
3.66 (t, J = 5.8 Hz, 2H), 2.68 (t, J = 5.8 Hz, 2H), 2.22 (br s, 1H). 13C {1H} NMR (CDCl3): 






1H NMR (CDCl3): δ 7.37-7.34 (multiple peaks, 2H), 7.31-7.27 (multiple peaks, 3H), 4.42 
(dd, J = 9.0, 6.0 Hz, 1H), 4.24 (t, J = 8.0 Hz, 1H), 4.17 (q, J = 8.0 Hz, 1H), 4.10 (dd, J = 
9.0, 8.0 Hz, 1H), 3.92 (dd,  J = 9.0, 7.0 Hz, 1H), 3.63 (q, J = 8.0 Hz, 1H). 13C {1H} NMR 






The second addition of catalyst, oxidant, and alcohol was after 10 h. The product was 
obtained as a 10:1 ratio of diastereomers (154 mg, 77% yield, Rf = 0.12 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(126): white solid, mp = 105.4-108.2 oC. 1H NMR (CDCl3): δ 7.82 (dd, J = 5.4, 3.1 Hz, 
2H), 7.71 (dd, J = 5.4, 3.1 Hz, 2H), 7.32-7.27 (multiple peaks, 4H), 7.22 (m, 1H), 5.07 (q, 
J = 8.3 Hz, 1H), 4.51 (dd, J = 8.6, 7.9 Hz, 1H), 4.26-4.17 (multiple peaks, 3H), 3.96 (dd, 
J = 8.7, 7.7 Hz, 1H). 13C {1H} NMR (CDCl3): δ 167.94, 139.58, 134.15, 131.69, 128.88, 
127.37, 127.19, 123.37, 75.04, 68.94, 56.95, 47.29. IR (thin film): 1713 cm–1. HRMS 
(ESI, m/z): [M + Na]+ calcd for C18H15NO3, 316.0950; found, 316.0948. Minor 
diastereomer: 1H NMR (CDCl3): δ 7.66 (dd, J = 5.4, 3.1 Hz, 2H), 7.61 (dd, J = 5.5, 3.2 
Hz, 2H), 7.14-7.08 (multiple peaks, 4H), 7.02 (m, 1H), 5.24 (td, J = 8.8, 5.3 Hz, 1H), 
4.63 (dd, J = 10.0, 8.3 1H), 4.57 (dd, J = 9.5, 5.3, 1H), 4.37-4.32 (multiple peaks, 2H), 
3.80 (q, J = 9.4, 1H). 13C {1H} NMR (CDCl3): δ 168.22, 135.43, 133.88, 131.18, 128.33, 
128.19, 126.96, 122.99, 71.37, 68.93, 54.00, 48.86.  
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Structure Determination of 126. 
 Colorless, needle-like crystals of 126 were grown by diffusion of pentane into a 
chlorobenzene solution at 22 deg. C.  A crystal of dimensions 0.48 x 0.13 x 0.12 mm was 
mounted on a standard Bruker SMART 1K 
CCD-based X-ray diffractometer equipped 
with a LT-2 low temperature device and 
normal focus Mo-target X-ray tube (λ = 
0.71073 A) operated at 2000 W power (50 
kV, 40 mA).  The X-ray intensities were 
measured at 108(2) K; the detector was 
placed at a distance 4.969 cm from the 
crystal.  A total of 2450 frames were collected 
with a scan width of 0.5° in ω and 0.45° in 
phi with an exposure time of 30 s/frame.  The 
integration of the data yielded a total of 28419 
reflections to a maximum 2θ value of 56.60° 
of which 2053 were independent and 1780 were greater than 2σ(I).  The final cell 
constants (Table 1) were based on the xyz centroids of 7712 reflections above 10σ(I).  
Analysis of the data showed negligible decay during data collection; the data were 
processed with SADABS and corrected for absorption.  The structure was solved and 
refined with the Bruker SHELXTL (version 6.12) software package, using the space 
group P2(1)2(1)2(1) with Z = 4 for the formula C18H15NO3.  All non-hydrogen atoms 
were refined anisotropically with the hydrogen atoms placed in idealized positions.  Full 
matrix least-squares refinement based on F2 converged at R1 = 0.0297 and wR2 = 0.0689 
[based on I > 2sigma(I)], R1 = 0.0402 and wR2 = 0.0742 for all data.   
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of 
Area Detector Data, University of Gottingen: Gottingen, Germany, 2003.   








The second addition of catalyst, oxidant, and alcohol was after 30 min. The product was 
obtained as a 15:1 ratio of diastereomers (136 mg, 62% yield, Rf = 0.08 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(127): white solid, mp = 129.2-130.8 oC. 1H NMR (CDCl3): δ 7.81 (dd, J = 5.4, 3.1 Hz, 
2H), 7.70 (dd, J = 5.5, 3.1 Hz, 2H), 7.20 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 
5.02 (q, J = 8.4 Hz, 1H), 4.46 (t, J = 8.0 Hz, 1H), 4.23-4.14 (multiple peaks, 3H), 3.90 
(dd, J = 8.7, 8.1 Hz, 1H), 3.75 (s, 3H). 13C {1H} NMR (CDCl3): δ 167.91, 158.65, 
134.08, 131.65, 131.11, 128.36, 123.30, 114.23, 74.98, 68.71, 56.97, 55.18, 46.42. IR 
(thin film): 1712 cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for C19H17NO4, 346.1055; 
found, 346.1051. Minor diastereomer: 1H NMR (CDCl3): δ 7.68 (dd, J = 5.0, 3.3 Hz, 
2H), 7.62 (dd, J = 5.1, 3.2 Hz, 2H), 7.04 (d, J = 8.8 Hz, 2H), 6.64 (d, J = 8.7 Hz, 2H), 
5.18 (td, J = 8.7, 5.2 Hz, 1H), 4.59-4.53 (multiple peaks, 2H), 4.36-4.29 (multiple peaks, 
2H), 3.76 (m, 1H), 3.63 (s, 3H). 13C {1H} NMR (CDCl3): δ 168.31, 158.31, 133.91, 







The second addition of catalyst, oxidant, and alcohol was after 3.5 h. The product was 
obtained as a 5.4:1 ratio of diastereomers (121 mg, 55% yield, Rf = 0.07 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(128): white solid, mp = 95.8-100.8 oC. 1H NMR (CDCl3): δ 7.81 (dd, J = 5.4, 3.1 Hz, 
2H), 7.70 (dd, J = 5.6, 3.1 Hz, 2H), 7.21 (t, J = 7.8 Hz, 1H), 6.87 (d, J = 7.7 Hz, 1H), 
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6.82 (t, J = 2.2 Hz, 1H), 6.76 (dd, J = 8.2, 2.6 Hz, 1H), 5.07 (q, J = 8.3 Hz, 1H), 4.49 (t, J 
= 8.2 Hz, 1H), 4.25-4.14 (multiple peaks, 3H), 3.95 (dd, J = 8.6, 7.7 Hz, 1H), 3.77 (s, 
3H). 13C {1H} NMR (CDCl3): δ 167.88, 159.86, 141.25, 134.11, 131.66, 129.85, 123.32, 
119.56, 113.08, 112.43, 74.91, 68.88, 56.76, 55.14, 47.26. IR (thin film): 1712 cm–1. 
HRMS (ESI, m/z): [M + Na]+ calcd for C19H17NO4, 346.1055; found, 346.1056. Minor 
diastereomer: 1H NMR (CDCl3): δ 7.81 (dd, J = 5.4, 3.1 Hz, 2H), 7.70 (dd, J = 5.6, 3.1 
Hz, 2H), 7.22-7.19 (multiple peaks, 2H), 6.84-6.82 (multiple peaks, 2H), 5.02 (q, J = 8.4 
Hz, 1H), 4.46 (t, J = 8.3 Hz, 1H), 4.18-4.13 (multiple peaks, 3H), 3.90 (t, J = 8.4 Hz, 1H), 
3.75 (s, 3H). 13C {1H} NMR (CDCl3): δ 167.93, 158.65, 141.25, 134.13, 131.11, 128.37, 
123.31, 119.57, 114.23, 74.99, 68.72, 56.97, 55.19, 46.43. The minor diastereomer was 
isolated in a mixture with the major diastereomer (128); one 13C resonance of this 







The second addition of catalyst, oxidant, and alcohol was after 3 h. The product was 
obtained as a 7.8:1 ratio of diastereomers (139 mg, 63% yield, Rf = 0.09 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm).  Major diastereomer 
(129): white solid, mp = 115.8-120.7 oC. 1H NMR (CDCl3): δ 7.82 (dd, J = 5.6, 3.0 Hz, 
2H), 7.70 (dd, J = 5.4, 3.0 Hz, 2H), 7.31 (d, J = 7.6 Hz, 1H), 7.19 (t, J = 8.1 Hz, 1H), 
6.91 (t, J = 8.3 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 5.14 (q, J = 8.1 Hz, 1H), 4.51 (t, J = 8.2 
Hz, 1H), 4.44 (q, J = 7.6 Hz, 1H), 4.21 (d, J = 8.3 Hz, 2H), 4.01 (t, J = 8.4 Hz, 1H), 3.67 
(s, 3H). 13C {1H} NMR (CDCl3): δ 167.99, 157.56, 133.97, 131.80, 128.03, 127.66, 
127.18, 123.19, 120.75, 110.42, 72.94, 68.93, 55.18, 55.17, 41.97. IR (thin film): 1712 
cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for C19H17NO4, 346.1055; found, 346.1054. 
Minor diastereomer: 1H NMR (CDCl3): δ 7.64 (dd, J = 5.3, 3.1 Hz, 2H), 7.59 (dd, J = 
5.6, 3.1 Hz, 2H), 7.12 (d, J = 8.5 Hz, 1H), 7.02 (t, J = 8.1 Hz, 1H), 6.73 (t, J = 7.8 Hz, 
1H), 6.62 (d, J = 8.2 Hz, 1H), 5.41 (q, J = 8.1 Hz, 1H), 4.75 (dd, J = 10.6, 8.0 Hz, 1H), 
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4.36-4.35 (multiple peaks, 2H), 4.29 (t, J = 7.3 Hz, 1H), 3.96 (q, J = 9.3 Hz, 1H), 3.70 (s, 
3H). 13C {1H} NMR (CDCl3): δ 167.78, 157.06, 133.61, 131.24, 127.91, 127.86, 123.68, 







The second addition of catalyst, oxidant, and alcohol was after 4.5 h. The product 130 
was obtained as white solid as a single diastereomer (133 mg, 54% yield, Rf = 0.18 in 
70% hexanes/30% ethyl acetate). mp = 87.1-89.4 oC. 1H NMR (CDCl3): δ 7.83 (dd, J = 
5.6, 3.3 Hz, 2H), 7.73 (dd, J = 5.5, 3.3 Hz, 2H), 7.56 (d, J = 8.1 Hz, 2H), 7.41 (d, J = 8.5 
Hz, 2H), 5.04 (q, J = 8.2 Hz, 1H), 4.53 (dd, J = 8.6, 8.0 Hz, 1H), 4.28-4.17 (multiple 
peaks, 3H), 3.97 (dd, J = 8.8, 6.9 Hz, 1H). 13C {1H} NMR (CDCl3): δ 167.83, 144.29, 
134.30, 131.57, 129.47 (q, 2JC-F = 32.3 Hz), 127.70, 125.86 (q, 3JC-F = 3.9 Hz), 124.01 (q, 
1JC-F = 271 Hz), 123.46, 74.85, 68.97, 56.98, 47.37. 19F NMR (CDCl3): δ –62.59. IR (thin 








The second addition of catalyst, oxidant and alcohol was after 12 h. The product was 
obtained as a 16:1 ratio of diastereomers (147 mg, 60% yield, Rf = 0.17 in 70% 
hexanes/20% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(131): white solid, mp = 117.9-120.7 oC. 1H NMR (CDCl3): δ 7.83 (dd, J = 5.3, 3.0 Hz, 
2H), 7.72 (dd, J = 5.3, 3.0 Hz, 2H), 7.51-7.41 (multiple peaks, 4H), 5.03 (q, J = 8.2 Hz, 
1H), 4.54 (q, J = 8.4 Hz, 1H), 4.27 (t, J = 8.4 Hz, 1H), 4.22-4.16 (multiple peaks, 2H), 
3.97 (dd, J = 8.8, 6.7 Hz, 1H). 13C {1H} NMR (CDCl3): δ 167.83, 141.45, 134.27, 
131.59, 131.14 (q, 2JC-F = 32.2 Hz), 130.55 (q, 4JC–F = 1.3 Hz), 129.46, 123.92 (q, 1JC-F = 
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272.6 Hz), 124.30 (q, 1JC-F = 3.7 Hz), 124.10 (q, 1JC-F = 3.7 Hz), 123.45, 75.00, 69.05, 
57.11, 47.46. 19F NMR (CDCl3): δ –62.64. IR (thin film): 1713 cm–1. HRMS (ESI, m/z): 
[M + Na]+ calcd for C19H14NO3F3, 384.0823; found, 384.0824. Minor diastereomer: 1H 
NMR (CDCl3): δ 7.67 (dd, J = 5.6, 3.1 Hz, 2H), 7.63 (dd, J = 5.5, 3.3 Hz, 2H), 7.37-7.35 
(multiple peaks, 2H), 7.30-7.24 (multiple peaks, 2H), 5.26 (m, 1H), 4.64-4.60 (multiple 
peaks, 2H), 4.38-4.33 (multiple peaks, 2H), 3.84 (q, J = 9.6 Hz, 1H). 13C {1H} NMR 
(CDCl3): δ 168.14, 147.00, 136.86, 134.08, 131.91, 131.01, 128.72, 125.13 (q, 3JC-F = 3.8 








The second addition of catalyst, oxidant, and alcohol was after 12 h. The product 132 was 
obtained as a white solid as a single diastereomer (142 mg, 56% yield, Rf = 0.19 in 70% 
hexanes/30% ethyl acetate). mp = 40.7-45.3 oC. 1H NMR (CDCl3): δ 7.82 (dd, J = 5.3, 
3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.1 Hz, 2H), 7.41 (d, J = 8.3 Hz, 2H), 7.15 (d, J = 8.3 Hz, 
2H), 4.99 (q, J = 8.2 Hz, 1H), 4.48 (t, J = 8.35 Hz, 1H), 4.24-4.10 (multiple peaks, 3H), 
3.92 (dd, J = 8.7, 7.4 Hz, 1H). 13C {1H} NMR (CDCl3): δ 167.84, 138.85, 134.21, 
131.86, 131.58, 129.06, 123.40, 121.02, 74.78, 68.81, 56.96, 46.89. IR (thin film): 1713 






The second addition of catalyst, oxidant, and alcohol was after 3 h. The product was 
obtained as a 12:1 ratio of diastereomers (187 mg, 80% yield, Rf = 0.20 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(133): white solid, mp = 105.6-108.6 oC. 1H NMR (CDCl3): δ 7.83-7.75 (multiple peaks, 
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5H), 7.71-7.68 (multiple peaks, 3H), 7.46-7.42 (multiple peaks, 3H), 5.18 (q, J = 8.3 Hz, 
1H), 4.58 (dd, J = 8.6, 8.0 Hz, 1H), 4.37 (q, J = 7.8 Hz, 1H), 4.32-4.23 (multiple peaks, 
2H), 4.07 (dd, J = 8.7, 7.4 Hz, 1H). 13C {1H} NMR (CDCl3): δ 167.92, 137.02, 134.12, 
133.38, 132.55, 131.66, 128.83, 127.62, 127.60, 126.33, 126.21, 125.77, 125.16, 123.35, 
75.01, 68.97, 57.01, 47.50. IR (thin film): 1711 cm–1. HRMS (ESI, m/z): [M + Na]+ calcd 
for C22H17NO3, 366.1106; found, 366.1103. Minor diastereomer: 1H NMR (CDCl3): δ 
8.05 (d, J = 9.3 Hz, 1H), 7.80 (dd, J = 5.5, 3.1 Hz, 2H), 7.74 (d, J = 8.2 Hz, 1H), 7.69 
(dd, J = 5.5, 3.1 Hz, 2H), 7.65 (d, J = 6.8 Hz, 1H), 7.49-7.44 (multiple peaks, 4H), 5.38 
(q, J = 8.4 Hz, 1H), 5.09 (q, J = 8.0 Hz, 1H), 4.73 (dd, J = 8.7, 8.1, 1H), 4.33 (d, J = 8.3 
Hz, 2H), 4.00 (dd, J = 8.8, 7.4 Hz, 1H). 13C {1H} NMR (CDCl3): δ 168.05, 135.37, 
134.15, 133.91, 132.16, 131.64, 128.92, 127.65, 126.34, 125.75, 125.70, 123.37, 123.20, 






The second addition of catalyst, oxidant, and alcohol was after 2.5 h. The product was 
obtained as a 1.4:1 mixture of diastereomers (164 mg, 72% yield, Rf = 0.24 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
(134): white solid, mp = 111.3-115.3 oC. 1H NMR (CDCl3): δ 7.81 (dd, J = 5.3, 3.1 Hz, 
2H), 7.70 (dd, J = 5.4, 3.1 Hz, 2H), 6.79 (s, 2H), 5.37 (q, J = 9.5 Hz, 1H), 4.83 (q, J = 9.5 
Hz, 1H), 4.42 (t, J = 9.8 Hz, 1H), 4.25 (d, J = 7.6 Hz, 2H), 4.11 (t, J = 8.6 Hz, 1H), 2.36 
(s, 6H), 2.19 (s, 3H). 13C {1H} NMR (CDCl3): δ 168.06, 137.02, 136.02, 134.09, 131.95, 
131.61, 130.28, 123.30, 72.12, 68.68, 54.89, 41.08, 20.91, 20.61. IR (thin film): 1714 cm-
1. HRMS (ESI, m/z): [M + Na]+ calcd for C21H21NO3, 358.1419; found, 358.1414. Minor 
diastereomer: white solid, mp = 130.6-134.2 oC. 1H NMR (CDCl3): δ 7.68 (dd, J = 5.4, 
3.0 Hz, 2H), 7.62 (dd, J = 5.5, 3.0 Hz, 2H), 6.64 (s, 2H), 5.33 (td, J = 8.4, 4.6 Hz, 1H), 
4.89 (dd, J = 9.7, 8.3 Hz, 1H), 4.61 (dd, J = 9.6, 4.5 Hz, 1H), 4.29-4.20 (multiple peaks, 
2H), 3.99 (q, J = 9.2 Hz, 1H), 2.35 (s, 3H), 2.07 (s, 6H). 13C{1H} NMR (CDCl3): δ 
 213 
168.06, 137.85, 135.95, 133.83, 131.30, 130.18, 129.03, 122.99, 70.86, 67.93, 53.06, 
48.13, 21.91, 20.41. IR (thin film): 1710 cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for 






Five reactions, each carried out on a 20 mg scale with respect to phthalimide, were 
combined for this substrate. The product was obtained as 1.4:1 mixture of diastereomers 
(47 mg, 30% yield, Rf = 0.28 in 70% hexanes/30% ethyl acetate). The diastereomers were 
separated by HPLC (90% hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 
mm).  Major diastereomer (135): viscous oil. 1H NMR (CDCl3): δ 7.84 (dd, J = 5.6, 3.1 
Hz, 2H), 7.73 (dd, J = 5.6, 3.1 Hz, 2H), 4.92 (td, J = 8.6, 5.2 Hz, 1H), 4.32 (dd, J = 9.5, 
5.1 Hz, 1H), 4.21 (dd, J = 9.5, 8.4 Hz, 1H), 4.08 (t, J = 7.8 Hz, 1H), 3.80 (dd, J = 10.1, 
8.1 Hz, 1H), 2.58 (m, 1H), 0.88 (d, J = 7.0 Hz, 3H). 13C{1H} NMR (CDCl3): δ 168.64, 
134.12, 131.55, 123.29, 74.56, 69.15, 53.19, 37.56, 10.53. IR (thin film): 1713 cm–1. 
Minor diastereomer: white solid, mp = 85.9-87.9 oC. 1H NMR (CDCl3): δ 7.84 (dd, J = 
5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.6, 3.0 Hz, 2H), 4.47 (q, J = 7.6 Hz, 1H), 4.28 (t, J = 8.1 
Hz, 1H), 4.10-4.02 (multiple peaks, 2H), 3.51 (t, J = 7.4 Hz, 1H), 2.92 (m, 1H), 1.09 (d, J 
= 6.8 Hz, 3H). 13C {1H} NMR (CDCl3): δ 168.08, 134.08, 131.75, 123.26, 74.85, 68.57, 
57.22, 36.83, 16.32. IR (thin film): 1713 cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for 






The second addition of catalyst, oxidant, and alcohol was after 5 h. The product was 
obtained as 1.5:1 mixture of diastereomers (56 mg, 27% yield, Rf = 0.25 in 70% 
hexanes/30% ethyl acetate). The diastereomers were separated by HPLC (90% 
hexanes/10% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Major diastereomer 
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(136): off-white viscous oil. 1H NMR (CDCl3): δ 7.74 (dd, J = 5.5, 3.1 Hz, 2H), 7.68 (dd, 
J = 5.4, 3.1 Hz, 2H), 7.12-7.08 (multiple peaks, 4H), 6.95 (m, 1H), 4.62 (q, J = 8.3 Hz, 
1H), 4.25 (dd, J = 8.6, 7.6 Hz, 1H), 4.08-4.00 (multiple peaks, 2H), 3.68 (dd, J = 8.76, 
7.35 Hz, 1H), 3.34 (m, 1H), 2.84 (dd, J = 13.8, 7.6 Hz, 1H), 2.72 (dd, J = 13.79, 7.9, 1H). 
13C {1H} NMR (CDCl3): δ 167.84, 138.89, 133.91, 131.61, 128.53, 128.32, 126.05, 
123.06, 72.98, 68.74, 55.26, 42.28, 37.98. IR (thin film): 1712 cm–1. HRMS (ESI, m/z): 
[M + Na]+ calcd for C19H17NO3, 330.1106; found, 330.1100.  Minor diastereomer: white 
solid, mp = 81.1-84.8 oC. 1H NMR (CDCl3): δ 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.74 (dd, J 
= 5.5, 3.1 Hz, 2H), 7.19-7.10 (multiple peaks, 3H), 7.05-7.03 (multiple peaks, 2H), 5.01 
(td, J = 8.8, 5.5 Hz, 1H), 4.33 (dd, J = 9.4, 5.5 Hz, 1H), 4.23 (dd, J = 9.4, 8.5 Hz, 1H), 
4.05-3.98 (multiple peaks, 2H), 2.86 (m, 1H), 2.67 (dd, J = 13.9, 6.2 Hz, 1H), 2.56 (dd, J 
= 13.8, 9.7 Hz, 1H). 13C{1H} NMR (CDCl3): δ 168.53, 139.40, 134.18, 131.58, 128.47, 
128.22, 126.21, 123.34, 73.36, 69.50, 52.00, 44.16, 32.99. IR (thin film): 1712 cm–1. 






The second addition of catalyst, oxidant, and alcohol was after 1 h. The product 138 was 
obtained as a white solid (78 mg, 47% yield, Rf = 0.20 in 70% hexanes/30% ethyl 
acetate). mp = 93.8-94.6 oC. 1H NMR (CDCl3): δ 7.82 (dd, J = 5.4, 3.1 Hz, 2H), 7.71 (dd, 
J = 5.4, 3.1 Hz, 2H), 4.99 (m, 1H), 4.20 (t, J = 9.2 Hz, 1H), 4.04 (t, J = 8.3 Hz, 1H), 2.45 
(dd, J = 12.1, 9.6 Hz, 1H), 2.06 (dd, J = 12.1, 9.4 Hz, 1H), 1.48 (s, 3H), 1.31 (s, 3H). 13C 
{1H} NMR (CDCl3): δ 168.06, 134.06, 131.79, 123.21, 81.14, 66.86, 50.15, 40.40, 28.26, 
28.15. IR (thin film): 1710 cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for C14H15NO3, 







The product 158 was obtained as a yellow oil. 1H NMR (CDCl3): δ 7.88-7.83 (multiple 
peaks, 4H), 7.73-7.72 (multiple peaks, 4H), 7.23 (t, J = 7.5 Hz, 2H), 7.18 (t, J = 7.5 Hz, 
2H), 6.93-6.84 (multiple peaks, 4 H), 6.70 (d, J = 8.5 Hz, 2H), 4.81-4.78 (multiple peaks, 
2H), 4.50 (dd, J = 9.5, 4.5 Hz, 1H), 4.22 (d, J = 6.0 Hz, 1H), 4.17-4.09 (multiple peaks, 
2H), 3.99 (m, 1H), 3.95 (m, 1H), 2.61 (m, 1H), 2.52 (m, 1H), 2.25 (m, 2H), 1.98 (s, 3H), 





The product 159 was obtained as a white solid (78 mg, 47% yield, Rf = 0.20 in 70% 
hexanes/30% ethyl acetate). mp = 93.8-94.6 oC. 1H NMR (CDCl3): δ 7.88 (dd, J = 5.0, 
2.5 Hz, 4H), 7.75 (dd, J = 5.0, 3.0 Hz, 4H), 7.19 (t, J = 7.5 Hz, 4H), 6.88 (t, J = 7.5 Hz, 
2H), 6.72 (d, J = 8.0 Hz, 4H), 5.51 (s, 1H), 5.28 (s, 1H), 4.11 (t, J = 6.0 Hz, 4H), 2.98 (t, 






The second addition of catalyst, oxidant, and alcohol was after 7.5 h. The product 160 
was obtained as a white solid as a single diastereomer (120 mg, 60% yield, Rf = 0.12 in 
70% hexanes/30% ethyl acetate). mp = 125.6-128.4 oC. 1H NMR (CDCl3): δ 7.83 (dd, J = 
5.5, 3.0 Hz, 2H), 7.72 (dd, J = 5.5, 3.5 Hz, 2H), 7.34-7.25 (multiple peaks, 5H), 5.23 (d, J 
= 8.0 Hz, 1H), 4.76 (m, 1H), 4.40 (q, J = 8.5 Hz, 1H), 4.29 (td, J = 8.0, 5.0 Hz, 1H), 2.59 
(m, 1H), 2.41 (m, 1H). 13C {1H} NMR (CDCl3): δ 167.94, 139.31, 134.14, 131.71, 
128.56, 128.09, 126.01, 123.36, 80.68, 67.82, 56.82, 29.58. IR (thin film): 1712 cm–1. 
HRMS (ESI, m/z): [M + Na]+ calcd for C18H15NO3, 316.095; found, 316.0941.   
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Structure Determination of 160. 
 Colorless, needle-like crystals of 160 were grown by diffusion of pentane into a 
dichloromethane solution at 22 deg. C.  A crystal of dimensions 0.40 x 0.08 x 0.04 mm 
was mounted on a standard Bruker SMART 1K 
CCD-based X-ray diffractometer equipped with a 
LT-2 low temperature device and normal focus Mo-
target X-ray tube (λ = 0.71073 A) operated at 2000 
W power (50 kV, 40 mA).  The X-ray intensities 
were measured at 108(2) K; the detector was placed 
at a distance 4.969 cm from the crystal.  A total of 
2640 frames were collected with a scan width of 0.6° 
in ω and 0.45° in phi with an exposure time of 75 
s/frame.  The integration of the data yielded a total of 
10058 reflections to a maximum 2θ value of 45.32° 
of which 1947 were independent and 1198 were 
greater than 2σ(I).  The final cell constants (Table 1) 
were based on the xyz centroids of 2032 reflections above 10σ(I).  Analysis of the data 
showed negligible decay during data collection; the data were processed with SADABS 
and corrected for absorption.  The structure was solved and refined with the Bruker 
SHELXTL (version 6.12) software package, using the space group P1bar with Z = 2 for 
the formula C15H18NO3.  All non-hydrogen atoms were refined anisotropically with the 
hydrogen atoms placed in idealized positions.  Full matrix least-squares refinement based 
on F2 converged at R1 = 0.0546 and wR2 = 0.1212 [based on I > 2sigma(I)], R1 = 0.1094 
and wR2 = 0.1415 for all data.   
Sheldrick, G.M. SHELXTL, v. 6.12; Bruker Analytical X-ray, Madison, WI, 2001. 
Sheldrick, G.M. SADABS, v. 2.10.  Program for Empirical Absorption Correction of 
Area Detector Data, University of Gottingen: Gottingen, Germany, 2003.   







Phthalimide (100 mg, 0.68 mmol, 1 equiv), AgBF4 (13 mg, 0.07 mmol, 0.10 equiv), and 
Pd(OAc)2 (8 mg, 0.034 mmol, 0.05 equiv) were combined in CH3CN (1.4 mL) in a 20 
mL vial.  cis-1-Phenyl-buten-4-ol (0.202 g, 1.36 mmol, 2.0 equiv) was added to the 
reaction. The vial was purged with O2 and sealed with a Teflon-lined cap, and the 
reaction was heated at 60 oC for 12 h. The resulting mixture was cooled to room 
temperature and evaporated to dryness, then taken up in ether (10 mL). The ether layer 
washed with 10% aqueous Et3N (10 mL), H2O (2 x 20 mL), saturated aqueous NaHCO3 
(20 mL), and saturated aqueous NaCl (20 mL). The ether layer was then dried over 
MgSO4, filtered, and concentrated to afford a red oil, which was purified by 
chromatography on silica gel. The product Z-163 was obtained as a major isomer (>10:1 
as determined by HPLC analysis of the crude reaction mixture), (6 mg, 3% yield, Rf = 
0.21 in 55% hexanes/45% ethyl acetate). An authentic sample of the E-isomer (165) was 
obtained by repeating the reaction above in DCE without AgBF4. These conditions led to 
a 2:1 mixture of the Z and E-isomers, which could be separated by HPLC (65% 
hexanes/35% ethyl acetate, 20 mL/min, Waters µ-porasil 19.1 mm). Z-isomer (163): 
viscous oil. 1H NMR (CDCl3): δ 7.85 (dd, J = 5.3, 3.6 Hz, 2H), 7.75 (dd, J = 5.3, 3.6 Hz, 
2H), 7.20-7.15 (multiple peaks, 5H), 6.94 (s, 1H), 3.69 (t, J = 5.1 Hz, 2H), 2.73 (t, J = 5.5 
Hz, 2H), 2.56 (br s, 1H). 13C {1H} NMR (CDCl3): δ 167.79, 134.45, 134.43, 134.32, 
131.69, 128.55, 127.95, 127.50, 127.42, 123.86, 58.85, 39.62. IR (thin film): 3461, 1712 
cm–1. HRMS (ESI, m/z): [M + Na]+ calcd for C18H15NO3, 316.0950; found, 317.0977. E-
isomer (165):  1H NMR (CDCl3): δ 7.92 (dd, J = 5.6, 3.1 Hz, 2H), 7.79 (dd, J = 5.6, 3.1 
Hz, 2H), 7.53 (d, J = 7.5 Hz, 2H), 7.39 (t, J = 7.3 Hz, 2H), 7.38 (d, J = 7.2 Hz, 1H), 6.78 
(s, 1H), 3.71 (t, J = 5.4 Hz, 2H), 2.86 (t, J = 5.7 Hz, 2H), 2.55 (br s, 1H). 
 
Discussion of low yield of 163. 1H NMR studies (with 1,3,5-trimethoxybenzene as an 
internal standard) were carried out in order to determine the reasons for the low yield of 
163 in these transformations. The low yield of 163 appears to be due to several factors. 
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First, in all of these reactions, the precipitation of Pd black was observed almost 
immediately (approximately 2 min) after heating was commenced, suggesting that 
catalyst decomposition is extremely fast (and/or reoxidation of Pd(0) to Pd(II) is very 
slow) under these conditions). Second, the cis-starting material 155 exhibited low 
reactivity under these conditions, and significant quantities of unreacted 155 are 
recovered. In addition, significant isomerization of 155 to the corresponding trans isomer 
(which is unreactive towards aminopalladation) was observed, particularly at higher 
catalyst loadings. Finally, 1H NMR spectroscopy of the crude mixture showed the 
presence of a significant quantity of a resonance at 10.03 ppm, consistent with an 
aldehyde functionality. This suggests that one mode of catalyst decomposition under 
these conditions likely involves oxidation of the alcohol substrate with concomitant 




The product 171 was obtained as a yellow oil (10% yield). 1H NMR (CDCl3): δ 7.76 (m, 
2H), 7.67 (m, 2H), 7.42-7.26 (multiple peaks, 5H), 5.53 (br s, 1H), 5.27 (br s, 1H), 3.83 





The product 172 was obtained as a viscous oil (25% yield, 4.5:1). Major Isomer: 1H 
NMR (CDCl3): δ 7.65 (dd, J = 5.5, 3.0 Hz, 2H), 7.59 (dd, J = 5.5, 3.0 Hz, 2H), 7.12-7.08 
(m, 4H), 7.01 (m, 1H), 4.75 (dd, J = 10.5, 2.5 Hz, 1H), 4.66-4.59 (multiple peaks, 2H),  
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